UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-22883
ARK ETF Trust
(Exact name of registrant as specified in charter)
c/o ARK Investment Management LLC
3 East 28th Street, 7th Floor
New York, NY 10016
(Address of principal executive offices) (Zip code)
Corporation Service Company
2711 Centerville Road
Suite 400
Wilmington, DE 19808
(Name and address of agent for service)
Registrant’s telephone number, including area code: (212) 426-7040
Date of fiscal year end: July 31
Date of reporting period: July 31, 2021
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Item 1. Reports to Stockholders.
| (a) | The Report to Shareholders is attached herewith. |
ARK ETF TRUST
ANNUAL REPORT
JULY 31, 2021
INVESTING AT THE PACE OF INNOVATION
ARK Genomic Revolution ETF (ARKG)
ARK Autonomous Technology & Robotics ETF (ARKQ)
ARK Innovation ETF (ARKK)
ARK Next Generation Internet ETF (ARKW)
ARK Fintech Innovation ETF (ARKF)
ARK Space Exploration & Innovation ETF (ARKX)
The 3D Printing ETF (PRNT)
The ARK Israel Innovative Technology ETF (IZRL)
ARK Invest | 3 E. 28th Street, 7th Floor, New York, NY 10016 | 212.426.7040 | info@ark-invest.com | ark-funds.com
| | | Important Notice | | |
| | | As permitted by regulations adopted by the Securities and Exchange Commission, paper copies of each Fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from the Fund or from your financial intermediary, such as a broker-dealer or bank. Instead, shareholder reports will be made available on http://ark-funds.com/investor-resources, and you will be notified by mail each time a report is posted and provided with a website link to access the report. If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from the Funds electronically anytime by contacting your financial intermediary or, if you are a direct investor, by calling (212) 426-7040. You may elect to receive all future shareholder reports in paper free of charge. If you invest through a financial intermediary, you can contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. If you invest directly with a Fund, you can call (212) 426-7040 to let the Fund know you wish to continue receiving paper copies of your shareholder reports. Your election to receive shareholder reports in paper will apply to all funds held in your account if you invest through your financial intermediary or all funds held with the fund complex if you invest directly with the Funds. | | |
| | | | | | | 1 | | |
| | | | | | | 2 | | |
| | | | | | | 3 | | |
| | | | | | | 5 | | |
| | | | | | | 6 | | |
| | | | | | | 8 | | |
| | | | | | | 10 | | |
| | | | | | | 11 | | |
| | | | | | | 12 | | |
| | | | | | | 13 | | |
| | | | | | | 14 | | |
| | | | | | | 15 | | |
| | Schedule of Investments | | | | | | | |
| | | | | | | 17 | | |
| | | | | | | 20 | | |
| | | | | | | 22 | | |
| | | | | | | 25 | | |
| | | | | | | 27 | | |
| | | | | | | 29 | | |
| | | | | | | 31 | | |
| | | | | | | 33 | | |
| | | | | | | 37 | | |
| | | | | | | 39 | | |
| | | | | | | 41 | | |
| | | | | | | 45 | | |
| | | | | | | 53 | | |
| | | | | | | 59 | | |
| | | | | | | 61 | | |
| | | | | | | 62 | | |
| | | | | | | 63 | | |
| | | | | | | 65 | | |
This report should be read in conjunction with the Trust’s prospectus.
The principal risks of investing in the ARK ETFs include: Market Risk. The value of the Funds’ assets will fluctuate as the markets in which the Funds invest fluctuate. The value of the Funds’ investments may decline, sometimes rapidly and unpredictably, simply because of economic changes or other events, such as inflation (or expectations for inflation), interest rates, global demand for particular products or resources, natural disasters or events, exchange trading suspensions and closures (including exchanges of a Fund’s underlying securities), infectious disease outbreaks or pandemics, terrorism, regulatory events and government controls, that affect large portions of the market. Equity Securities Risk: The value of the equity securities the Funds hold may fall due to general market and economic conditions, perceptions regarding the industries in which the issuers of securities the Funds hold participate or factors relating to specific companies in which the Funds invest (e.g., litigation or government regulation), among other factors. Equity securities may also be particularly sensitive to general movements in the stock market, and a decline in the broader market may affect the value of the Fund’s equity investments. The Funds may invest in stock of, warrants to purchase stock of, and other interests in special purpose acquisition companies (SPACs) or similar special purposes entities. A SPAC is a publicly traded company that raises investment capital for the purpose of acquiring or merging with an existing company. Investments in SPACs and similar entities are subject to a variety of risks beyond those associated with other equity securities. Because SPACs and similar entities do not have any operating history or ongoing business other than seeking acquisitions, the value of their securities is particularly dependent on the ability of the SPAC’s management to identify a merger target and complete an acquisition. Until an acquisition or merger is completed, a SPAC generally invests its assets, less a portion retained to cover expenses, in U.S. government securities, money market securities and cash and does not typically pay dividends in respect of its common stock. As a result, it is possible that an investment in a SPAC may lose value. Foreign Securities Risk: Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities such as risks of currency exchange rates, differences in foreign accounting and legal standards, the availability of less reliable financial information, and government restrictions on repatriation of capital. Health Care Sector Risk: Companies in the health care sector may be adversely affected by government regulations and government health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Consumer Discretionary Risk: The consumer discretionary sector may be affected by changes in domestic and international economies, exchange and interest rates, competition, consumers’ disposable income and consumer preferences, social trends and marketing campaigns. Industrials Sector Risk: Companies in the industrials sector may be adversely affected by changes in government regulation (such as through the imposition or removal of tariffs), world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk: Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. The markets in which many information technology companies compete face rapidly evolving industry standards and government regulations, frequent new service and product announcements, introductions and enhancements, and changing customer demands. Communications Sector Risk: Communication companies are particularly vulnerable to the potential obsolescence of products and services due to technological advancement and the innovation of competitors. Companies in the communications sector may also be affected by other competitive pressures, such as pricing competition, as well as research and development costs, substantial capital requirements and government regulation. Financial Technology Sector Risk: Companies in the financial technology (“FinTech”) sector that are developing financial technologies that seek to disrupt or displace established financial institutions generally face competition from much larger and more established firms. FinTech companies may not currently derive any revenue, and there is no assurance that such companies will derive any revenue from innovative technologies in the future. Cryptocurrency Investment Risk: The Funds may have exposure to cryptocurrency, such as bitcoin, indirectly through an investment in a grantor trust (e.g., the Grayscale Bitcoin Trust (BTC)) that will experience any associated volatility of the underlying cryptocurrency. ARKW may also have exposure to bitcoin through other pooled investment vehicles that invest in bitcoin, such as exchange-traded funds that are domiciled and listed for trading in Canada. The Funds’ exposure to cryptocurrencies may change over time and, accordingly, such exposure may not always be present in the Funds’ portfolios. Cryptocurrencies such as bitcoin are not “fiat” currencies of any central bank or government and currently are not subject to the authority of any central bank or government authority and are therefore not backed by any government, and regulatory and tax treatment of cryptocurrencies continues to develop. Disruptive Innovation Risk: Companies that the adviser and sub-adviser believe create and capitalize on disruptive innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. The Fund may invest in a company that does not currently derive any revenue from disruptive innovations or technologies, and there is no assurance that a company will derive any revenue from disruptive innovations or technologies in the future. Please see the ARK ETFs’ current prospectuses for more detailed descriptions of the risks of investing in the ARK ETFs.
The views expressed in the Shareholder Letter are those of ARK Investment Management LLC (“ARK”) as of July 31, 2021. Management’s Discussion of Fund Performance presents information about the ARK ETFs’ holdings that is believed to be accurate, and the views of the Funds’ portfolio manager, as of July 31, 2021. The Shareholder Letter and Management’s Discussion of Fund Performance may not necessarily reflect the views or holdings on the date this Annual Report is first published or anytime thereafter. The information in the Shareholder Letter and Management’s Discussion of Fund Performance may change, and the ARK ETFs disclaim any obligation to advise shareholders of any such changes. Certain information was obtained from sources that ARK believes to be reliable; however, ARK does not guarantee the accuracy or completeness of any information obtained from any third party.
Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security. Please visit www.ark-funds.com for the most current list of portfolio holdings for the ARK ETFs.
The S&P 500 Index is a widely recognized capitalization-weighted index that measures the performance of the large-capitalization sector of the U.S. stock market. The MSCI World Index represents large and mid-cap equity performance across 23 developed markets. Returns shown for
the MSCI World Index are net of foreign withholding taxes applicable to U.S. investors. Securities indexes assume reinvestment of all distributions and interest payments and do not take into account brokerage fees or taxes. Index performance information was furnished by sources deemed reliable and is believed to be accurate, however, no warranty or representation is made as to the accuracy thereof and the information is subject to correction. You cannot invest directly in an index, securities in an ARK ETF will not exactly match those in an index, and performance of an ARK ETF will differ from the performance of an index. Although reinvestment of dividend and interest payments is assumed, no expenses are netted against an index’s returns.
Dear Shareholder:
ARK Investment Management LLC (“ARK”), the investment adviser to the ARK ETFs, specializes in thematic investing in disruptive innovation. The ARK ETFs include portfolio companies that we believe are leading and benefiting from five innovation platforms: artificial intelligence (AI), energy storage, robotics, DNA sequencing, and blockchain technology. These platforms involve 14 technologies including gene therapies, 3D printing, cloud computing, big data analytics, and cryptocurrencies. According to our estimates, the five innovation platforms and 14 technologies should generate more than $75 trillion in business value and wealth creation over the next decade. Today, we believe these platforms account for less than $14 trillion in global equity market capitalization, giving investors an opportunity to capitalize on long term growth opportunities if they stay on the right side of change.
ARK believes it is imperative for investors to stay on the right side of change because our research suggests that the global economy has entered a period of convulsive changes, some exceptionally good and others devastating, that will shape financial markets for years to come. Thanks to seeds planted during the tech and telecom bubble more than 20 years ago, record-breaking technological changes are creating not only exponential growth opportunities but also black holes in global economies and financial markets. Staying on the right side of change could determine success and failure not only in investment portfolios but also in careers, companies, and countries.
Where are the black holes associated with technologically enabled innovation? In our view, any company not investing aggressively in one or more of five major innovation platforms and 14 technologies evolving today will lose its way. In harm’s way are companies that have spent the last 10-20 years engineering their financial results to satisfy the short-term demands of short-sighted investors. We believe those that have leveraged their balance sheets to buy back shares and pay dividends are at particular risk because deflation can ravage debt holders: technologically enabled innovation is deflationary. Stretching for yield, fixed income investors have enabled this behavior and, at some point, could have to pay for it.
So, investors beware. According to our research, innovation is evolving at such a rapid pace that traditional equity and fixed income benchmarks are being populated increasingly by so-called value traps, stocks and bonds that are “cheap” for a reason. Critical to investment success will be moving to the right side of change, avoiding industries and companies in the crosshairs of “creative destruction” and embracing those creating “disruptive innovation”
On the following pages, you will find information relating to your ARK ETF investment. If you have any questions, I encourage you to contact your financial advisor or ARK directly. You can find additional information, including our daily portfolio holdings, on the ARK ETF website located at: www.ark-funds.com.
We appreciate the opportunity to help you meet your investment goals and thank you for enabling us to invest for you at the pace of innovation!
Sincerely,
Catherine D. Wood
Chief Investment Officer and Chief Executive Officer
ARK Investment Management LLC
Management’s Discussion of Fund Performance
(Unaudited)
Market Review and Investment Strategy
During the fiscal year ended July 31, 2021, global equity markets appreciated despite the continued volatility associated with COVID‐19. At the start of the fiscal year in August 2020, the markets already had recovered rapidly from the sharp 30%+ drawdown in the equity market earlier in the year. This V-shaped rebound set the stage for strong economic momentum in a world scrambling to adjust to the "new normal."
On the back of record‐breaking monetary and fiscal stimulus, public equities rebounded dramatically. Growth stocks – particularly those associated with companies solving problems created by the pandemic– outperformed value stocks significantly through the end of 2020 and the beginning of 2021. This divergence also could have been related to fears of a relapse into recession and the “creative destruction” that innovation is fomenting in traditional value sectors like financial services, energy, and industrials. In mid‐February, however, cyclical sectors around the world began to recover as producers were scrambling to catch up with consumer demand that had depleted inventories. ARK's expectations for a healthy rotation into more value‐oriented, cyclical strategies proved correct as the bull market broadened out and strengthened.
During the fiscal year, the movement in interest rates was remarkable. In December 2020, the US Treasury yield curve steepened suddenly, suggesting that bond investors were anticipating rapid GDP growth and/or higher inflation. During the first quarter of 2021, 10‐year Treasury bond yields nearly doubled from 0.91% on January 4th to 1.74% on March 31st, stoking fears of inflation. Never have interest rates doubled in such a short period of time. By the end of July 2021, the US Treasury 10‐Year yield had declined 50 basis points to 1.24%, suggesting that deflation instead of inflation could be the key risk to the global economic outlook.
While many economists and strategists are weighing the odds of inflation, ARK remains focused on the risks of deflation. Despite a record jump in the US consumer savings rate during the pandemic, spending shifted from services to goods, forcing businesses to scramble to keep up with higher‐than‐expected demand. ARK believes this profound shift in consumer behavior may have resulted in businesses double and triple‐ordering goods which, as consumers shift spending back from goods to services, could result in excess inventory accumulation, ending supply chain disruptions as quickly as they began. In response to the excess supply, commodity prices could unwind as sharply as they have increased, causing cyclical deflation. Secular price deflation – both good and bad – could add to the pressures. We believe innovation is the source of good deflation, as learning curves cut costs and increase productivity. Conversely, companies that have not prepared for the surge in innovation now underway, acquiescing instead to the demands of short‐term oriented shareholders demanding share buybacks and dividends and leveraging their balance sheets to do so, are likely to suffer from bad deflation. To service debt, they could be forced to cut prices as innovation disrupts their existing world order.
ARK continues to research and discover companies it believes are causing or embracing disruptive innovation, creating potential pockets of rapid growth in an otherwise uncertain growth environment. Relative to the S&P 500 Index and the MSCI World Index, ARK’s active ETFs outperformed these broad-based indexes during the fiscal year ended July 31, 2021, while ARK’s self‐indexed ETFs turned in mixed performance.
Management’s Discussion of Fund Performance (continued)
Investment Results: ARK Genomic Revolution ETF (ARKG)
The ARK Genomic Revolution ETF is an actively managed exchange traded fund that invests in companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
During the fiscal year ended July 31, 2021, the ARK Genomic Revolution ETF (ARKG) outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKG’s performance were Pacific Biosciences (PACB), CRISPR Therapeutics (CRSP), Invitae Corp (NVTA), Intellia Therapeutics (NTLA), and Twist Bioscience (TWST). Pacific Biosciences (PACB) announced major technological and business breakthroughs as well as a $900 million investment from SoftBank in the first quarter of 2021. Both the UK-based Welcome Sanger Institute and the Children’s Mercy Hospital Kansas City have increased their investments in Sequel IIe sequencers and Pacific Biosciences also expanded its management team by hiring two Illumina (ILMN) alumni. Finally, in the first quarter of 2021, the company announced a multi-year collaboration with Invitae (NVTA) to develop an ultra-high-throughput sequencing platform based on Pacific Biosciences’ HiFi, a technology which, in our view, provides the most accurate and complete view of the genome. CRISPR Therapeutics (CRSP) also contributed to performance thanks to positive industry and company news, primarily in the fourth quarter of 2020. Jennifer Doudna and Emmanuelle Charpentier, the former a co-founder of Editas, Intellia, and Caribou and the latter a co-founder of CRISPR Therapeutics, won the Nobel Prize in Chemistry for their discovery of CRISPR Cas9 gene-editing technology. Additionally, CRISPR Therapeutics announced encouraging data on early but potential cures for sickle cell disease and beta-thalassemia at the American Society of Hematology (ASH). The company also presented data on its CAR-T cell trial targeting B cell malignancies, which demonstrated a 50% complete response rate at three months in its third dose level cohort. Lastly, CRISPR Therapeutics received funding from the Bill and Melinda Gates Foundation to support CRISPR Cas9-based HIV therapies research. Intellia Therapeutics (NTLA) contributed to performance after publishing the first-ever clinical data demonstrating the potential safety and efficacy of in vivo genome editing. The drug candidate,
NTLA-2001, is positioned as a single-dose cure for the hereditary form of ATTR amyloidosis (hATTR), a deadly disease caused by excessive expression of the amyloid protein.
The biggest detractors from ARKG’s performance were Teladoc Health (TDOC), Illumina (ILMN), Ionis Pharmaceuticals (IONS), Berkely Lights (BLI), and Vertex Pharmaceuticals (VRTX). Despite reporting a strong fiscal year, shares of Teladoc (TDOC) detracted in the face of competitive noise in the telemedicine space from Amazon (AMZN), Talkspace, and Hims & Hers (HIMS). Additionally, “stay-at-home stocks” underwent a valuation reset as COVID-19 vaccinations proliferated. ARK believes that virtual care is here to stay and that Teladoc’s data science and comprehensive platform are its moats. Historically in the US, healthcare data has been highly fragmented, an impediment that Teladoc appears to be overcoming. Thanks to its recent acquisition of Livongo, we believe that Teladoc has strengthened its data and analytical capabilities. Shares of Berkely Lights (BLI) struggled as the company announced missed earnings with mixed guidance. In ARK’s view, Berkeley Lights will be a central actor in developing and manufacturing cell-based products. Berkeley’s products will be used by pharmaceutical companies, contract manufacturing organizations (CMOs), and contract development and manufacturing organizations (CDMOs), and hospitals to optimize cell therapies. During the period, Vertex Pharmaceuticals (VRTX) abandoned further development of VX-864, a phase 2 drug for alpha-1 antitrypsin deficiency (AATD). We believe that the disappointing news put selling pressure on the company’s public shares.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | 5 Year | | | Since
Inception
(Annualized) | |
| ARK Genomic Revolution ETF (ARKG) | |
| Net Asset Value | | | | | 58.48% | | | | | | 44.98% | | | | | | 37.07% | | | | | | 25.09% | | |
| Market Price | | | | | 58.39% | | | | | | 44.89% | | | | | | 37.07% | | | | | | 25.09% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.35% | | | | | | 14.64% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 14.29% | | | | | | 11.28% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKG’s inception date is 10/31/14.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKG is
Management’s Discussion of Fund Performance (continued)
(Unaudited)
0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
Investment Results: ARK Autonomous Technology & Robotics ETF (ARKQ)
The ARK Autonomous Technology & Robotics ETF is an actively managed exchange traded fund that invests in securities of autonomous technology and robotics companies that are relevant to the Fund’s investment theme of robotics and autonomous technology.
During the fiscal year ended July 31, 2021, the ARK Robotics & Autonomous Technology ETF (ARKQ) outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKQ’s performance were Tesla (TSLA), Materialise (MTLS), BYD Co (BYDDY), Deere & Co (DE), and Trimble (TRMB). Appreciation in Tesla (TSLA) was driven by a strong second half of 2020, during which time the stock was added to the S&P 500 Index (December), and a 2021 second quarter earnings report that beat both top- and bottom-line expectations while improving its automotive gross margin (excluding regulatory credits) year-over-year. We believe that many sources of volatility have begun to dissipate, including tweets from Elon Musk around Bitcoin. Tesla has since surprised investors to the upside with the number of China-made EV deliveries, and Gigafactory Shanghai is now the primary export hub of high-quality vehicles. Tesla continues to be a leader in electric vehicle market share and we believe that its growing fleet gives it access to an unparalleled amount of valuable driving data as it ramps up its autonomous capabilities. Deere & Co (DE) appreciated in anticipation of President Biden’s infrastructure proposal and better than expected first quarter 2021 results thanks to improved conditions in the agriculture and construction sectors. Shares of Trimble (TRMB) appreciated on the back of positive news relating to new partnerships, new technology developments, and strong earnings beats on both the top and bottom
lines. Over the past year, Trimble has focused its portfolio and divested non-core businesses, while continuing to invest in its cloud platform and autonomy.
The biggest detractors from ARKQ’s performance were 2U Inc (TWOU), Blade Air Mobility (BLDE), Splunk (SPLK), Baidu (BIDU), and Vuzix (VUZI). Shares of education technology firm 2U Inc (TWOU) depreciated in February 2021 after a mixed earnings release and the general unwinding of “stay-at-home stocks” as COVID-19 vaccinations proliferated. Blade Air Mobility (BLDE) experienced volatility after its SPAC announcement in December 2020. Shares traded up substantially and eventually reverted to their original levels. Part of this decline could have been due to concerns with its approach to investor relations before going public. ARK believes air taxi growth will pick up faster than expected, and Blade should benefit as air travel increases. Chinese stocks, in particular shares of technology-focused companies, sold off broadly after the central government continued its regulatory crackdown. Shares of Baidu Inc. (BIDU) were impacted by the broad sell-off.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | 5 Year | | | Since
Inception
(Annualized) | |
| ARK Autonomous Technology & Robotics ETF (ARKQ) | |
| Net Asset Value | | | | | 55.31% | | | | | | 34.08% | | | | | | 32.72% | | | | | | 23.85% | | |
| Market Price | | | | | 55.17% | | | | | | 34.01% | | | | | | 32.78% | | | | | | 23.87% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.35% | | | | | | 14.60% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 14.29% | | | | | | 11.02% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKQ’s inception date is 9/30/14.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKQ is 0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
(Unaudited)
Investment Results: ARK Innovation ETF (ARKK)
The ARK Innovation ETF is an actively managed exchange traded fund that invests in securities of companies that rely on or benefit from the development of new products or services, technological improvements and advancements in scientific research relating to the areas of genomics (“Genomic Revolution Theme”), robotics and autonomous technology (“Robotics and Autonomous Technology Theme”), next generation internet (“Next Generation Internet Theme”) or financial technology (“Fintech Theme”).
During the fiscal year ended July 31, 2021, the ARK Innovation ETF outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKK’s performance were Tesla (TSLA), Roku (ROKU), Intellia Therapeutics (NTLA), Square (SQ), and CRISPR Therapeutics (CRSP). Appreciation in Tesla (TSLA) was driven by a strong second half of 2020, during which time the stock was added to the S&P 500 Index (December), and a 2021 second quarter earnings report that beat both top- and bottom-line expectations while improving its automotive gross margin (excluding regulatory credits) year-over-year. We believe that many sources of volatility have begun to dissipate, including tweets from Elon Musk around Bitcoin. Tesla has since surprised investors to the upside with the number of China-made EV deliveries, and Gigafactory Shanghai is now the primary export hub of high-quality vehicles. Tesla continues to be a leader in electric vehicle market share and we believe that its growing fleet gives it access to an unparalleled amount of valuable driving data as it ramps up its autonomous capabilities. Roku (ROKU) contributed to performance after positive developments in content agreements and acquisitions, the consumer shift out of traditional TV into streaming resulting in account growth, international expansion, and platform revenue strength. Intellia Therapeutics (NTLA) contributed to performance after publishing the first-ever clinical data demonstrating the safety and efficacy of in vivo genome editing. The drug candidate, NTLA-2001, is positioned as a single-dose cure for the hereditary form of ATTR amyloidosis (hATTR), a deadly disease caused by excessive expression of the amyloid protein.
The biggest detractors from ARKK’s performance were Teladoc Health (TDOC), LendingTree (TREE), Coinbase Global (COIN), 2U Inc (TWOU), and Illumina (ILMN). Despite reporting a strong fiscal year, shares of Teladoc (TDOC) detracted in the face of competitive noise in the telemedicine space from Amazon (AMZN), Talkspace, and Hims & Hers (HIMS). Additionally, “stay-at-home stocks” underwent a valuation reset as COVID-19 vaccinations proliferated. ARK believes that virtual care is here to stay and that Teladoc’s data science and comprehensive platform are its moats. Historically in the US, healthcare data has been highly fragmented, an impediment that Teladoc appears to be overcoming. Thanks to its recent acquisition of Livongo, we believe that Teladoc has strengthened its data and analytical capabilities. LendingTree (TREE) detracted from performance primarily in the fourth quarter of 2020 after it lowered guidance and again after GCI Liberty disclosed that it would sell its stake in the stock. Additionally, in the first half of 2021, shares of LendingTree responded to mixed earnings and increased competitive pressure. Coinbase Global (COIN) responded to a 45% drop in the price of bitcoin from May 12, 2021 through July 19, 2021, precipitated in part we believe by Elon Musk’s second thoughts about the heavy use of energy in bitcoin mining. ARK believes that bitcoin mining, when incorporated into solar+battery utility ecosystems, could accelerate the proliferation of renewables faster than otherwise would be the case.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | 5 Year | | | Since
Inception
(Annualized) | |
| ARK Innovation ETF (ARKK) | |
| Net Asset Value | | | | | 51.65% | | | | | | 41.56% | | | | | | 44.05% | | | | | | 32.07% | | |
| Market Price | | | | | 51.76% | | | | | | 41.55% | | | | | | 44.12% | | | | | | 32.10% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.35% | | | | | | 14.64% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 14.29% | | | | | | 11.28% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKK’s inception date is 10/31/14.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKK is 0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on
Management’s Discussion of Fund Performance (continued)
the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
(Unaudited)
Investment Results: ARK Next Generation Internet ETF (ARKW)
The ARK Next Generation Internet ETF is an actively managed exchange traded fund that invests in securities of companies that are relevant to the Fund’s investment theme of next generation internet.
During the fiscal year ended July 31, 2021, the ARK Next Generation Internet ETF (ARKW) outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKW’s performance were Tesla (TSLA), Roku (ROKU), Square (SQ), Grayscale Bitcoin Trust (GBTC), and Snap (SNAP). Appreciation in Tesla (TSLA) was driven by a strong second half of 2020, during which time the stock was added to the S&P 500 Index (December), and a 2021 second quarter earnings report that beat both top- and bottom-line expectations while improving its automotive gross margin (excluding regulatory credits) year-over-year. We believe that many sources of volatility have begun to dissipate, including tweets from Elon Musk around Bitcoin. Tesla has since surprised investors to the upside with the number of China-made EV deliveries, and Gigafactory Shanghai is now the primary export hub of high-quality vehicles. Tesla continues to be a leader in electric vehicle market share and we believe that its growing fleet gives it access to an unparalleled amount of valuable driving data as it ramps up its autonomous capabilities. Roku (ROKU) also contributed after positive developments in content agreements and acquisitions, the consumer shift out of traditional TV into streaming resulting in account growth, international expansion, and platform revenue strength. Square (SQ) appreciated as the pandemic accelerated the adoption of digital wallets, as seen by the rapid growth of Square’s Cash App. The company also experienced a faster than expected rebound of its seller business, strong earnings reports, and strategic initiatives, including activity in the cryptocurrency space.
The biggest detractors from ARKW’s performance were Teladoc Health (TDOC), Skillz (SKLZ), Coinbase Global (COIN), LendingTree (TREE), and Pinduoduo (PDD). Despite reporting a strong fiscal year, shares of Teladoc (TDOC) detracted in the face of competitive noise in the telemedicine space from Amazon (AMZN), Talkspace, and Hims & Hers (HIMS). Additionally, “stay-at-home stocks” underwent a valuation reset as COVID-19 vaccinations proliferated. ARK believes that virtual care is here to stay and that Teladoc’s data science and comprehensive platform are its moats. Historically in the US, healthcare data has been highly fragmented, an impediment that Teladoc appears to be overcoming. Thanks to its recent acquisition of Livongo, we believe that Teladoc has strengthened its data and analytical capabilities. Shares of Skillz Inc. (SKLZ) depreciated based on concerns surrounding a short report in March 2021 and questioning of the company’s concentration of revenue. ARK believes that Skillz’ platform is misunderstood and that Skillz’ growth is being underestimated by consensus views. Coinbase Global (COIN) responded to a 45% drop in the price of bitcoin from May 12, 2021 through July 19, 2021, precipitated in part we believe by Elon Musk’s second thoughts about the heavy use of energy in bitcoin mining. ARK believes that bitcoin mining, when incorporated into solar+battery utility ecosystems, could accelerate the proliferation of renewables faster than otherwise would be the case.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | 5 Year | | | Since
Inception
(Annualized) | |
| ARK Next Generation Internet ETF (ARKW) | |
| Net Asset Value | | | | | 50.06% | | | | | | 45.29% | | | | | | 48.11% | | | | | | 37.50% | | |
| Market Price | | | | | 50.24% | | | | | | 45.35% | | | | | | 48.28% | | | | | | 37.53% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.35% | | | | | | 14.60% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 14.29% | | | | | | 11.02% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKW’s inception date is 9/30/14.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKW is 0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares
Management’s Discussion of Fund Performance (continued)
outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
(Unaudited)
Investment Results: ARK Fintech Innovation ETF (ARKF)
The ARK Fintech Innovation ETF is an actively managed exchange traded fund that invests in securities of companies that are relevant to the Fund’s investment theme of financial technology (“Fintech”) innovation.
During the fiscal year ended July 31, 2021, the ARK Fintech Innovation ETF (ARKF) outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKF’s performance were Square (SQ), Sea Ltd (SE), Pinterest (PINS), Snap (SNAP), and Silvergate Capital (SI). Square (SQ) appreciated as the pandemic accelerated the adoption of digital wallets, as seen by the rapid growth of Square’s Cash App. The company also experienced a faster than expected rebound of its seller business, strong earnings reports, and strategic initiatives, including activity in the cryptocurrency space. Sea Limited (SE) saw its revenues increase over the period. The company continued to do well with its self-developed global hit game, Free Fire, and grew average daily orders significantly within its e-commerce platform, Shopee. Pinterest (PINS) contributed to performance after reporting better than expected revenue growth in multiple quarters, alongside positive trends in net income improvement and growth in monthly active users. Pinterest could be benefitting from an accelerated shift in the advertising market from linear TV to social media platforms.
The biggest detractors from ARKF’s performance were KE Holdings (BEKE), Opendoor Technologies (OPEN), LendingTree (TREE),
Coinbase Global (COIN), and Ping An Healthcare and Technology (188 HK). Shares of KE Holdings (BEKE), China’s largest real estate brokerage platform, sold off during the government crackdown in China. Specifically, China issued a joint notice from eight ministries that plans to introduce regulations across the broad real estate industry, covering developers, brokers, rental platforms, and HOAs. Despite beating first-quarter 2021 expectations, shares of Opendoor Technologies (OPEN) sold off in part due to potential signs of the housing market slowing down. ARK also believes that shares are continuing to be punished in a higher interest rate environment. LendingTree (TREE) detracted from performance primarily in the fourth quarter of 2020 after it lowered guidance and again after GCI Liberty disclosed that it would sell its stake in the stock. Additionally, in the first half of 2021, shares of LendingTree responded to mixed earnings and increased competitive pressure.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | Since
Inception
(Annualized) | |
| ARK Fintech Innovation ETF (ARKF) | |
| Net Asset Value | | | | | 40.58% | | | | | | 46.13% | | |
| Market Price | | | | | 40.29% | | | | | | 46.14% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 23.67% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 20.11% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKF’s inception date is 2/4/19.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKF is 0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
Investment Results: ARK Space Exploration & Innovation ETF (ARKX)
The ARK Space Exploration & Innovation ETF is an actively managed exchange traded fund that invests in securities of companies that are relevant to the Fund’s investment theme of space exploration. ARK defines “Space Exploration” as leading, enabling, or benefitting from technologically enabled products and/or services that occur beyond the surface of the Earth.
Since the inception of the fund on March 30, 2021, through July 31, 2021, the ARK Space Exploration & Innovation ETF (ARKX) underperformed the S&P 500 Index and the MSCI World Index.
The top contributors to ARKX’s performance were Trimble (TRMB), NVIDIA (NVDA), Raven Industries (RAVN), Alphabet (GOOG), and Iridium Communications (IRDM). Shares of Trimble (TRMB) appreciated on the back of positive news relating to new partnerships, new technology developments, and strong earnings beats on both the top and bottom lines. Over the past year, Trimble has focused its portfolio and divested non-core businesses, while continuing to invest in its cloud platform and autonomy. Nvidia (NVDA) appreciated throughout the period following several quarters of strong revenue growth and positive guidance. Gaming revenue outperformed following launch of the RTX 3000 GPU line and on the back of a surge in cryptocurrency miner demand, while Datacenter revenue was boosted by continued adoption of GPUs for accelerating AI training. The stock also benefited from CEO Jensen Hwang’s optimism surrounding the ARM acquisition, sell-side upgrades, and a strong move in semiconductor stocks generally during the second quarter. During Investor Day, Nvidia also unveiled the Omniverse Platform, its Grace CPU, and an AI LaunchPad. In June 2021, CNH announced an agreement to acquire Raven Industries
(RAVN) for a significant premium. Raven Industries makes precision agriculture and high-altitude balloons and has placed a strong focus on autonomous agriculture equipment in recent years, while CNH is the second-largest agricultural equipment manufacturer globally.
The biggest detractors from ARKX’s performance were JD Logistics (2618 HK), Virgin Galactic (SPCE), Workhorse Group (WKHS), Komatsu Ltd (6301 JP), and JD.com (JD). Chinese stocks, in particular shares of technology-focused companies, sold off broadly after the central government continued its regulatory crackdown. Shares of JD Logistics (2618 HK) were impacted by the broad sell-off. Virgin Galactic (SPCE) depreciated not only in response to intensified competition from Blue Origin and SpaceX but also to lower than expected earnings and revenue. Furthermore, the stock was impacted by flight schedule delays and Founder Richard Branson’s decision to sell shares. WKHS suffered as Capitol Hill failed to clarify its position on the conversion of the US Postal Services’ fleet to electric vehicles. ARK exited WKHS to capitalize on the market’s downside volatility by rotating into higher conviction names.
Average Annual Total Returns as of 7/31/21
| | | | Since
Inception | |
| ARK Space Exploration & Innovation ETF (ARKX) | |
| Net Asset Value | | | | | 1.77% | | |
| Market Price | | | | | 1.70% | | |
| S&P 500 Index | | | | | 11.54% | | |
| MSCI World Net Index | | | | | 9.94% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
ARKX's inception date is 3/30/21.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for ARKX is 0.75%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (continued)
(Unaudited)
Investment Results: The 3D Printing ETF (PRNT)
The 3D Printing ETF is an indexed exchange traded fund that seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Total 3D-Printing Index, which is designed to track the price movements of the stocks of companies involved in the 3D printing industry.
The 3D Printing ETF is the only pure-play ETF dedicated to the 3D printing ecosystem. During the fiscal year ended July 31, 2021, The 3D Printing ETF (PRNT) outperformed the S&P 500 Index and the MSCI World Index.
The top contributors to PRNT’s performance were 3D Systems (DDD), SLM Solutions (AM3D GR), Materialise (MTLS), Straumann Holding (STMN SW), and ExOne (XONE). 3D Systems (DDD) was a top contributor after the company reported better than expected preliminary results in early January 2021, leading to a gap up in share price.
The biggest detractors from PRNT’s performance were Desktop Metal (DM), Nano Dimension (NNDM), Proto Labs (PRLB), Exco Technologies (XTC CN), and Eastman Kodak (KODK). Desktop Metal (DM) was the largest detractor from performance after Velo3D, another metal 3D printing company, announced in the first quarter of 2021 that it would go public via SPAC. In our view, each company specializes in a different printing technology focused on different applications.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | 5 Year | | | Since
Inception
(Annualized) | |
| The 3D Printing ETF (PRNT) | |
| Net Asset Value | | | | | 70.76% | | | | | | 16.59% | | | | | | 14.38% | | | | | | 14.31% | | |
| Market Price | | | | | 71.48% | | | | | | 16.38% | | | | | | 14.26% | | | | | | 14.28% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.35% | | | | | | 17.28% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 14.29% | | | | | | 14.42% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
PRNT’s inception date is 7/19/16.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for PRNT is 0.66%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares.
Management’s Discussion of Fund Performance (concluded)
Investment Results: The ARK Israel Innovative Technology ETF (IZRL)
The ARK Israel Innovative Technology ETF is an indexed exchange traded fund that seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, biotechnology, industrials, manufacturing, the Internet, and/or information technology.
During the fiscal year ended July 31, 2021, the ARK Israel Innovative Technology ETF (IZRL) underperformed the S&P 500 Index and the MSCI World Index.
The top contributors to IZRL’s performance were Fiverr International (FVRR), Perion Network (PERI), InMode (INMD), Fattal Holdings (FTAL IT), and Stratasys (SSYS). Shares of InMode (INMD) appreciated steadily over the fiscal period due to strong earnings reports for each quarter, beating both revenue and earnings estimates.
The biggest detractors from IZRL’s performance were BiondVax Pharmaceuticals (BVXV), Pluristem Therapeutics (PSTI), PolyPid Ltd
(PYPD), RoboGroup (ROBO IT), and Nano-X Imaging (NNOX). Pluristem Therapeutics (PSTI) depreciated sharply in the fourth quarter of 2020 due to unfavorable results of a Phase III study for the treatment of critical limb ischemia (CLI). Following a recommendation from the independent Data Monitoring Committee (DMC), the company decided to terminate the CLI study to focus on different therapeutic areas.
Average Annual Total Returns as of 7/31/21
| | | | 1 Year | | | 3 Year | | | Since
Inception
(Annualized) | |
| The ARK Israel Innovative Technology ETF (IZRL) | |
| Net Asset Value | | | | | 21.06% | | | | | | 15.19% | | | | | | 13.60% | | |
| Market Price | | | | | 21.87% | | | | | | 14.72% | | | | | | 13.49% | | |
| S&P 500 Index | | | | | 36.45% | | | | | | 18.16% | | | | | | 17.10% | | |
| MSCI World Net Index | | | | | 35.07% | | | | | | 14.49% | | | | | | 13.35% | | |
Growth of an Assumed $10,000 Investment Since Inception* Through 7/31/21 (At Net Asset Value)
*
IZRL’s inception date is 12/5/17.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. To obtain performance information current to the most recent month end, please visit www.arkfunds.com. As stated in the ARK ETFs’ current prospectuses, the expense ratio for IZRL is 0.49%. Additional information about fees and expense levels can be found in the ARK ETFs’ current prospectuses. Net asset value (“NAV”) returns are based on the dollar value of a single share of an ARK ETF, calculated using the value of the underlying assets of the ARK ETF minus its liabilities, divided by the number of shares outstanding. The NAV is typically calculated at 4:00 pm Eastern time on each business day the New York Stock Exchange is open for trading. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Market performance does not represent the returns you would receive if you traded shares at other times.
The returns for the Fund do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or upon sale of Fund shares. Returns for less than one year are not annualized.
Shareholder Expense Examples
(Unaudited)
As a shareholder of an ARK ETF (each, a “Fund” and collectively, “Funds”) you incur two types of costs: (1) transaction costs for purchasing and selling shares; and (2) ongoing costs, including management fees and other Fund expenses. The following examples are intended to help you understand your ongoing costs (in dollars and cents) of investing in the Funds and to compare these costs with the ongoing costs of investing in other funds.
The examples below are based on an investment of $1,000 invested at the beginning of the six-month period and held for the entire period (February 1, 2021 through July 31, 2021).
Actual Expenses
The first line under each Fund in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Fund under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during the period.
Hypothetical Example for Comparison Purposes
The second line under each Fund in the table below provides information about hypothetical account values and hypothetical expenses based on each Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate your actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund to other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of Fund shares. Therefore, the second line under each Fund in the table is useful in comparing ongoing Fund costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
| | | | Beginning
Account Value
2/1/2021 | | | Ending
Account Value
7/31/2021 | | | Annualized
Expense Ratios
for the Period | | | Expenses Paid
During the
Period(a) | |
| ARK Genomic Revolution ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 827.50 | | | | | | 0.75% | | | | | $ | 3.40 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
| ARK Autonomous Technology & Robotics ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 930.10 | | | | | | 0.75% | | | | | $ | 3.59 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
| ARK Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 872.70 | | | | | | 0.75% | | | | | $ | 3.48 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
| ARK Next Generation Internet ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 928.40 | | | | | | 0.75% | | | | | $ | 3.59 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
| ARK Fintech Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 972.20 | | | | | | 0.75% | | | | | $ | 3.67 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
| ARK Space Exploration & Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 1,017.70 | | | | | | 0.71% | | | | | $ | 2.43(b) | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.27 | | | | | | 0.71% | | | | | $ | 3.56 | | |
| The 3D Printing ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 959.90 | | | | | | 0.66% | | | | | $ | 3.21 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.52 | | | | | | 0.66% | | | | | $ | 3.31 | | |
| The ARK Israel Innovative Technology ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual | | | | $ | 1,000.00 | | | | | $ | 930.20 | | | | | | 0.49% | | | | | $ | 2.35 | | |
| Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,022.36 | | | | | | 0.49% | | | | | $ | 2.46 | | |
(a)
Expenses are equal to each Fund’s annualized expense ratio, multiplied by the average account value over the period, multiplied by 181/365 (the number of days in the period, then divided by 365).
(b)
Expenses are equal to each Fund’s annualized expense ratio, multiplied by the average account value over the period, multiplied by 124/365 (the number of days in the period, then divided by 365).
Sector Diversification (as a percentage of total investments)
July 31, 2021 (Unaudited)
ARK Genomic Revolution
ETF (ARKG)
| | ■ | | | Health Care | | | | | 96.1% | | |
| | ■ | | | Information Technology | | | | | 3.1 | | |
| | ■ | | | Materials | | | | | 0.4 | | |
| | ■ | | | Financials | | | | | 0.2 | | |
| | ■ | | | Money Market Fund | | | | | 0.2 | | |
| | | | | | | | | | 100.0 | | |
ARK Autonomous Technology
& Robotics ETF (ARKQ)
| | ■ | | | Information Technolorgy | | | | | 30.5% | | |
| | ■ | | | Industrials | | | | | 26.5 | | |
| | ■ | | | Consumer Discretionary | | | | | 25.1 | | |
| | ■ | | | Communication Services | | | | | 13.1 | | |
| | ■ | | | Money Market Fund | | | | | 2.5 | | |
| | ■ | | | Health Care | | | | | 1.4 | | |
| | ■ | | | Technology | | | | | 0.9 | | |
| | | | | | | | | | 100.0 | | |
ARK Innovation ETF (ARKK)
| | ■ | | | Information Technology | | | | | 32.2% | | |
| | ■ | | | Health Care | | | | | 27.3 | | |
| | ■ | | | Communication Services | | | | | 19.9 | | |
| | ■ | | | Consumer Discretionary | | | | | 13.8 | | |
| | ■ | | | Financials | | | | | 5.2 | | |
| | ■ | | | Industrials | | | | | 1.4 | | |
| | ■ | | | Money Market Fund | | | | | 0.2 | | |
| | | | | | | | | | 100.0 | | |
ARK Next Generation
Internet ETF (ARKW)
| | ■ | | | Information Technology | | | | | 35.5% | | |
| | ■ | | | Communication Services | | | | | 23.0 | | |
| | ■ | | | Consumer Discretionary | | | | | 22.4 | | |
| | ■ | | | Financials | | | | | 12.9 | | |
| | ■ | | | Health Care | | | | | 5.9 | | |
| | ■ | | | Money Market Fund | | | | | 0.3 | | |
| | | | | | | | | | 100.0 | | |
ARK Fintech Innovation
ETF (ARKF)
| | ■ | | | Information Technology | | | | | 43.3% | | |
| | ■ | | | Communication Services | | | | | 20.9 | | |
| | ■ | | | Financials | | | | | 16.5 | | |
| | ■ | | | Consumer Discretionary | | | | | 12.9 | | |
| | ■ | | | Health Care | | | | | 3.3 | | |
| | ■ | | | Real Estate | | | | | 2.8 | | |
| | ■ | | | Money Market Fund | | | | | 0.3 | | |
| | | | | | | | | | 100.0 | | |
ARK Space Exploration
& Innovation ETF (ARKX)
| | ■ | | | Industrials | | | | | 47.2% | | |
| | ■ | | | Information Technology | | | | | 25.8 | | |
| | ■ | | | Communication Services | | | | | 12.0 | | |
| | ■ | | | Equity Fund | | | | | 6.8 | | |
| | ■ | | | Consumer Discretionary | | | | | 6.1 | | |
| | ■ | | | Technology | | | | | 1.1 | | |
| | ■ | | | Money Market Fund | | | | | 1.0 | | |
| | | | | | | | | | 100.0 | | |
Sector Diversification (as a percentage of total investments) (concluded)
July 31, 2021 (Unaudited)
The 3D Printing ETF (PRNT)
| | ■ | | | Information Technology | | | | | 53.3% | | |
| | ■ | | | Industrials | | | | | 24.7 | | |
| | ■ | | | Health Care | | | | | 13.4 | | |
| | ■ | | | Consumer Discretionary | | | | | 4.8 | | |
| | ■ | | | Materials | | | | | 3.6 | | |
| | ■ | | | Consumer Staples | | | | | 0.1 | | |
| | ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | | 100.0 | | |
The ARK Israel Innovative
Technology ETF (IZRL)
| | ■ | | | Information Technology | | | | | 49.0% | | |
| | ■ | | | Health Care | | | | | 27.1 | | |
| | ■ | | | Industrials | | | | | 12.3 | | |
| | ■ | | | Communication Services | | | | | 6.8 | | |
| | ■ | | | Consumer Discretionary | | | | | 4.1 | | |
| | ■ | | | Money Market Fund | | | | | 0.7 | | |
| | | | | | | | | | 100.0 | | |
ARK Genomic Revolution ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 99.9% | |
| Biotechnology – 49.9% | |
| AquaBounty Technologies, Inc.*† | | | | | 6,605,904 | | | | | $ | 32,699,225 | | |
| Arcturus Therapeutics Holdings, Inc.*† | | | | | 2,711,242 | | | | | | 84,888,987 | | |
| Beam Therapeutics, Inc.* | | | | | 1,707,285 | | | | | | 157,070,220 | | |
| CareDx, Inc.*† | | | | | 3,690,771 | | | | | | 310,172,395 | | |
| Caribou Biosciences, Inc.* | | | | | 1,484,672 | | | | | | 24,051,686 | | |
| Cellectis SA (France)*†(a) | | | | | 4,393,624 | | | | | | 56,897,431 | | |
| CRISPR Therapeutics AG (Switzerland)* | | | | | 1,773,623 | | | | | | 214,643,856 | | |
| Dicerna Pharmaceuticals, Inc.* | | | | | 315,434 | | | | | | 11,831,929 | | |
| Editas Medicine, Inc.* | | | | | 1,248,440 | | | | | | 52,259,698 | | |
| Evogene Ltd. (Israel)*† | | | | | 3,157,559 | | | | | | 9,030,619 | | |
| Exact Sciences Corp.* | | | | | 4,043,106 | | | | | | 436,008,551 | | |
| Fate Therapeutics, Inc.* | | | | | 4,316,228 | | | | | | 357,383,678 | | |
| Incyte Corp.* | | | | | 3,046,079 | | | | | | 235,614,211 | | |
| Intellia Therapeutics, Inc.* | | | | | 1,501,146 | | | | | | 212,937,560 | | |
| Invitae Corp.* | | | | | 4,618,185 | | | | | | 129,262,998 | | |
| Ionis Pharmaceuticals, Inc.*† | | | | | 9,025,335 | | | | | | 335,200,942 | | |
| Iovance Biotherapeutics, Inc.* | | | | | 6,270,302 | | | | | | 139,639,625 | | |
| Organovo Holdings, Inc.* | | | | | 259,097 | | | | | | 1,987,274 | | |
| Pluristem Therapeutics, Inc.* | | | | | 577,080 | | | | | | 1,892,822 | | |
| Recursion Pharmaceuticals, Inc., Class A* | | | | | 2,750,117 | | | | | | 83,466,051 | | |
| Regeneron Pharmaceuticals, Inc.* | | | | | 685,000 | | | | | | 393,607,850 | | |
| Repare Therapeutics, Inc. (Canada)*† | | | | | 2,796,024 | | | | | | 93,387,201 | | |
| Sarepta Therapeutics, Inc.* | | | | | 484,541 | | | | | | 32,842,189 | | |
| Seres Therapeutics, Inc.* | | | | | 2,447,801 | | | | | | 17,379,387 | | |
| Surface Oncology, Inc.*† | | | | | 4,327,530 | | | | | | 26,008,455 | | |
| Twist Bioscience Corp.*† | | | | | 2,468,853 | | | | | | 303,792,362 | | |
| Veracyte, Inc.* | | | | | 1,937,800 | | | | | | 86,348,368 | | |
| Vertex Pharmaceuticals, Inc.* | | | | | 1,813,163 | | | | | | 365,497,398 | | |
| Verve Therapeutics, Inc.* | | | | | 1,248,853 | | | | | | 74,219,334 | | |
| Total Biotechnology | | | | | 4,280,022,302 | | |
| Chemicals – 0.4% | |
| Zymergen, Inc.* | | | | | 1,055,590 | | | | | | 36,723,976 | | |
| Electronic Equipment, Instruments & Components – 1.0% | |
| 908 Devices, Inc.*† | | | | | 2,620,273 | | | | | | 81,883,531 | | |
| Financial Services – 0.2% | |
Dynamics Special Purpose Corp., Class A*† | | | | | 2,003,952 | | | | | | 19,718,888 | | |
| Health Care Equipment & Supplies – 1.3% | |
| Butterfly Network, Inc.* | | | | | 7,623,822 | | | | | | 81,879,849 | | |
| Cerus Corp.* | | | | | 5,617,976 | | | | | | 28,314,599 | | |
| Total Health Care Equipment & Supplies | | | | | 110,194,448 | | |
| Health Care Providers & Services – 7.4% | | | | | | | | | | | | | |
| 1Life Healthcare, Inc.* | | | | | 3,130,499 | | | | | | 84,648,693 | | |
| Accolade, Inc.*† | | | | | 5,546,261 | | | | | | 259,620,477 | | |
| Castle Biosciences, Inc.*† | | | | | 2,242,615 | | | | | | 156,646,658 | | |
| Signify Health, Inc., Class A* | | | | | 5,284,084 | | | | | | 139,077,091 | | |
| Total Health Care Providers & Services | | | | | 639,992,919 | | |
| Investments | | | Shares | | | Value | |
| Health Care Technology – 12.7% | |
| Schrodinger, Inc.* | | | | | 2,510,581 | | | | | $ | 169,891,016 | | |
| Sema4 Holdings Corp.* | | | | | 4,530,685 | | | | | | 51,106,127 | | |
| Teladoc Health, Inc.* | | | | | 3,999,730 | | | | | | 593,759,919 | | |
| Veeva Systems, Inc., Class A* | | | | | 814,964 | | | | | | 271,146,672 | | |
| Total Health Care Technology | | | | | 1,085,903,734 | | |
| Life Sciences Tools & Services – 15.5% | |
| 10X Genomics, Inc., Class A* | | | | | 793,671 | | | | | | 145,424,337 | | |
| Adaptive Biotechnologies Corp.* | | | | | 4,197,778 | | | | | | 153,890,542 | | |
| Berkeley Lights, Inc.* | | | | | 3,189,773 | | | | | | 145,389,853 | | |
| Codexis, Inc.*† | | | | | 6,417,351 | | | | | | 135,791,147 | | |
| Compugen Ltd. (Israel)* | | | | | 3,941,643 | | | | | | 26,763,756 | | |
| NanoString Technologies, Inc.* | | | | | 918,658 | | | | | | 56,901,677 | | |
| Pacific Biosciences of California, Inc.*† | | | | | 14,322,897 | | | | | | 460,481,139 | | |
| Personalis, Inc.*† | | | | | 4,643,578 | | | | | | 97,468,702 | | |
| Quantum-Si, Inc.*† | | | | | 7,570,025 | | | | | | 71,309,635 | | |
| Seer, Inc.* | | | | | 1,264,045 | | | | | | 40,373,597 | | |
| Total Life Sciences Tools & Services | | | | | 1,333,794,385 | | |
| Molecular Diagnostics – 0.4% | | | | | | | | | | | | | |
| CM Life Sciences II, Inc.*† | | | | | 2,740,375 | | | | | | 32,363,829 | | |
| Pharmaceuticals – 9.0% | | | | | | | | | | | | | |
| Bristol-Myers Squibb Co. | | | | | 1,300,025 | | | | | | 88,232,697 | | |
| Novartis AG (Switzerland)(a) | | | | | 2,528,010 | | | | | | 233,562,844 | | |
| Roche Holding AG (Switzerland)(a) | | | | | 4,407,446 | | | | | | 212,703,344 | | |
| Takeda Pharmaceutical Co. Ltd. (Japan)(a) | | | | | 14,615,090 | | | | | | 241,148,985 | | |
| Total Pharmaceuticals | | | | | | | | | | | 775,647,870 | | |
| Software – 1.7% | | | | | | | | | | | | | |
| UiPath, Inc., Class A* | | | | | 2,375,452 | | | | | | 148,608,277 | | |
| Technology Hardware, Storage & Peripherals – 0.4% | |
| Pure Storage, Inc., Class A* | | | | | 1,492,363 | | | | | | 29,130,926 | | |
| Total Common Stocks | | | | | | | | | | | | | |
| (Cost $9,174,033,733) | | | | | | | | | | | 8,573,985,085 | | |
| MONEY MARKET FUND – 0.2% | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b) | | | | | | | | | | | | | |
| (Cost $18,866,018) | | | | | 18,866,018 | | | | | | 18,866,018 | | |
Total Investments – 100.1%
(Cost $9,192,899,751) | | | | | | | | | | | 8,592,851,103 | | |
| Liabilities in Excess of Other Assets – (0.1)% | | | | | | | | | | | (4,837,354) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 8,588,013,749 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Genomic Revolution ETF
July 31, 2021
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stocks — 29.9% | |
| Biotechnology — 14.6% | |
| AquaBounty Technologies, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 4,007,184 | | | | | 46,405,965 | | | | | | (17,562,715) | | | | | | 9,948,164 | | | | | | (10,099,373) | | | | | | — | | | | | | — | | | | | | 6,605,904 | | | | | | 32,699,225 | | |
| Arcturus Therapeutics Holdings, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 102,661,199 | | | | | 189,641,949 | | | | | | (130,709,214) | | | | | | 50,273,705 | | | | | | (126,978,652) | | | | | | — | | | | | | — | | | | | | 2,711,242 | | | | | | 84,888,987 | | |
| CareDx, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 56,180,009 | | | | | 418,853,405 | | | | | | (287,043,938) | | | | | | 69,548,787 | | | | | | 52,634,132 | | | | | | — | | | | | | — | | | | | | 3,690,771 | | | | | | 310,172,395 | | |
| Cellectis SA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 44,530,240 | | | | | 77,506,824 | | | | | | (38,001,947) | | | | | | 4,636,350 | | | | | | (31,774,036) | | | | | | — | | | | | | — | | | | | | 4,393,624 | | | | | | 56,897,431 | | |
| Evogene Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 471,804 | | | | | 7,367,652 | | | | | | (6,924,098) | | | | | | 4,401,410 | | | | | | 3,713,851 | | | | | | — | | | | | | — | | | | | | 3,157,559 | | | | | | 9,030,619 | | |
| Ionis Pharmaceuticals, Inc. | | | | | | | | | | | | ��� | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 23,692,732 | | | | | 507,299,348 | | | | | | (94,525,097) | | | | | | 5,161,189 | | | | | | (106,427,230) | | | | | | — | | | | | | — | | | | | | 9,025,335 | | | | | | 335,200,942 | | |
| Iovance Biotherapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 57,865,957 | | | | | 327,559,233 | | | | | | (100,612,735) | | | | | | 8,903,506 | | | | | | (154,076,336) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Organovo Holdings, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 5,023,413 | | | | | 56,549 | | | | | | (1,237,735) | | | | | | 245,270 | | | | | | (2,100,223) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Pluristem Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 13,398,579 | | | | | 21,525,386 | | | | | | (15,768,364) | | | | | | (13,901,777) | | | | | | (3,361,002) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Repare Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 110,854,042 | | | | | | (18,413,385) | | | | | | 2,849,076 | | | | | | (1,902,532) | | | | | | — | | | | | | — | | | | | | 2,796,024 | | | | | | 93,387,201 | | |
| Surface Oncology, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 52,738,225 | | | | | | (12,025,122) | | | | | | 1,090,786 | | | | | | (15,795,434) | | | | | | — | | | | | | — | | | | | | 4,327,530 | | | | | | 26,008,455 | | |
| Syros Pharmaceuticals, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 31,650,621 | | | | | 7,286,853 | | | | | | (26,648,338) | | | | | | (10,216,444) | | | | | | (2,072,692) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Twist Bioscience Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 65,138,038 | | | | | 474,508,560 | | | | | | (275,988,255) | | | | | | 84,059,843 | | | | | | (43,925,824) | | | | | | — | | | | | | — | | | | | | 2,468,853 | | | | | | 303,792,362 | | |
| Electronic Equipment, Instruments & Components — 1.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 908 Devices, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 133,883,101 | | | | | | (22,382,829) | | | | | | 9,316,990 | | | | | | (38,933,731) | | | | | | — | | | | | | — | | | | | | 2,620,273 | | | | | | 81,883,531 | | |
| Financial Services — 0.2% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dynamics Special Purpose Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 21,943,695 | | | | | | (1,892,159) | | | | | | (12,016) | | | | | | (320,632) | | | | | | — | | | | | | — | | | | | | 2,003,952 | | | | | | 19,718,888 | | |
| Health Care Providers & Services — 4.8% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Accolade, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 8,343,860 | | | | | 342,698,992 | | | | | | (86,087,272) | | | | | | 15,645,729 | | | | | | (20,980,832) | | | | | | — | | | | | | — | | | | | | 5,546,261 | | | | | | 259,620,477 | | |
| Castle Biosciences, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 21,460,870 | | | | | 217,112,803 | | | | | | (100,695,086) | | | | | | 21,721,069 | | | | | | (2,952,998) | | | | | | — | | | | | | — | | | | | | 2,242,615 | | | | | | 156,646,658 | | |
| Health Care Technology — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Sema4 Holdings Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 112,398,026 | | | | | | (20,102,169) | | | | | | (1,380,242) | | | | | | (39,809,488) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Life Sciences Tools & Services — 8.9% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Codexis, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 13,842,945 | | | | | 161,497,645 | | | | | | (48,240,496) | | | | | | 16,143,106 | | | | | | (7,452,053) | | | | | | — | | | | | | — | | | | | | 6,417,351 | | | | | | 135,791,147 | | |
| Compugen Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 81,843,425 | | | | | 19,096,166 | | | | | | (30,898,863) | | | | | | 8,997,692 | | | | | | (52,274,664) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Genomic Revolution ETF
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Life Sciences Tools & Services — 8.9% (continued) | | | | | | | | |
| Pacific Biosciences of California, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 35,920,859 | | | | | 207,923,105 | | | | | | (278,465,663) | | | | | | 201,756,617 | | | | | | 293,346,221 | | | | | | — | | | | | | — | | | | | | 14,322,897 | | | | | | 460,481,139 | | |
| Personalis, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 42,136,152 | | | | | 138,148,204 | | | | | | (59,500,308) | | | | | | 29,381,429 | | | | | | (52,696,775) | | | | | | — | | | | | | — | | | | | | 4,643,578 | | | | | | 97,468,702 | | |
| Quantum-Si, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 89,436,855 | | | | | | (2,691,586) | | | | | | 788,886 | | | | | | (16,224,520) | | | | | | — | | | | | | — | | | | | | 7,570,025 | | | | | | 71,309,635 | | |
| Molecular Diagnostics — 0.4% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| CM Life Sciences II, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 41,055,232 | | | | | | (3,243,329) | | | | | | 98,994 | | | | | | (5,547,068) | | | | | | — | | | | | | — | | | | | | 2,740,375 | | | | | | 32,363,829 | | |
| $608,167,887 | | | | $ | 3,726,797,815 | | | | | $ | (1,679,660,703) | | | | | $ | 519,458,119 | | | | | $ | (386,011,891) | | | | | $ | — | | | | | $ | — | | | | | | 87,284,169 | | | | | $ | 2,567,361,623 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Genomic
Revolution ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 8,573,985,085 | | | | | $ | — | | | | | $ | — | | | | | $ | 8,573,985,085 | | |
| Money Market Fund | | | | | 18,866,018 | | | | | | — | | | | | | — | | | | | | 18,866,018 | | |
| Total | | | | $ | 8,592,851,103 | | | | | $ | — | | | | | $ | — | | | | | $ | 8,592,851,103 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Autonomous Technology & Robotics ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 97.8% | |
| Aerospace & Defense – 13.7% | |
| AeroVironment, Inc.* | | | | | 384,693 | | | | | $ | 38,892,462 | | |
| Elbit Systems Ltd. (Israel) | | | | | 255,009 | | | | | | 33,821,844 | | |
| Kratos Defense & Security Solutions, Inc.*† | | | | | 7,093,120 | | | | | | 192,932,864 | | |
| Lockheed Martin Corp. | | | | | 212,355 | | | | | | 78,925,983 | | |
| Teledyne Technologies, Inc.* | | | | | 87,733 | | | | | | 39,722,870 | | |
| Total Aerospace & Defense | | | | | | | | | | | 384,296,023 | | |
| Airlines – 1.1% | |
| Blade Air Mobility, Inc.*† | | | | | 3,905,347 | | | | | | 29,954,012 | | |
| Auto Components – 2.3% | |
| Magna International, Inc. (Canada) | | | | | 764,564 | | | | | | 64,093,400 | | |
| Automobiles – 14.9% | |
| BYD Co. Ltd. (China)(a) | | | | | 540,324 | | | | | | 33,348,797 | | |
| Niu Technologies (China)*(a) | | | | | 2,209,887 | | | | | | 56,573,107 | | |
| Tesla, Inc.* | | | | | 476,788 | | | | | | 327,648,714 | | |
| Total Automobiles | | | | | | | | | | | 417,570,618 | | |
| Biotechnology – 0.0%(b) | |
| Organovo Holdings, Inc.* | | | | | 146,241 | | | | | | 1,121,668 | | |
| Computer Hardware – 0.9% | |
| Jaws Spitfire Acquisition Corp., Class A*† | | | | | 2,656,357 | | | | | | 26,430,752 | | |
| Diversified Consumer Services – 1.4% | |
| 2U, Inc.* | | | | | 891,565 | | | | | | 38,693,921 | | |
| Diversified Telecommunication – 5.2% | |
| Iridium Communications, Inc.* | | | | | 3,439,256 | | | | | | 145,239,781 | | |
| Electronic Equipment, Instruments & Components – 6.9% | |
| Trimble, Inc.* | | | | | 2,280,083 | | | | | | 194,947,097 | | |
| Health Care Equipment & Supplies – 1.4% | |
| Intuitive Surgical, Inc.* | | | | | 39,624 | | | | | | 39,285,611 | | |
| Household Durables – 1.1% | |
| Vuzix Corp.* | | | | | 2,089,598 | | | | | | 30,926,050 | | |
| Interactive Media & Services – 7.9% | |
| Alphabet, Inc., Class C* | | | | | 52,357 | | | | | | 141,595,318 | | |
| Baidu, Inc. (China)*(a) | | | | | 482,219 | | | | | | 79,088,738 | | |
| Kanzhun Ltd. (China)*(a) | | | | | 396 | | | | | | 13,642 | | |
| Tencent Holdings Ltd. (China)(a) | | | | | 13,144 | | | | | | 804,413 | | |
| Total Interactive Media & Services | | | | | | | | | | | 221,502,111 | | |
| Internet & Direct Marketing Retail – 5.6% | |
| Alibaba Group Holding Ltd. (China)*(a) | | | | | 151,531 | | | | | | 29,577,336 | | |
| JD.com, Inc. (China)*(a) | | | | | 1,785,427 | | | | | | 126,551,066 | | |
| Total Internet & Direct Marketing Retail | | | | | | | | | | | 156,128,402 | | |
| Investments | | | Shares | | | Value | |
| Machinery – 8.8% | |
| Caterpillar, Inc. | | | | | 235,940 | | | | | $ | 48,780,595 | | |
| Deere & Co. | | | | | 212,285 | | | | | | 76,760,133 | | |
| ExOne Co. (The)* | | | | | 740,247 | | | | | | 12,288,100 | | |
| Komatsu Ltd. (Japan)(a) | | | | | 2,711,972 | | | | | | 67,853,540 | | |
| Markforged Holding Corp.* | | | | | 2,638,196 | | | | | | 28,017,642 | | |
| PACCAR, Inc. | | | | | 6,713 | | | | | | 557,112 | | |
| Proto Labs, Inc.* | | | | | 192,023 | | | | | | 15,014,278 | | |
| Total Machinery | | | | | | | | | | | 249,271,400 | | |
| Road & Rail – 1.9% | |
| TuSimple Holdings, Inc., Class A* | | | | | 1,417,427 | | | | | | 52,161,314 | | |
| Semiconductors & Semiconductor Equipment – 5.9% | |
| NVIDIA Corp. | | | | | 179,872 | | | | | | 35,073,241 | | |
| NXP Semiconductors NV (China) | | | | | 281,192 | | | | | | 58,035,217 | | |
| Teradyne, Inc. | | | | | 580,850 | | | | | | 73,767,950 | | |
| Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 166,876,408 | | |
| Software – 12.7% | |
| ANSYS, Inc.* | | | | | 90,726 | | | | | | 33,428,902 | | |
| Materialise NV (Belgium)*(a) | | | | | 1,517,989 | | | | | | 33,046,621 | | |
| Synopsys, Inc.* | | | | | 127,690 | | | | | | 36,773,443 | | |
| UiPath, Inc., Class A* | | | | | 2,076,288 | | | | | | 129,892,577 | | |
| Unity Software, Inc.* | | | | | 1,149,956 | | | | | | 123,183,287 | | |
| Total Software | | | | | | | | | | | 356,324,830 | | |
| Technology Hardware, Storage & Peripherals – 5.1% | |
| 3D Systems Corp.* | | | | | 2,655,313 | | | | | | 73,127,320 | | |
| Nano Dimension Ltd. (Israel)*(a) | | | | | 7,418,031 | | | | | | 46,956,136 | | |
| Stratasys Ltd.* | | | | | 1,095,591 | | | | | | 21,626,966 | | |
| Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 141,710,422 | | |
| Transportation – 1.0% | |
| Atlas Crest Investment Corp., Class A*† | | | | | 2,876,215 | | | | | | 28,560,815 | | |
Total Common Stocks
(Cost $2,751,687,677) | | | | | | | | | | | 2,745,094,635 | | |
| MONEY MARKET FUND – 2.5% | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(c)
(Cost $69,573,952) | | | | | 69,573,952 | | | | | | 69,573,952 | | |
Total Investments – 100.3%
(Cost $2,821,261,629) | | | | | | | | | | | 2,814,668,587 | | |
| Liabilities in Excess of Other Assets – (0.3)% | | | | | (8,028,850) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 2,806,639,737 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Autonomous Technology & Robotics ETF
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year is as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stocks — 9.9% | |
| Aerospace & Defense — 6.9% | |
| Kratos Defense & Security Solutions, Inc. | |
| 15,331,156 | | | | | 214,059,176 | | | | | | (44,697,216) | | | | | | 12,492,225 | | | | | | (4,252,477) | | | | | | — | | | | | | — | | | | | | 7,093,120 | | | | | | 192,932,864 | | |
| Airlines — 1.1% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Blade Air Mobility, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 62,031,690 | | | | | | (8,545,565) | | | | | | (927,361) | | | | | | (22,604,752) | | | | | | — | | | | | | — | | | | | | 3,905,347 | | | | | | 29,954,012 | | |
| Computer Hardware — 0.9% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Jaws Spitfire Acquisition Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 31,761,829 | | | | | | (4,160,854) | | | | | | (13,145) | | | | | | (1,157,078) | | | | | | — | | | | | | — | | | | | | 2,656,357 | | | | | | 26,430,752 | | |
| Machinery – 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| ExOne (The) Co. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 7,142,895 | | | | | 2,428,561 | | | | | | (7,093,163) | | | | | | 4,902,197 | | | | | | 4,907,610 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Markforged Holding Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 35,797,734 | | | | | | (5,012,027) | | | | | | (145,858) | | | | | | (2,622,207) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Metal Fabrication — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Galileo Acquisition Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 16,066,826 | | | | | | (15,897,512) | | | | | | (169,314) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Technology Hardware, Storage & Peripherals — 0.0% | |
| Nano Dimension Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 304,389 | | | | | 94,569,493 | | | | | | (40,824,286) | | | | | | 10,374,619 | | | | | | (17,468,079) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Transportation — 1.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Atlas Crest Investment Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 37,849,413 | | | | | | (4,912,282) | | | | | | (182,314) | | | | | | (4,194,002) | | | | | | — | | | | | | — | | | | | | 2,876,215 | | | | | | 28,560,815 | | |
| $22,778,440 | | | | $ | 494,564,722 | | | | | $ | (131,142,905) | | | | | $ | 26,331,049 | | | | | $ | (47,390,985) | | | | | $ | — | | | | | $ | — | | | | | | 16,531,039 | | | | | $ | 277,878,443 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Less than 0.05%
(c)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Autonomous
Technology &
Robotics ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 2,745,094,635 | | | | | $ | — | | | | | $ | — | | | | | $ | 2,745,094,635 | | |
| Money Market Fund | | | | | 69,573,952 | | | | | | — | | | | | | — | | | | | | 69,573,952 | | |
| Total | | | | $ | 2,814,668,587 | | | | | $ | — | | | | | $ | — | | | | | $ | 2,814,668,587 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 99.9% | |
| Automobiles – 10.7% | |
| Tesla, Inc.* | | | | | 3,500,833 | | | | | $ | 2,405,772,438 | | |
| Biotechnology – 16.7% | |
| Beam Therapeutics, Inc.*† | | | | | 4,670,285 | | | | | | 429,666,220 | | |
CRISPR Therapeutics AG (Switzerland)*† | | | | | 4,876,394 | | | | | | 590,141,202 | | |
| Editas Medicine, Inc.*† | | | | | 4,279,930 | | | | | | 179,157,870 | | |
| Exact Sciences Corp.* | | | | | 6,356,385 | | | | | | 685,472,559 | | |
| Fate Therapeutics, Inc.* | | | | | 4,448,004 | | | | | | 368,294,731 | | |
| Intellia Therapeutics, Inc.*† | | | | | 4,152,036 | | | | | | 588,966,306 | | |
| Invitae Corp.*† | | | | | 11,855,181 | | | | | | 331,826,516 | | |
| Iovance Biotherapeutics, Inc.*† | | | | | 8,489,319 | | | | | | 189,057,134 | | |
| Seres Therapeutics, Inc.* | | | | | 3,722,898 | | | | | | 26,432,576 | | |
| Twist Bioscience Corp.* | | | | | 1,841,440 | | | | | | 226,589,192 | | |
| Veracyte, Inc.* | | | | | 3,285,861 | | | | | | 146,417,966 | | |
| Total Biotechnology | | | | | | | | | | | 3,762,022,272 | | |
| Capital Markets – 5.3% | |
| Coinbase Global, Inc., Class A* | | | | | 4,263,190 | | | | | | 1,008,585,490 | | |
| Robinhood Markets, Inc., Class A* | | | | | 4,914,748 | | | | | | 172,753,392 | | |
| Total Capital Markets | | | | | | | | | | | 1,181,338,882 | | |
| Diversified Consumer Services – 1.0% | |
| 2U, Inc.*† | | | | | 5,156,616 | | | | | | 223,797,134 | | |
| Diversified Telecommunication – 1.6% | |
| Iridium Communications, Inc.*† | | | | | 8,319,135 | | | | | | 351,317,071 | | |
| Electronic Equipment, Instruments & Components – 0.6% | |
| Trimble, Inc.* | | | | | 1,683,849 | | | | | | 143,969,089 | | |
| Entertainment – 12.8% | |
| Nintendo Co. Ltd. (Japan)(a) | | | | | 3,576,384 | | | | | | 229,782,672 | | |
| Roku, Inc.* | | | | | 2,982,667 | | | | | | 1,277,506,103 | | |
| Sea Ltd. (Taiwan)*(a) | | | | | 1,362,250 | | | | | | 376,198,960 | | |
| Skillz, Inc.* | | | | | 13,748,010 | | | | | | 193,571,981 | | |
| Spotify Technology SA* | | | | | 3,485,591 | | | | | | 797,050,094 | | |
| Total Entertainment | | | | | | | | | | | 2,874,109,810 | | |
| Health Care Equipment & Supplies – 0.3% | |
| Cerus Corp.*† | | | | | 12,202,803 | | | | | | 61,502,127 | | |
| Health Care Technology – 5.8% | |
| Teladoc Health, Inc.*† | | | | | 8,818,488 | | | | | | 1,309,104,544 | | |
| Hotels Restaurants & Leisure – 2.1% | |
| DraftKings, Inc., Class A* | | | | | 9,562,144 | | | | | | 463,763,984 | | |
| Interactive Media & Services – 5.5% | |
| Twitter, Inc.* | | | | | 8,291,547 | | | | | | 578,335,403 | | |
| Zillow Group, Inc., Class C* | | | | | 6,298,654 | | | | | | 669,294,974 | | |
| Total Interactive Media & Services | | | | | | | | | | | 1,247,630,377 | | |
| Investments | | | Shares | | | Value | |
| IT Services – 13.1% | |
| Shopify, Inc., Class A (Canada)* | | | | | 674,117 | | | | | $ | 1,011,128,312 | | |
| Square, Inc., Class A* | | | | | 4,404,371 | | | | | | 1,089,024,773 | | |
| Twilio, Inc., Class A* | | | | | 2,282,564 | | | | | | 852,743,085 | | |
| Total IT Services | | | | | | | | | | | 2,952,896,170 | | |
| Life Sciences Tools & Services – 4.5% | |
| 10X Genomics, Inc., Class A* | | | | | 2,409,361 | | | | | | 441,467,216 | | |
| Berkeley Lights, Inc.*† | | | | | 3,472,513 | | | | | | 158,277,143 | | |
| Compugen Ltd. (Israel)*† | | | | | 6,419,980 | | | | | | 43,591,664 | | |
| NanoString Technologies, Inc.* | | | | | 1,878,436 | | | | | | 116,350,326 | | |
| Pacific Biosciences of California, Inc.* | | | | | 7,678,367 | | | | | | 246,859,499 | | |
| Total Life Sciences Tools & Services | | | | | | | | | | | 1,006,545,848 | | |
| Machinery – 0.7% | |
| Proto Labs, Inc.*† | | | | | 1,990,334 | | | | | | 155,624,215 | | |
| Road & Rail – 0.7% | |
| TuSimple Holdings, Inc., Class A* | | | | | 4,534,846 | | | | | | 166,882,333 | | |
| Semiconductors & Semiconductor Equipment – 1.1% | |
| Teradyne, Inc. | | | | | 1,903,801 | | | | | | 241,782,727 | | |
| Software – 17.0% | |
| DocuSign, Inc.* | | | | | 1,763,876 | | | | | | 525,705,603 | | |
| Materialise NV (Belgium)*†(a) | | | | | 3,692,041 | | | | | | 80,375,733 | | |
| PagerDuty, Inc.*† | | | | | 5,533,880 | | | | | | 224,620,189 | | |
| Palantir Technologies, Inc., Class A* | | | | | 22,189,818 | | | | | | 481,740,949 | | |
| UiPath, Inc., Class A* | | | | | 8,138,273 | | | | | | 509,130,359 | | |
| Unity Software, Inc.* | | | | | 8,521,637 | | | | | | 912,837,755 | | |
| Zoom Video Communications, Inc., Class A* | | | | | 2,899,163 | | | | | | 1,096,173,530 | | |
| Total Software | | | | | | | | | | | 3,830,584,118 | | |
| Technology Hardware, Storage & Peripherals – 0.4% | |
| Stratasys Ltd.*† | | | | | 4,144,793 | | | | | | 81,818,214 | | |
Total Common Stocks
(Cost $21,642,749,532) | | | | | | | | | | | 22,460,461,353 | | |
| MONEY MARKET FUND – 0.2% | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b)
(Cost $55,063,857) | | | | | 55,063,857 | | | | | | 55,063,857 | | |
Total Investments – 100.1%
(Cost $21,697,813,389) | | | | | | | | | | | 22,515,525,210 | | |
| Liabilities in Excess of Other Assets – (0.1)% | | | | | (20,096,356) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 22,495,428,854 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
Value ($) at
7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | | |
| Common Stocks — 22.2% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Biotechnology — 10.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Beam Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 511,716,012 | | | | | | (132,410,423) | | | | | | 25,043,598 | | | | | | 25,317,033 | | | | | | — | | | | | | — | | | | | | 4,670,285 | | | | | | 429,666,220 | | | |
| CRISPR Therapeutics AG | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 349,654,719 | | | | | 400,731,306 | | | | | | (389,395,223) | | | | | | 220,061,095 | | | | | | 9,089,305 | | | | | | — | | | | | | — | | | | | | 4,876,394 | | | | | | 590,141,202 | | | |
| Editas Medicine, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 167,727,632 | | | | | 54,225,083 | | | | | | (140,771,775) | | | | | | 65,966,160 | | | | | | 32,010,770 | | | | | | — | | | | | | — | | | | | | 4,279,930 | | | | | | 179,157,870 | | | |
| Intellia Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 124,058,583 | | | | | 2,669,475 | | | | | | (213,718,529) | | | | | | 169,898,383 | | | | | | 506,058,394 | | | | | | — | | | | | | — | | | | | | 4,152,036 | | | | | | 588,966,306 | | | |
| Invitae Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 436,592,122 | | | | | 151,153,207 | | | | | | (266,311,338) | | | | | | 175,890,772 | | | | | | (165,498,247) | | | | | | — | | | | | | — | | | | | | 11,855,181 | | | | | | 331,826,516 | | | |
| Iovance Biotherapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 111,737,202 | | | | | 423,279,172 | | | | | | (181,134,836) | | | | | | (27,046,587) | | | | | | (137,777,817) | | | | | | — | | | | | | — | | | | | | 8,489,319 | | | | | | 189,057,134 | | | |
| Organovo Holdings, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 11,151,324 | | | | | 50,716 | | | | | | (12,555,733) | | | | | | (5,411,069) | | | | | | 6,764,762 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Seres Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 31,255,090 | | | | | 80,085,762 | | | | | | (155,908,172) | | | | | | 48,118,839 | | | | | | 22,881,057 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Syros Pharmaceuticals, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 52,386,859 | | | | | 14,833,590 | | | | | | (41,251,618) | | | | | | (25,229,878) | | | | | | (738,953) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Twist Bioscience Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 57,775,335 | | | | | 271,958,960 | | | | | | (161,477,689) | | | | | | 68,880,350 | | | | | | (10,547,764) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Veracyte, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 111,568,341 | | | | | 88,395,401 | | | | | | (91,900,646) | | | | | | 61,059,084 | | | | | | (22,704,214) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Consumer Finance — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| LendingTree, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 224,789,652 | | | | | 187,805,535 | | | | | | (254,412,310) | | | | | | (97,999,605) | | | | | | (60,183,272) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Diversified Consumer Services — 1.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2U, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 288,737,750 | | | | | 93,515,725 | | | | | | (133,167,991) | | | | | | 73,877,398 | | | | | | (99,165,748) | | | | | | — | | | | | | — | | | | | | 5,156,616 | | | | | | 223,797,134 | | | |
| Diversified Telecommunication — 1.6% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Iridium Communications, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 73,837,798 | | | | | 378,734,919 | | | | | | (149,604,326) | | | | | | 44,737,970 | | | | | | 3,610,710 | | | | | | — | | | | | | — | | | | | | 8,319,135 | | | | | | 351,317,071 | | | |
| Entertainment – 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| HUYA, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 71,876,179 | | | | | 91,855,010 | | | | | | (117,130,759) | | | | | | (45,976,601) | | | | | | (623,829) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | |
| Health Care Equipment & Supplies — 0.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Cerus Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 110,213,187 | | | | | 28,115,213 | | | | | | (44,120,574) | | | | | | 9,695,955 | | | | | | (42,401,654) | | | | | | — | | | | | | — | | | | | | 12,202,803 | | | | | | 61,502,127 | | | |
| Health Care Technology — 5.8% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Teladoc Health, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 2,378,569,710 | | | | | | (596,833,930) | | | | | | 20,636,217 | | | | | | (493,267,453) | | | | | | — | | | | | | — | | | | | | 8,818,488 | | | | | | 1,309,104,544 | | | |
| Life Sciences Tools & Services — 0.9% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Berkeley Lights, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 232,291,692 | | | | | | (52,135,303) | | | | | | 1,852,167 | | | | | | (23,731,413) | | | | | | — | | | | | | — | | | | | | 3,472,513 | | | | | | 158,277,143 | | | |
| Compugen Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 142,266,832 | | | | | 41,789,751 | | | | | | (62,545,510) | | | | | | 14,932,550 | | | | | | (92,851,959) | | | | | | — | | | | | | — | | | | | | 6,419,980 | | | | | | 43,591,664 | | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Innovation ETF
July 31, 2021
Value ($) at
7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Life Sciences Tools & Services — 0.9% (continued) | | | | | | | |
| NanoString Technologies, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 102,159,848 | | | | | 177,481,886 | | | | | | (233,304,566) | | | | | | 90,974,269 | | | | | | (20,961,110) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Machinery — 0.7% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| ExOne (The) Co. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 18,236,340 | | | | | 4,714,545 | | | | | | (29,603,143) | | | | | | 8,186,732 | | | | | | (1,534,473) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Proto Labs, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 218,068,251 | | | | | 205,119,051 | | | | | | (157,357,018) | | | | | | 31,569,580 | | | | | | (141,775,649) | | | | | | — | | | | | | — | | | | | | 1,990,334 | | | | | | 155,624,215 | | |
| Software — 1.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Materialise NV | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 90,286,259 | | | | | 96,087,427 | | | | | | (101,533,787) | | | | | | 45,380,498 | | | | | | (49,844,664) | | | | | | — | | | | | | — | | | | | | 3,692,041 | | | | | | 80,375,733 | | |
| PagerDuty, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 107,564,804 | | | | | 146,914,239 | | | | | | (118,397,600) | | | | | | 59,275,022 | | | | | | 29,263,724 | | | | | | — | | | | | | — | | | | | | 5,533,880 | | | | | | 224,620,189 | | |
| Technology Hardware, Storage & Peripherals — 0.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pure Storage, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 145,380,257 | | | | | 276,633,507 | | | | | | (458,726,068) | | | | | | 51,053,337 | | | | | | (14,341,032) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Stratasys Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 114,094,825 | | | | | — | | | | | | (92,495,606) | | | | | | 26,577,390 | | | | | | 33,641,605 | | | | | | — | | | | | | — | | | | | | 4,144,793 | | | | | | 81,818,214 | | |
| $3,161,419,189 | | | | $ | 6,338,726,894 | | | | | $ | (4,388,204,473) | | | | | $ | 1,112,003,626 | | | | | $ | (709,311,891) | | | | | $ | — | | | | | $ | — | | | | | | 98,073,728 | | | | | $ | 4,998,843,282 | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Innovation
ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 22,460,461,353 | | | | | $ | — | | | | | $ | — | | | | | $ | 22,460,461,353 | | |
| Money Market Fund | | | | | 55,063,857 | | | | | | — | | | | | | — | | | | | | 55,063,857 | | |
| Total | | | | $ | 22,515,525,210 | | | | | $ | — | | | | | $ | — | | | | | $ | 22,515,525,210 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Next Generation Internet ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 94.6% | |
| Automobiles – 10.6% | |
| Tesla, Inc.* | | | | | 896,697 | | | | | $ | 616,210,178 | | |
| Biotechnology – 0.9% | | | | | | | | | | | | | |
| Veracyte, Inc.* | | | | | 1,117,490 | | | | | | 49,795,354 | | |
| Capital Markets – 6.3% | | | | | | | | | | | | | |
| Coinbase Global, Inc., Class A* | | | | | 1,096,974 | | | | | | 259,522,109 | | |
| Concord Acquisition Corp., Class A*† | | | | | 2,794,940 | | | | | | 28,340,692 | | |
Khosla Ventures Acquisition Co. II, Class A*† | | | | | 4,174,229 | | | | | | 44,079,858 | | |
| Robinhood Markets, Inc., Class A* | | | | | 953,729 | | | | | | 33,523,574 | | |
| Total Capital Markets | | | | | | | | | | | 365,466,233 | | |
| Consumer Finance – 1.3% | | | | | | | | | | | | | |
| LendingClub Corp.* | | | | | 3,127,763 | | | | | | 76,317,417 | | |
| Diversified Consumer Services – 0.9% | | | | | | | | | | | | | |
| 2U, Inc.* | | | | | 1,240,377 | | | | | | 53,832,362 | | |
| Entertainment – 14.0% | | | | | | | | | | | | | |
| Netflix, Inc.* | | | | | 89,159 | | | | | | 46,146,024 | | |
| Nintendo Co. Ltd. (Japan)(a) | | | | | 1,277 | | | | | | 82,047 | | |
| ROBLOX Corp., Class A* | | | | | 1,255,593 | | | | | | 96,655,549 | | |
| Roku, Inc.* | | | | | 453,912 | | | | | | 194,415,049 | | |
| Sea Ltd. (Taiwan)*(a) | | | | | 413,623 | | | | | | 114,226,128 | | |
| Skillz, Inc.* | | | | | 6,646,176 | | | | | | 93,578,158 | | |
| Spotify Technology SA* | | | | | 914,550 | | | | | | 209,130,148 | | |
| Walt Disney Co. (The)* | | | | | 352,361 | | | | | | 62,022,583 | | |
| Total Entertainment | | | | | | | | | | | 816,255,686 | | |
| Health Care Technology – 5.1% | | | | | | | | | | | | | |
| Teladoc Health, Inc.* | | | | | 2,010,176 | | | | | | 298,410,627 | | |
| Hotels Restaurants & Leisure – 2.7% | |
| DraftKings, Inc., Class A* | | | | | 3,235,427 | | | | | | 156,918,210 | | |
| Household Durables – 1.0% | | | | | | | | | | | | | |
| Vuzix Corp.*† | | | | | 4,038,094 | | | | | | 59,763,791 | | |
| Interactive Media & Services – 9.0% | |
| Kanzhun Ltd. (China)*(a) | | | | | 291 | | | | | | 10,025 | | |
| Snap, Inc., Class A* | | | | | 835,981 | | | | | | 62,213,706 | | |
| Tencent Holdings Ltd. (China)(a) | | | | | 291 | | | | | | 17,809 | | |
| Twitter, Inc.* | | | | | 4,738,006 | | | | | | 330,475,919 | | |
| Zillow Group, Inc., Class C* | | | | | 1,229,115 | | | | | | 130,605,760 | | |
| Total Interactive Media & Services | | | | | | | | | | | 523,323,219 | | |
| Internet & Direct Marketing Retail – 3.9% | |
| Etsy, Inc.* | | | | | 397,729 | | | | | | 72,987,249 | | |
| Farfetch Ltd., Class A (United Kingdom)* | | | | | 1,178,942 | | | | | | 59,088,573 | | |
| JD.com, Inc. (China)*(a) | | | | | 291 | | | | | | 20,626 | | |
| MercadoLibre, Inc. (Argentina)* | | | | | 60,400 | | | | | | 94,749,480 | | |
| Investments | | | Shares | | | Value | |
| Pinduoduo, Inc. (China)*(a) | | | | | 97 | | | | | $ | 8,886 | | |
| Total Internet & Direct Marketing Retail | | | | | | | | | | | 226,854,814 | | |
| IT Services – 16.8% | | | | | | | | | | | | | |
| Adyen NV (Netherlands)*(a) | | | | | 1,153,546 | | | | | | 62,556,799 | | |
| Okta, Inc.* | | | | | 350,359 | | | | | | 86,815,457 | | |
| PayPal Holdings, Inc.* | | | | | 208,205 | | | | | | 57,366,724 | | |
| Shopify, Inc., Class A (Canada)* | | | | | 189,005 | | | | | | 283,494,270 | | |
| Snowflake, Inc., Class A* | | | | | 98 | | | | | | 26,040 | | |
| Square, Inc., Class A* | | | | | 1,051,476 | | | | | | 259,987,956 | | |
| Twilio, Inc., Class A* | | | | | 607,032 | | | | | | 226,781,085 | | |
| Total IT Services | | | | | | | | | | | 977,028,331 | | |
| Leisure Products – 3.3% | | | | | | | | | | | | | |
| Peloton Interactive, Inc., Class A* | | | | | 1,616,901 | | | | | | 190,875,163 | | |
| Software – 18.0% | | | | | | | | | | | | | |
| Cloudflare, Inc., Class A* | | | | | 512,786 | | | | | | 60,831,803 | | |
| DocuSign, Inc.* | | | | | 197,570 | | | | | | 58,883,763 | | |
| PagerDuty, Inc.* | | | | | 1,329,878 | | | | | | 53,979,748 | | |
| Palantir Technologies, Inc., Class A* | | | | | 4,576,908 | | | | | | 99,364,673 | | |
| Splunk, Inc.* | | | | | 411,122 | | | | | | 58,371,101 | | |
| Trade Desk, Inc. (The), Class A* | | | | | 1,709,592 | | | | | | 140,032,681 | | |
| UiPath, Inc., Class A* | | | | | 1,954,064 | | | | | | 122,246,244 | | |
| Unity Software, Inc.* | | | | | 2,191,384 | | | | | | 234,741,054 | | |
| Zoom Video Communications, Inc., Class A* | | | | | 568,182 | | | | | | 214,829,614 | | |
| Total Software | | | | | | | | | | | 1,043,280,681 | | |
| Technology Hardware, Storage & Peripherals – 0.8% | |
| Nano Dimension Ltd. (Israel)*(a) | | | | | 7,414,417 | | | | | | 46,933,260 | | |
Total Common Stocks
(Cost $5,270,700,990) | | | | | | | | | | | 5,501,265,326 | | |
| UNIT TRUST – 5.3% | | | | | | | | | | | | | |
| Financials – 5.3% | | | | | | | | | | | | | |
Grayscale Bitcoin Trust BTC*
(Cost $270,118,667) | | | | | 8,872,902 | | | | | | 308,200,251 | | |
| MONEY MARKET FUND – 0.3% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b)
(Cost $17,727,566) | | | | | 17,727,566 | | | | | | 17,727,566 | | |
Total Investments – 100.2%
(Cost $5,558,547,223) | | | | | | | | | | | 5,827,193,143 | | |
| Liabilities in Excess of Other Assets – (0.2)% | | | | | (13,553,227) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 5,813,639,916 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Next Generation Internet ETF
July 31, 2021
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stocks — 2.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Capital Markets — 1.3% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Concord Acquisition Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 30,484,796 | | | | | | (1,215,603) | | | | | | (16,017) | | | | | | (912,484) | | | | | | — | | | | | | — | | | | | | 2,794,940 | | | | | | 28,340,692 | | |
| Khosla Ventures Acquisition Co. II | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 45,816,028 | | | | | | (1,709,605) | | | | | | 9,742 | | | | | | (36,307) | | | | | | — | | | | | | — | | | | | | 4,174,229 | | | | | | 44,079,858 | | |
| Consumer Finance — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| LendingClub Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 16,678,229 | | | | | 24,679,703 | | | | | | (38,444,677) | | | | | | 7,787,276 | | | | | | 65,616,886 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Entertainment — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| HUYA, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 56,125,769 | | | | | 64,892,115 | | | | | | (93,157,648) | | | | | | (16,021,118) | | | | | | (11,839,118) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Household Durables — 1.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Vuzix Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 76,369,904 | | | | | | (4,852,335) | | | | | | 32,456 | | | | | | (11,786,234) | | | | | | — | | | | | | — | | | | | | 4,038,094 | | | | | | 59,763,791 | | |
| $72,803,998 | | | | $ | 242,242,546 | | | | | $ | (139,379,868) | | | | | $ | (8,207,661) | | | | | $ | 41,042,743 | | | | | $ | — | | | | | $ | — | | | | | | 11,007,263 | | | | | $ | 132,184,341 | | |
*
Non-income producing security
†
Affiliated security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Next
Generation Internet
ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 5,501,265,326 | | | | | $ | — | | | | | $ | — | | | | | $ | 5,501,265,326 | | |
| Unit Trust‡ | | | | | 308,200,251 | | | | | | — | | | | | | — | | | | | | 308,200,251 | | |
| Money Market Fund | | | | | 17,727,566 | | | | | | — | | | | | | — | | | | | | 17,727,566 | | |
| Total | | | | $ | 5,827,193,143 | | | | | $ | — | | | | | $ | — | | | | | $ | 5,827,193,143 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Fintech Innovation ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 99.8% | |
| Banks – 4.2% | |
| HDFC Bank Ltd. (India)(a) | | | | | 250,528 | | | | | $ | 17,679,761 | | |
| Silvergate Capital Corp., Class A* | | | | | 672,615 | | | | | | 69,144,822 | | |
TCS Group Holding PLC, Class Reg S (Russia)(b) | | | | | 807,708 | | | | | | 66,813,606 | | |
| Total Banks | | | | | | | | | | | 153,638,189 | | |
| Capital Markets – 6.9% | | | | | | | | | | | | | |
| Charles Schwab Corp. (The) | | | | | 1,061 | | | | | | 72,095 | | |
| Coinbase Global, Inc., Class A* | | | | | 681,038 | | | | | | 161,119,970 | | |
| Intercontinental Exchange, Inc. | | | | | 541,624 | | | | | | 64,902,804 | | |
| Robinhood Markets, Inc., Class A* | | | | | 594,494 | | | | | | 20,896,464 | | |
| Total Capital Markets | | | | | | | | | | | 246,991,333 | | |
| Consumer Finance – 2.3% | | | | | | | | | | | | | |
| Kaspi.KZ JSC (Kazakhstan)(b) | | | | | 222,375 | | | | | | 25,172,850 | | |
| LendingClub Corp.* | | | | | 2,407,772 | | | | | | 58,749,637 | | |
| Total Consumer Finance | | | | | | | | | | | 83,922,487 | | |
| Entertainment – 4.5% | | | | | | | | | | | | | |
| Sea Ltd. (Taiwan)*(a) | | | | | 582,151 | | | | | | 160,766,820 | | |
| Health Care Providers & Services – 0.9% | |
Ping An Healthcare and Technology Co. Ltd.
(China)*(c) | | | | | 3,520,100 | | | | | | 32,840,345 | | |
| Health Care Technology – 2.4% | | | | | | | | | | | | | |
| Teladoc Health, Inc.* | | | | | 588,437 | | | | | | 87,353,473 | | |
| Hotels Restaurants & Leisure – 1.4% | | | | | | | | | | | | | |
| DraftKings, Inc., Class A* | | | | | 1,064,855 | | | | | | 51,645,468 | | |
| Insurance – 3.1% | | | | | | | | | | | | | |
| Discovery Ltd. (South Africa)* | | | | | 4,931,593 | | | | | | 39,584,017 | | |
ZhongAn Online P&C Insurance Co. Ltd., Class H (China)*(c) | | | | | 13,321,163 | | | | | | 72,081,340 | | |
| Total Insurance | | | | | | | | | | | 111,665,357 | | |
| Interactive Media & Services – 16.5% | | | | | | | | | | | | | |
| Alphabet, Inc., Class C* | | | | | 7,186 | | | | | | 19,433,962 | | |
| Facebook, Inc., Class A* | | | | | 277,705 | | | | | | 98,946,291 | | |
| Pinterest, Inc., Class A* | | | | | 1,740,807 | | | | | | 102,533,532 | | |
| Snap, Inc., Class A* | | | | | 933,953 | | | | | | 69,504,782 | | |
| Tencent Holdings Ltd. (China)(a) | | | | | 853,074 | | | | | | 52,208,129 | | |
| Z Holdings Corp. (Japan) | | | | | 14,421,106 | | | | | | 71,839,337 | | |
| Zillow Group, Inc., Class C* | | | | | 1,694,718 | | | | | | 180,080,735 | | |
| Total Interactive Media & Services | | | | | | | | | | | 594,546,768 | | |
| Investments | | | Shares | | | Value | |
| Internet & Direct Marketing Retail – 11.5% | |
| Alibaba Group Holding Ltd. (China)*(a) | | | | | 147,838 | | | | | $ | 28,856,499 | | |
| Amazon.com, Inc.* | | | | | 12,082 | | | | | | 40,203,942 | | |
| Farfetch Ltd., Class A (United Kingdom)* | | | | | 944,845 | | | | | | 47,355,631 | | |
| JD.com, Inc. (China)*(a) | | | | | 1,011,380 | | | | | | 71,686,614 | | |
| Meituan, Class B (China)*(c) | | | | | 1,391,119 | | | | | | 38,487,301 | | |
| MercadoLibre, Inc. (Argentina)* | | | | | 94,408 | | | | | | 148,097,830 | | |
| Pinduoduo, Inc. (China)*(a) | | | | | 426,663 | | | | | | 39,086,598 | | |
| Total Internet & Direct Marketing Retail | | | | | | | | | | | 413,774,415 | | |
| IT Services – 33.4% | | | | | | | | | | | | | |
| Adyen NV (Netherlands)*(c) | | | | | 50,587 | | | | | | 137,390,641 | | |
| BASE, Inc. (Japan)* | | | | | 2,531,000 | | | | | | 26,300,898 | | |
| PayPal Holdings, Inc.* | | | | | 621,481 | | | | | | 171,236,660 | | |
| Shopify, Inc., Class A (Canada)* | | | | | 161,918 | | | | | | 242,865,666 | | |
| Square, Inc., Class A* | | | | | 1,594,118 | | | | | | 394,161,617 | | |
| StoneCo Ltd., Class A (Brazil)* | | | | | 1,040,286 | | | | | | 61,210,428 | | |
| Twilio, Inc., Class A* | | | | | 356,756 | | | | | | 133,280,474 | | |
| Yeahka Ltd. (China)* | | | | | 8,270,400 | | | | | | 39,749,514 | | |
| Total IT Services | | | | | | | | | | | 1,206,195,898 | | |
| Real Estate Management & Development – 2.8% | |
| Opendoor Technologies, Inc.* | | | | | 6,918,590 | | | | | | 102,533,504 | | |
| Software – 9.9% | | | | | | | | | | | | | |
| Bill.com Holdings, Inc.* | | | | | 214,230 | | | | | | 44,307,049 | | |
| DocuSign, Inc.* | | | | | 339,513 | | | | | | 101,188,454 | | |
| Intuit, Inc. | | | | | 139,366 | | | | | | 73,859,799 | | |
| UiPath, Inc., Class A* | | | | | 1,477,934 | | | | | | 92,459,551 | | |
| Workday, Inc., Class A* | | | | | 192,277 | | | | | | 45,069,729 | | |
| Total Software | | | | | | | | | | | 356,884,582 | | |
Total Common Stocks
(Cost $3,577,057,157) | | | | | | | | | | | 3,602,758,639 | | |
| MONEY MARKET FUND – 0.3% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(d)
(Cost $9,506,787) | | | | | 9,506,787 | | | | | | 9,506,787 | | |
Total Investments – 100.1%
(Cost $3,586,563,944) | | | | | | | | | | | 3,612,265,426 | | |
| Liabilities in Excess of Other Assets – (0.1)% | | | | | | | | | | | (1,996,366) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 3,610,269,060 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Fintech Innovation ETF
July 31, 2021
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stock — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Banks — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Silvergate Capital Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| $1,646,155 | | | | $ | 134,189,781 | | | | | $ | (88,593,084) | | | | | $ | (3,481,480) | | | | | $ | 25,383,450 | | | | | $ | — | | | | | $ | ��� | | | | | | — | | | | | $ | — | | |
†
Affiliated security
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Global Depositary Receipt
(c)
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
(d)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Fintech
Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 3,602,758,639 | | | | | $ | — | | | | | $ | — | | | | | $ | 3,602,758,639 | | |
| Money Market Fund | | | | | 9,506,787 | | | | | | — | | | | | | — | | | | | | 9,506,787 | | |
| Total | | | | $ | 3,612,265,426 | | | | | $ | — | | | | | $ | — | | | | | $ | 3,612,265,426 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
ARK Space Exploration & Innovation ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 92.9% | | | | | | | | | | | | | |
| Aerospace & Defense – 33.6% | | | | | | | | | | | | | |
| AeroVironment, Inc.* | | | | | 171,610 | | | | | $ | 17,349,771 | | |
| Airbus SE (France)* | | | | | 69,618 | | | | | | 9,555,039 | | |
| Boeing Co. (The)* | | | | | 74,056 | | | | | | 16,772,203 | | |
| Elbit Systems Ltd. (Israel) | | | | | 63,838 | | | | | | 8,466,834 | | |
| HEICO Corp. | | | | | 44,790 | | | | | | 6,057,848 | | |
| Kratos Defense & Security Solutions, Inc.* | | | | | 1,417,778 | | | | | | 38,563,562 | | |
| L3Harris Technologies, Inc. | | | | | 150,416 | | | | | | 34,105,324 | | |
| Lockheed Martin Corp. | | | | | 73,735 | | | | | | 27,405,087 | | |
| Spirit AeroSystems Holdings, Inc., Class A | | | | | 346,164 | | | | | | 14,957,746 | | |
| Teledyne Technologies, Inc.* | | | | | 12,260 | | | | | | 5,550,960 | | |
| Thales SA (France) | | | | | 241,827 | | | | | | 25,387,833 | | |
| Total Aerospace & Defense | | | | | | | | | | | 204,172,207 | | |
| Air Freight & Logistics – 2.9% | | | | | | | | | | | | | |
| JD Logistics, Inc. (China)*(a) | | | | | 4,888,223 | | | | | | 17,644,062 | | |
| Airlines – 1.2% | | | | | | | | | | | | | |
| Blade Air Mobility, Inc.* | | | | | 973,420 | | | | | | 7,466,131 | | |
| Computer Hardware – 1.1% | | | | | | | | | | | | | |
| Jaws Spitfire Acquisition Corp., Class A* | | | | | 693,861 | | | | | | 6,903,917 | | |
| Diversified Telecommunication – 6.3% | | | | | | | | | | | | | |
| Iridium Communications, Inc.* | | | | | 910,271 | | | | | | 38,440,744 | | |
| Electronic Equipment, Instruments & Components – 10.2% | |
| Trimble, Inc.* | | | | | 721,323 | | | | | | 61,673,117 | | |
| Entertainment – 2.6% | | | | | | | | | | | | | |
| Netflix, Inc.* | | | | | 30,372 | | | | | | 15,719,636 | | |
| Household Durables – 1.2% | | | | | | | | | | | | | |
| Garmin Ltd. | | | | | 44,236 | | | | | | 6,953,899 | | |
| Industrial Conglomerates – 1.2% | | | | | | | | | | | | | |
| Honeywell International, Inc. | | | | | 31,092 | | | | | | 7,268,999 | | |
| Raven Industries, Inc.* | | | | | 50 | | | | | | 2,912 | | |
| Total Industrial Conglomerates | | | | | | | | | | | 7,271,911 | | |
| Interactive Media & Services – 3.2% | | | | | | | | | | | | | |
| Alphabet, Inc., Class C* | | | | | 7,077 | | | | | | 19,139,180 | | |
| Internet & Direct Marketing Retail – 5.1% | |
| Alibaba Group Holding Ltd. (China)*(b) | | | | | 41,676 | | | | | | 8,134,738 | | |
| Amazon.com, Inc.* | | | | | 5,123 | | | | | | 17,047,244 | | |
| Meituan, Class B (China)*(a) | | | | | 206,663 | | | | | | 5,717,628 | | |
| Total Internet & Direct Marketing Retail | | | | | | | | | | | 30,899,610 | | |
| Investments | | | Shares | | | Value | |
| Machinery – 5.9% | | | | | | | | | | | | | |
| Deere & Co. | | | | | 27,096 | | | | | $ | 9,797,643 | | |
| Komatsu Ltd. (Japan) | | | | | 895,688 | | | | | | 23,097,410 | | |
| Markforged Holding Corp.* | | | | | 291,339 | | | | | | 3,094,020 | | |
| Total Machinery | | | | | | | | | | | 35,989,073 | | |
| Semiconductors & Semiconductor Equipment – 3.8% | |
| NVIDIA Corp. | | | | | 61,252 | | | | | | 11,943,528 | | |
| Teradyne, Inc. | | | | | 87,180 | | | | | | 11,071,860 | | |
| Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 23,015,388 | | |
| Software – 12.0% | | | | | | | | | | | | | |
| ANSYS, Inc.* | | | | | 17,882 | | | | | | 6,588,802 | | |
| Dassault Systemes SE (France) | | | | | 324,987 | | | | | | 17,934,252 | | |
| Synopsys, Inc.* | | | | | 24,534 | | | | | | 7,065,547 | | |
| UiPath, Inc., Class A* | | | | | 272,618 | | | | | | 17,054,982 | | |
| Unity Software, Inc.* | | | | | 227,665 | | | | | | 24,387,475 | | |
| Total Software | | | | | | | | | | | 73,031,058 | | |
| Transportation – 2.6% | | | | | | | | | | | | | |
| Atlas Crest Investment Corp., Class A* | | | | | 396,460 | | | | | | 3,936,848 | | |
| Reinvent Technology Partners, Class A* | | | | | 1,190,925 | | | | | | 11,885,431 | | |
| Total Transportation | | | | | | | | | | | 15,822,279 | | |
Total Common Stocks
(Cost $558,368,417) | | | | | | | | | | | 564,142,212 | | |
| EXCHANGE – TRADED FUND – 6.9% | |
| Equity Fund – 6.9% | | | | | | | | | | | | | |
The 3D Printing ETF*†
(Cost $42,839,289) | | | | | 1,095,858 | | | | | | 41,642,604 | | |
| MONEY MARKET FUND – 1.0% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(c)
(Cost $6,356,450) | | | | | 6,356,450 | | | | | | 6,356,450 | | |
Total Investments – 100.8%
(Cost $607,564,156) | | | | | | | | | | | 612,141,266 | | |
| Liabilities in Excess of Other Assets – (0.8)% | | | | | (4,587,962) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 607,553,304 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
ARK Space Exploration & Innovation ETF
July 31, 2021
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 3/30/2021 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Exchange – Traded Fund — 6.8% | |
| Equity Fund — 6.8% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| The 3D Printing ETF | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| $ — | | | | $ | 47,555,768 | | | | | $ | (4,859,306) | | | | | $ | 142,827 | | | | | $ | (1,196,685) | | | | | $ | — | | | | | $ | — | | | | | | 1,095,858 | | | | | $ | 41,642,604 | | |
†
Affiliated security
*
Non-income producing security
(a)
Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
(b)
American Depositary Receipt
(c)
Rate shown represents annualized 7-day yield as of July 31, 2021.
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
ARK Space Exploration &
Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 564,142,212 | | | | | $ | — | | | | | $ | — | | | | | $ | 564,142,212 | | |
| Exchange – Traded Fund | | | | | 41,642,604 | | | | | | — | | | | | | — | | | | | | 41,642,604 | | |
| Money Market Fund | | | | | 6,356,450 | | | | | | — | | | | | | — | | | | | | 6,356,450 | | |
| Total | | | | $ | 612,141,266 | | | | | $ | — | | | | | $ | — | | | | | $ | 612,141,266 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 99.8% | |
| Aerospace & Defense – 2.4% | | | | | | | | | | | | | |
| Aerojet Rocketdyne Holdings, Inc. | | | | | 126,735 | | | | | $ | 5,979,358 | | |
| Hexcel Corp.* | | | | | 9,567 | | | | | | 520,636 | | |
| Moog, Inc., Class A | | | | | 74,021 | | | | | | 5,764,015 | | |
| Total Aerospace & Defense | | | | | | | | | | | 12,264,009 | | |
| Air Freight & Logistics – 1.0% | |
| United Parcel Service, Inc., Class B | | | | | 28,045 | | | | | | 5,366,691 | | |
| Auto Components – 2.3% | | | | | | | | | | | | | |
Cie Generale des Etablissements Michelin SCA
(France) | | | | | 36,718 | | | | | | 5,997,780 | | |
| Exco Technologies Ltd. (Canada) | | | | | 705,475 | | | | | | 5,812,987 | | |
| Total Auto Components | | | | | | | | | | | 11,810,767 | | |
| Chemicals – 0.8% | | | | | | | | | | | | | |
| 5N Plus, Inc. (Canada)* | | | | | 251,037 | | | | | | 535,234 | | |
| Arkema SA (France) | | | | | 4,407 | | | | | | 560,684 | | |
| DuPont de Nemours, Inc. | | | | | 7,002 | | | | | | 525,500 | | |
| Eastman Chemical Co. | | | | | 4,914 | | | | | | 553,906 | | |
| Evonik Industries AG (Germany) | | | | | 16,280 | | | | | | 565,848 | | |
| Koninklijke DSM NV (Netherlands) | | | | | 2,919 | | | | | | 588,481 | | |
| Toray Industries, Inc. (Japan) | | | | | 86,599 | | | | | | 566,144 | | |
| Total Chemicals | | | | | | | | | | | 3,895,797 | | |
| Commercial Services & Supplies – 0.1% | |
| PyroGenesis Canada, Inc. (Canada)* | | | | | 122,415 | | | | | | 451,354 | | |
| Electrical Equipment – 1.4% | | | | | | | | | | | | | |
| AMETEK, Inc. | | | | | 46,954 | | | | | | 6,528,954 | | |
| SGL Carbon SE (Germany)* | | | | | 50,545 | | | | | | 562,417 | | |
| Total Electrical Equipment | | | | | | | | | | | 7,091,371 | | |
| Electronic Equipment, Instruments & Components – 10.2% | |
| FARO Technologies, Inc.* | | | | | 83,294 | | | | | | 6,071,300 | | |
| Hexagon AB, Class B (Sweden) | | | | | 409,963 | | | | | | 6,786,363 | | |
| Renishaw PLC (United Kingdom) | | | | | 281,670 | | | | | | 20,006,862 | | |
| Trimble, Inc.* | | | | | 230,215 | | | | | | 19,683,383 | | |
Total Electronic Equipment, Instruments &
Components | | | | | | | | | | | 52,547,908 | | |
| Health Care Equipment & Supplies – 9.0% | |
| Align Technology, Inc.* | | | | | 9,967 | | | | | | 6,935,039 | | |
| Conformis, Inc.*† | | | | | 12,892,332 | | | | | | 19,209,575 | | |
| Straumann Holding AG (Switzerland) | | | | | 11,114 | | | | | | 20,612,154 | | |
| Total Health Care Equipment & Supplies | | | | | | | | | | | 46,756,768 | | |
| Industrial Conglomerates – 2.4% | |
| 3M Co. | | | | | 2,747 | | | | | | 543,741 | | |
| General Electric Co.* | | | | | 467,650 | | | | | | 6,056,067 | | |
| Siemens AG (Germany) | | | | | 37,573 | | | | | | 5,864,667 | | |
| Total Industrial Conglomerates | | | | | | | | | | | 12,464,475 | | |
| Internet & Direct Marketing Retail – 2.5% | |
| Xometry, Inc., Class A* | | | | | 164,937 | | | | | | 13,058,062 | | |
| Life Sciences Tools & Services – 4.4% | |
| CELLINK AB, Class B (Sweden)* | | | | | 346,037 | | | | | | 22,550,852 | | |
| Investments | | | Shares | | | Value | |
| Machinery – 17.4% | | | | | | | | | | | | | |
| Desktop Metal, Inc., Class A* | | | | | 2,052,312 | | | | | $ | 18,470,808 | | |
| ExOne Co. (The)*† | | | | | 1,133,482 | | | | | | 18,815,801 | | |
| Lincoln Electric Holdings, Inc. | | | | | 44,073 | | | | | | 6,145,098 | | |
| OC Oerlikon Corp. AG (Switzerland) | | | | | 526,134 | | | | | | 5,959,193 | | |
| Proto Labs, Inc.* | | | | | 226,408 | | | | | | 17,702,841 | | |
| Sandvik AB (Sweden) | | | | | 20,766 | | | | | | 541,078 | | |
| SLM Solutions Group AG (Germany)* | | | | | 944,745 | | | | | | 21,719,306 | | |
| Total Machinery | | | | | | | | | | | 89,354,125 | | |
| Metals & Mining – 2.8% | |
| Allegheny Technologies, Inc.* | | | | | 26,616 | | | | | | 546,427 | | |
| Arconic Corp.* | | | | | 176,681 | | | | | | 6,349,915 | | |
| Carpenter Technology Corp. | | | | | 14,565 | | | | | | 555,655 | | |
| Kaiser Aluminum Corp. | | | | | 50,847 | | | | | | 6,187,063 | | |
| voestalpine AG (Austria) | | | | | 13,242 | | | | | | 584,037 | | |
| Total Metals & Mining | | | | | | | | | | | 14,223,097 | | |
| Software – 25.8% | | | | | | | | | | | | | |
| Altair Engineering, Inc., Class A* | | | | | 279,087 | | | | | | 19,469,109 | | |
| ANSYS, Inc.* | | | | | 53,867 | | | | | | 19,847,835 | | |
| Autodesk, Inc.* | | | | | 63,859 | | | | | | 20,507,041 | | |
| Dassault Systemes SE (France) | | | | | 365,540 | | | | | | 20,172,150 | | |
| Materialise NV (Belgium)*(a) | | | | | 751,795 | | | | | | 16,366,577 | | |
| Microsoft Corp. | | | | | 66,170 | | | | | | 18,852,495 | | |
| PTC, Inc.* | | | | | 133,103 | | | | | | 18,028,801 | | |
| Total Software | | | | | | | | | | | 133,244,008 | | |
| Technology Hardware, Storage & Peripherals – 17.3% | |
| 3D Systems Corp.* | | | | | 873,271 | | | | | | 24,049,883 | | |
| Eastman Kodak Co.* | | | | | 75,025 | | | | | | 553,684 | | |
| HP, Inc. | | | | | 681,976 | | | | | | 19,688,647 | | |
| MGI Digital Graphic Technology (France)* | | | | | 278,869 | | | | | | 13,497,023 | | |
| Nano Dimension Ltd. (Israel)*(a) | | | | | 2,881,926 | | | | | | 18,242,592 | | |
| Stratasys Ltd.* | | | | | 648,124 | | | | | | 12,793,968 | | |
| Xerox Holdings Corp. | | | | | 23,604 | | | | | | 569,565 | | |
| Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 89,395,362 | | |
Total Common Stocks
(Cost $575,915,343) | | | | | | | | | | | 514,474,646 | | |
| PREFERRED STOCK – 0.1% | |
| Household Products – 0.1% | |
Henkel AG & Co. KGaA (Germany)
(Cost $583,106) | | | | | 5,407 | | | | | | 548,275 | | |
| MONEY MARKET FUND – 0.1% | |
Dreyfus Government Cash Management Fund, Institutional Shares, 0.03%(b)
(Cost $480,720) | | | | | 480,720 | | | | | | 480,720 | | |
Total Investments – 100.0%
(Cost $576,979,169) | | | | | | | | | | | 515,503,641 | | |
Liabilities in Excess of Other Assets – (0.0)%(c) | | | | | | | | | | | (115) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 515,503,526 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
The 3D Printing ETF
July 31, 2021
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stocks — 7.4% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Health Care Equipment & Supplies — 3.7% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Conformis, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| — | | | | | 14,561,885 | | | | | | (172,962) | | | | | | 30,515 | | | | | | 4,790,137 | | | | | | — | | | | | | — | | | | | | 12,892,332 | | | | | | 19,209,575 | | |
| Machinery — 3.7% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| ExOne (The) Co. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2,089,567 | | | | | 58,624,908 | | | | | | (16,321,877) | | | | | | (2,306,671) | | | | | | (23,270,126) | | | | | | — | | | | | | — | | | | | | 1,133,482 | | | | | | 18,815,801 | | |
| SLM Solutions Group AG | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2,127,620 | | | | | 34,584,008 | | | | | | (15,235,793) | | | | | | 961,223 | | | | | | (717,752) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| Technology Hardware, Storage & Peripherals — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| MGI Digital Graphic Technology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2,127,889 | | | | | 32,525,693 | | | | | | (13,396,541) | | | | | | (3,592,933) | | | | | | (4,167,085) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| $6,345,076 | | | | $ | 140,296,494 | | | | | $ | (45,127,173) | | | | | $ | (4,907,866) | | | | | $ | (23,364,826) | | | | | $ | — | | | | | $ | — | | | | | | 14,025,814 | | | | | $ | 38,025,376 | | |
*
Non-income producing security
†
Affiliated security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of July 31, 2021.
(c)
Less than 0.05%
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
| The 3D Printing ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 514,474,646 | | | | | $ | — | | | | | $ | — | | | | | $ | 514,474,646 | | |
| Preferred Stock‡ | | | | | 548,275 | | | | | | — | | | | | | — | | | | | | 548,275 | | |
| Money Market Fund | | | | | 480,720 | | | | | | — | | | | | | — | | | | | | 480,720 | | |
| Total | | | | $ | 515,503,641 | | | | | $ | — | | | | | $ | — | | | | | $ | 515,503,641 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
The ARK Israel Innovative Technology ETF
| Investments | | | Shares | | | Value | |
| COMMON STOCKS – 99.4% | | | | | | | | | | | | | |
| Aerospace & Defense – 4.2% | | | | | | | | | | | | | |
| Bet Shemesh Engines Holdings 1997 Ltd. (Israel)* | | | | | 197,115 | | | | | $ | 4,003,279 | | |
| Elbit Systems Ltd. (Israel) | | | | | 29,394 | | | | | | 3,888,283 | | |
| RADA Electronic Industries Ltd. (Israel)* | | | | | 313,235 | | | | | | 4,081,452 | | |
| Total Aerospace & Defense | | | | | | | | | | | 11,973,014 | | |
| Biotechnology – 13.4% | | | | | | | | | | | | | |
| BioLine RX Ltd. (Israel)*(a) | | | | | 1,137,910 | | | | | | 3,675,449 | | |
| Chemomab Therapeutics Ltd. (Israel)*(a) | | | | | 191,274 | | | | | | 3,180,887 | | |
| Collplant Biotechnologies Ltd. (Israel)* | | | | | 202,679 | | | | | | 3,605,659 | | |
| Enlivex Therapeutics Ltd. (Israel)* | | | | | 485,071 | | | | | | 3,686,540 | | |
| Entera Bio Ltd. (Israel)* | | | | | 531,569 | | | | | | 2,732,265 | | |
| Evogene Ltd. (Israel)* | | | | | 1,168,333 | | | | | | 3,409,400 | | |
| Gamida Cell Ltd. (Israel)* | | | | | 660,833 | | | | | | 3,409,898 | | |
| Kamada Ltd. (Israel)* | | | | | 686,122 | | | | | | 3,778,181 | | |
| Pluristem Therapeutics, Inc.* | | | | | 980,500 | | | | | | 3,216,040 | | |
| UroGen Pharma Ltd.* | | | | | 258,704 | | | | | | 4,009,912 | | |
| Vascular Biogenics Ltd. (Israel)* | | | | | 1,476,500 | | | | | | 3,218,770 | | |
| Total Biotechnology | | | | | | | | | | | 37,923,001 | | |
| Communications Equipment – 10.0% | | | | | | | | | | | | | |
| AudioCodes Ltd. (Israel) | | | | | 117,648 | | | | | | 3,854,148 | | |
| BATM Advanced Communications Ltd. (Israel)* | | | | | 3,246,850 | | | | | | 3,976,575 | | |
| Ceragon Networks Ltd. (Israel)* | | | | | 1,090,119 | | | | | | 4,360,476 | | |
| Gilat Satellite Networks Ltd. (Israel) | | | | | 407,160 | | | | | | 4,267,037 | | |
| Ituran Location and Control Ltd. (Israel) | | | | | 153,168 | | | | | | 3,888,936 | | |
| Radware Ltd. (Israel)* | | | | | 122,722 | | | | | | 3,955,330 | | |
| Silicom Ltd. (Israel)* | | | | | 91,836 | | | | | | 4,122,518 | | |
| Total Communications Equipment | | | | | | | | | | | 28,425,020 | | |
| Diversified Telecommunication – 1.4% | | | | | | | | | | | | | |
| Bezeq The Israeli Telecommunication Corp. Ltd. (Israel)* | | | | | 3,692,271 | | | | | | 3,949,845 | | |
| Electrical Equipment – 3.4% | | | | | | | | | | | | | |
| Aquarius Engines AM Ltd. (Israel)* | | | | | 275,214 | | | | | | 3,316,190 | | |
| Augwind Energy Tech Storage Ltd. (Israel)* | | | | | 194,091 | | | | | | 3,478,927 | | |
| Phinergy Ltd. (Israel)* | | | | | 857,161 | | | | | | 2,916,867 | | |
| Total Electrical Equipment | | | | | | | | | | | 9,711,984 | | |
| Electronic Equipment, Instruments & Components – 5.4% | |
| Arad Ltd. (Israel) | | | | | 297,836 | | | | | | 3,961,933 | | |
| Innoviz Technologies Ltd. (Israel)* | | | | | 373,830 | | | | | | 3,457,927 | | |
| Nayax Ltd. (Israel)* | | | | | 1,295,887 | | | | | | 3,952,806 | | |
| Priortech Ltd. (Israel) | | | | | 145,838 | | | | | | 3,767,200 | | |
Total Electronic Equipment, Instruments &
Components | | | | | | | | | | | 15,139,866 | | |
| Entertainment – 1.3% | | | | | | | | | | | | | |
| Playtika Holding Corp.* | | | | | 164,764 | | | | | | 3,662,704 | | |
| Investments | | | Shares | | | Value | |
| Health Care Equipment & Supplies – 5.3% | | | | | | | | | | | | | |
| Check Cap Ltd.* | | | | | 3,232,331 | | | | | $ | 3,555,564 | | |
| Icecure Medical Ltd. (Israel)* | | | | | 2,654,959 | | | | | | 3,570,335 | | |
| Inmode Ltd.* | | | | | 36,594 | | | | | | 4,159,640 | | |
| Nano-X Imaging Ltd. (Israel)* | | | | | 130,970 | | | | | | 3,712,999 | | |
| Total Health Care Equipment & Supplies | | | | | | | | | | | 14,998,538 | | |
| Hotels, Restaurants & Leisure – 1.2% | | | | | | | | | | | | | |
| Fattal Holdings 1998 Ltd. (Israel)* | | | | | 39,455 | | | | | | 3,455,440 | | |
| Household Durables – 1.3% | | | | | | | | | | | | | |
| Electra Consumer Products 1970 Ltd. (Israel) | | | | | 71,916 | | | | | | 3,788,800 | | |
| Internet & Direct Marketing Retail – 1.6% | | | | | | | | | | | | | |
| Fiverr International Ltd. (Israel)* | | | | | 17,875 | | | | | | 4,449,266 | | |
| IT Services – 7.0% | | | | | | | | | | | | | |
| E&M Computing Ltd. (Israel) | | | | | 640,592 | | | | | | 3,997,135 | | |
| Malam – Team Ltd. (Israel) | | | | | 120,173 | | | | | | 3,996,473 | | |
| Matrix IT Ltd. (Israel) | | | | | 148,310 | | | | | | 4,087,529 | | |
| One Software Technologies Ltd. (Israel) | | | | | 252,313 | | | | | | 3,868,409 | | |
| Wix.com Ltd. (Israel)* | | | | | 13,109 | | | | | | 3,914,872 | | |
| Total IT Services | | | | | | | | | | | 19,864,418 | | |
| Life Sciences Tools & Services – 0.9% | | | | | | | | | | | | | |
| Compugen Ltd. (Israel)* | | | | | 377,339 | | | | | | 2,562,132 | | |
| Machinery – 3.3% | | | | | | | | | | | | | |
| Kornit Digital Ltd. (Israel)* | | | | | 32,491 | | | | | | 4,294,010 | | |
| Plasson Industries Ltd. (Israel) | | | | | 73,484 | | | | | | 3,985,072 | | |
| RoboGroup T.E.K Ltd. (Israel)* | | | | | 1,198,258 | | | | | | 1,106,141 | | |
| Total Machinery | | | | | | | | | | | 9,385,223 | | |
| Media – 1.4% | | | | | | | | | | | | | |
| Perion Network Ltd. (Israel)* | | | | | 208,534 | | | | | | 3,966,317 | | |
| Pharmaceuticals – 7.5% | | | | | | | | | | | | | |
| Intercure Ltd. (Israel)* | | | | | 304,800 | | | | | | 2,023,515 | | |
| MediWound Ltd. (Israel)* | | | | | 810,453 | | | | | | 3,079,721 | | |
| PolyPid Ltd. (Israel)* | | | | | 499,502 | | | | | | 4,080,931 | | |
| Purple Biotech Ltd. (Israel)*(a) | | | | | 737,182 | | | | | | 4,069,245 | | |
| Redhill Biopharma Ltd. (Israel)*(a) | | | | | 20,266 | | | | | | 130,513 | | |
| Taro Pharmaceutical Industries Ltd.* | | | | | 54,212 | | | | | | 3,859,895 | | |
| Teva Pharmaceutical Industries Ltd. (Israel)*(a) | | | | | 428,057 | | | | | | 4,130,750 | | |
| Total Pharmaceuticals | | | | | | | | | | | 21,374,570 | | |
| Professional Services – 1.4% | | | | | | | | | | | | | |
| Danel Adir Yeoshua Ltd. (Israel) | | | | | 18,371 | | | | | | 3,921,988 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
The ARK Israel Innovative Technology ETF
July 31, 2021
| Investments | | | Shares | | | Value | |
| Semiconductors & Semiconductor Equipment – 5.6% | |
| Camtek Ltd. (Israel)* | | | | | 109,748 | | | | | $ | 4,104,575 | | |
| Nova Ltd. (Israel)* | | | | | 39,953 | | | | | | 3,907,403 | | |
| SolarEdge Technologies, Inc.* | | | | | 15,549 | | | | | | 4,034,655 | | |
| Tower Semiconductor Ltd. (Israel)* | | | | | 141,521 | | | | | | 3,941,360 | | |
| Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 15,987,993 | | |
| Software – 18.9% | | | | | | | | | | | | | |
| Abra Information Technologies Ltd. (Israel)* | | | | | 2,681,356 | | | | | | 3,488,044 | | |
| Allot Ltd. (Israel)* | | | | | 206,364 | | | | | | 3,900,280 | | |
| Check Point Software Technologies Ltd. (Israel)* | | | | | 30,403 | | | | | | 3,864,221 | | |
| Cognyte Software Ltd. (Israel)* | | | | | 152,667 | | | | | | 3,964,762 | | |
| CyberArk Software Ltd.* | | | | | 27,759 | | | | | | 3,942,611 | | �� |
| Hilan Ltd. (Israel) | | | | | 72,721 | | | | | | 3,745,722 | | |
| JFrog Ltd. (Israel)* | | | | | 85,891 | | | | | | 3,763,744 | | |
| Magic Software Enterprises Ltd. (Israel) | | | | | 223,665 | | | | | | 3,923,911 | | |
| Monday.com Ltd.* | | | | | 17,944 | | | | | | 3,970,828 | | |
| Nice Ltd. (Israel)*(a) | | | | | 14,736 | | | | | | 4,106,186 | | |
| Sapiens International Corp. NV (Israel) | | | | | 148,557 | | | | | | 3,745,122 | | |
| SimilarWeb Ltd. (Israel)* | | | | | 164,980 | | | | | | 3,956,220 | | |
| Tufin Software Technologies Ltd. (Israel)* | | | | | 364,785 | | | | | | 3,673,385 | | |
| WalkMe Ltd. (Israel)* | | | | | 125,378 | | | | | | 3,477,986 | | |
| Total Software | | | | | | | | | | | 53,523,022 | | |
| Technology Hardware, Storage & Peripherals – 2.2% | |
| Nano Dimension Ltd. (Israel)*(a) | | | | | 573,849 | | | | | | 3,632,464 | | |
| Stratasys Ltd.* | | | | | 136,900 | | | | | | 2,702,406 | | |
| Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 6,334,870 | | |
| Wireless Telecommunication Services – 2.7% | |
| Cellcom Israel Ltd. (Israel)* | | | | | 1,001,993 | | | | | | 3,794,090 | | |
| Partner Communications Co. Ltd. (Israel)* | | | | | 891,236 | | | | | | 3,846,169 | | |
| Total Wireless Telecommunication Services | | | | | | | | | | | 7,640,259 | | |
Total Common Stocks
(Cost $305,644,060) | | | | | | | | | | | 282,038,270 | | |
| MONEY MARKET FUND – 0.7% | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund,
Institutional Shares, 0.03%(b)
(Cost $2,101,652) | | | | | 2,101,652 | | | | | | 2,101,652 | | |
Total Investments – 100.1%
(Cost $307,745,712) | | | | | | | | | | | 284,139,922 | | |
| Liabilities in Excess of Other Assets – (0.1)% | | | | | | | | | | | (423,576) | | |
| Net Assets – 100.0% | | | | | | | | | | $ | 283,716,346 | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (continued)
The ARK Israel Innovative Technology ETF
Affiliated Issuer Transactions
A summary of the Fund’s fiscal year to date transactions with companies which are or were affiliated issuers during the year are as follows:
| Value ($) at 7/31/2020 | | | Purchases
Cost
($) | | | Sales
Proceeds
($) | | | Net Realized
Gain/(Loss)
($) | | | Net Change in
Unrealized
Appreciation
(Depreciation)
($) | | | Dividend
Income
($) | | | Capital Gain
Distributions
($) | | | Number of
Shares at
7/31/2021 | | | Value ($) at
7/31/2021 | |
| Common Stock — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Machinery — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| RoboGroup T.E.K Ltd. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| $ — | | | | $ | 8,845,857 | | | | | $ | (2,853,715) | | | | | $ | (3,730,271) | | | | | $ | (1,155,730) | | | | | $ | — | | | | | $ | — | | | �� | | | — | | | | | $ | — | | |
*
Non-income producing security
(a)
American Depositary Receipt
(b)
Rate shown represents annualized 7-day yield as of July 31, 2021.
| Country | | | Value | | | % of Net
Assets | |
| Israel | | | | $ | 244,924,016 | | | | | | 86.3% | | |
| United States | | | | | 39,215,906 | | | | | | 13.8 | | |
| Total Investments | | | | | 284,139,922 | | | | | | 100.1 | | |
| Liabilities in Excess of Other Assets | | | | | (423,576) | | | | | | (0.1) | | |
| Net Assets | | | | $ | 283,716,346 | | | | | | 100.0% | | |
See accompanying Notes to Financial Statements.
Schedule of Investments (concluded)
The ARK Israel Innovative Technology ETF
July 31, 2021
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
•
Level 1 – Quoted prices in active markets for identical assets.
•
Level 2 – Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
•
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of July 31, 2021, based upon the three levels defined above:
The ARK Israel
Innovative
Technology ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stocks‡ | | | | $ | 282,038,270 | | | | | $ | — | | | | | $ | — | | | | | $ | 282,038,270 | | |
| Money Market Fund | | | | | 2,101,652 | | | | | | — | | | | | | — | | | | | | 2,101,652 | | |
| Total | | | | $ | 284,139,922 | | | | | $ | — | | | | | $ | — | | | | | $ | 284,139,922 | | |
‡
Please refer to the Schedule of Investments to view securities segregated by industry type.
See accompanying Notes to Financial Statements.
Statements of Assets and Liabilities
| | | | ARK Genomic
Revolution
ETF | | | ARK
Autonomous
Technology &
Robotics ETF | | | ARK
Innovation
ETF | | | ARK Next
Generation
Internet ETF | |
| ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities at market value
(Note 2) | | | | $ | 6,025,489,480 | | | | | $ | 2,536,790,144 | | | | | $ | 17,516,681,928 | | | | | $ | 5,695,008,802 | | |
| Investments in affiliated securities at market value (Note 2) | | | | | 2,567,361,623 | | | | | | 277,878,443 | | | | | | 4,998,843,282 | | | | | | 132,184,341 | | |
| Cash | | | | | 28,905,693 | | | | | | — | | | | | | — | | | | | | — | | |
| Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dividends and interest | | | | | 1,625,430 | | | | | | 510,801 | | | | | | 1,396 | | | | | | 216 | | |
| Capital shares sold | | | | | — | | | | | | — | | | | | | 174,873,063 | | | | | | 104,384,445 | | |
| Investment securities sold | | | | | 85,852,300 | | | | | | 44,622,033 | | | | | | 386,063,110 | | | | | | 185,421,779 | | |
| Reclaims | | | | | 5,173,812 | | | | | | 9,177 | | | | | | 1,778,642 | �� | | | | | — | | |
| Total Assets | | | | | 8,714,408,338 | | | | | | 2,859,810,598 | | | | | | 23,078,241,421 | | | | | | 6,116,999,583 | | |
| LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Capital shares purchased | | | | | 55,052,711 | | | | | | 8,130,599 | | | | | | 102,257,720 | | | | | | 119,018,412 | | |
| Investment securities purchased | | | | | 65,576,735 | | | | | | 43,189,084 | | | | | | 465,708,021 | | | | | | 180,550,559 | | |
| Management fees (Note 3) | | | | | 5,765,143 | | | | | | 1,851,178 | | | | | | 14,846,826 | | | | | | 3,790,696 | | |
| Total Liabilities | | | | | 126,394,589 | | | | | | 53,170,861 | | | | | | 582,812,567 | | | | | | 303,359,667 | | |
| NET ASSETS | | | | $ | 8,588,013,749 | | | | | $ | 2,806,639,737 | | | | | $ | 22,495,428,854 | | | | | $ | 5,813,639,916 | | |
| NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Paid-in capital | | | | $ | 9,233,434,150 | | | | | $ | 2,836,986,588 | | | | | $ | 21,756,802,071 | | | | | $ | 5,564,382,858 | | |
| Total distributable earnings/accumulated (loss) | | | | | (645,420,401) | | | | | | (30,346,851) | | | | | | 738,626,783 | | | | | | 249,257,058 | | |
| NET ASSETS | | | | $ | 8,588,013,749 | | | | | $ | 2,806,639,737 | | | | | $ | 22,495,428,854 | | | | | $ | 5,813,639,916 | | |
| Shares outstanding | | | | | 101,755,000 | | | | | | 34,600,000 | | | | | | 187,600,000 | | | | | | 39,450,000 | | |
| Net asset value, per share | | | | $ | 84.40 | | | | | $ | 81.12 | | | | | $ | 119.91 | | | | | $ | 147.37 | | |
| Investments in non-affiliated securities at cost | | | | $ | 6,610,976,526 | | | | | $ | 2,512,241,828 | | | | | $ | 16,730,447,314 | | | | | $ | 5,413,627,857 | | |
| Investments in affiliated securities at cost | | | | $ | 2,581,923,225 | | | | | $ | 309,019,801 | | | | | $ | 4,967,366,075 | | | | | $ | 144,919,366 | | |
See accompanying Notes to Financial Statements.
Statements of Assets and Liabilities (concluded)
| | | | ARK Fintech
Innovation ETF | | | ARK Space
Exploration &
Innovation ETF | | | The 3D
Printing ETF | | | The ARK Israel
Innovative
Technology ETF | |
| ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Investments in non-affiliated securities at market value (Note 2) | | | | $ | 3,612,265,426 | | | | | $ | 570,498,662 | | | | | $ | 477,478,265 | | | | | $ | 284,139,922 | | |
| Investments in affiliated securities at market value (Note 2) | | | | | — | | | | | | 41,642,604 | | | | | | 38,025,376 | | | | | | — | | |
| Cash | | | | | — | | | | | | 60 | | | | | | — | | | | | | 96,972 | | |
| Foreign Currency | | | | | — | | | | | | — | | | | | | 14,688,509 | | | | | | — | | |
| Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Dividends and interest | | | | | 67,993 | | | | | | 24,473 | | | | | | 45,638 | | | | | | 53 | | |
| Capital shares sold | | | | | 4,729 | | | | | | — | | | | | | — | | | | | | — | | |
| Investment securities sold | | | | | 63,408,538 | | | | | | 18,335 | | | | | | 1,234,680 | | | | | | 2,278,426 | | |
| Reclaims | | | | | — | | | | | | 52,003 | | | | | | 135,859 | | | | | | — | | |
| Total Assets | | | | | 3,675,746,686 | | | | | | 612,236,137 | | | | | | 531,608,327 | | | | | | 286,515,373 | | |
| LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Due to custodian | | | | | 357 | | | | | | — | | | | | | — | | | | | | — | | |
| Due to custodian for foreign currency | | | | | 3,510 | | | | | | 3,399 | | | | | | — | | | | | | 451 | | |
| Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Capital shares purchased | | | | | 28,259,063 | | | | | | — | | | | | | — | | | | | | 2,270,177 | | |
| Investment securities purchased | | | | | 34,762,986 | | | | | | 4,311,189 | | | | | | 15,812,651 | | | | | | 405,903 | | |
| Management fees (Note 3) | | | | | 2,451,710 | | | | | | 368,245 | | | | | | 287,724 | | | | | | 119,988 | | |
| Other accrued expenses | | | | | — | | | | | | — | | | | | | 4,426 | | | | | | 2,508 | | |
| Total Liabilities | | | | | 65,477,626 | | | | | | 4,682,833 | | | | | | 16,104,801 | | | | | | 2,799,027 | | |
| NET ASSETS | | | | $ | 3,610,269,060 | | | | | $ | 607,553,304 | | | | | $ | 515,503,526 | | | | | $ | 283,716,346 | | |
| NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Paid-in capital | | | | $ | 3,838,676,547 | | | | | $ | 619,810,288 | | | | | $ | 597,061,475 | | | | | $ | 328,298,698 | | |
| Total accumulated loss | | | | | (228,407,487) | | | | | | (12,256,984) | | | | | | (81,557,949) | | | | | | (44,582,352) | | |
| NET ASSETS | | | | $ | 3,610,269,060 | | | | | $ | 607,553,304 | | | | | $ | 515,503,526 | | | | | $ | 283,716,346 | | |
| Shares outstanding | | | | | 71,250,001 | | | | | | 29,850,001 | | | | | | 13,550,001 | | | | | | 9,375,001 | | |
| Net asset value, per share | | | | $ | 50.67 | | | | | $ | 20.35 | | | | | $ | 38.04 | | | | | $ | 30.26 | | |
| Investments in non-affiliated securities at cost | | | | $ | 3,586,563,944 | | | | | $ | 564,724,867 | | | | | $ | 520,465,550 | | | | | $ | 307,745,712 | | |
| Investments in affiliated securities at cost | | | | $ | — | | | | | $ | 42,839,289 | | | | | $ | 56,513,619 | | | | | $ | — | | |
| Foreign currency at cost | | | | $ | — | | | | | $ | — | | | | | $ | 14,689,717 | | | | | $ | — | | |
See accompanying Notes to Financial Statements.
For the Year Ended July 31, 2021
| | | | ARK
Genomic
Revolution ETF | | | ARK
Autonomous
Technology &
Robotics ETF | | | ARK
Innovation
ETF | | | ARK Next
Generation
Internet
ETF | |
| INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Unaffiliated dividend income | | | | $ | 37,277,082 | | | | | $ | 7,871,072 | | | | | $ | 23,577,728 | | | | | $ | 3,519,543 | | |
| Foreign withholding tax | | | | | (4,859,763) | | | | | | (582,275) | | | | | | (2,913,354) | | | | | | (318,030) | | |
| Total Income | | | | | 32,417,319 | | | | | | 7,288,797 | | | | | | 20,664,374 | | | | | | 3,201,513 | | |
| EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Management fees (Note 3) | | | | | 51,716,966 | | | | | | 15,985,299 | | | | | | 132,792,042 | | | | | | 38,295,039 | | |
| Overdraft expense | | | | | 2,772 | | | | | | 72 | | | | | | 1,395 | | | | | | 1,290 | | |
| Total Expenses | | | | | 51,719,738 | | | | | | 15,985,371 | | | | | | 132,793,437 | | | | | | 38,296,329 | | |
Net Investment Loss(1) | | | | | (19,302,419) | | | | | | (8,696,574) | | | | | | (112,129,063) | | | | | | (35,094,816) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON
INVESTMENTS AND FOREIGN CURRENCY
TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Investments in non-affiliated securities | | | | | (14,049,237) | | | | | | (9,286,150) | | | | | | 319,235,734 | | | | | | 108,503,174 | | |
| Investments in affiliated securities | | | | | 3,267,064 | | | | | | (540,914) | | | | | | (105,614,986) | | | | | | (29,891,627) | | |
| In-kind redemptions - non-affiliated securities | | | | | 525,878,923 | | | | | | 310,388,370 | | | | | | 2,708,350,648 | | | | | | 1,083,984,588 | | |
| In-kind redemptions - affiliated securities | | | | | 516,191,055 | | | | | | 26,871,963 | | | | | | 1,217,618,612 | | | | | | 21,683,966 | | |
| Net realized gain | | | | | 1,031,287,805 | | | | | | 327,433,269 | | | | | | 4,139,590,008 | | | | | | 1,184,280,101 | | |
| Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Investments in non-affiliated securities | | | | | (873,826,183) | | | | | | (67,548,050) | | | | | | (463,407,190) | | | | | | (233,070,179) | | |
| Investments in affiliated securities | | | | | (129,133,574) | | | | | | (31,141,358) | | | | | | (663,678,593) | | | | | | (12,735,025) | | |
| Change in unrealized depreciation | | | | | (1,002,959,757) | | | | | | (98,689,408) | | | | | | (1,127,085,783) | | | | | | (245,805,204) | | |
Net realized and unrealized gain on investments and foreign
currency translation | | | | | 28,328,048 | | | | | | 228,743,861 | | | | | | 3,012,504,225 | | | | | | 938,474,897 | | |
| Net Increase in Net Assets Resulting From Operations | | | | $ | 9,025,629 | | | | | $ | 220,047,287 | | | | | $ | 2,900,375,162 | | | | | $ | 903,380,081 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Operations (concluded)
For the Year Ended July 31, 2021
| | | | ARK Fintech
Innovation
ETF | | | ARK Space
Exploration &
Innovation ETF(1) | | | The 3D Printing
ETF | | | The ARK Israel
Innovative
Technology ETF | |
| INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Unaffiliated dividend income | | | | $ | 3,952,354 | | | | | $ | 993,098 | | | | | $ | 2,259,322 | | | | | $ | 1,593,907 | | |
| Foreign withholding tax | | | | | (107,393) | | | | | | (81,117) | | | | | | (118,792) | | | | | | (388,098) | | |
| Total Income | | | | | 3,844,961 | | | | | | 911,981 | | | | | | 2,140,530 | | | | | | 1,205,809 | | |
| EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Management fees (Note 3) | | | | | 18,942,471 | | | | | | 1,521,907 | | | | | | 2,087,183 | | | | | | 899,278 | | |
| Overdraft expense | | | | | 15,047 | | | | | | 4,325 | | | | | | 5,413 | | | | | | 769 | | |
| Other expenses | | | | | — | | | | | | — | | | | | | 32,013 | | | | | | 18,726 | | |
| Total Expenses | | | | | 18,957,518 | | | | | | 1,526,232 | | | | | | 2,124,609 | | | | | | 918,773 | | |
| Less expense waivers and reimbursements | | | | | — | | | | | | (86,395)(3) | | | | | | — | | | | | | — | | |
| Net Expenses | | | | | 18,957,518 | | | | | | 1,439,837 | | | | | | 2,124,609 | | | | | | 918,773 | | |
Net Investment Income (Loss)(2) | | | | | (15,112,557) | | | | | | (527,856) | | | | | | 15,921 | | | | | | 287,036 | | |
| NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Investments in non-affiliated securities | | | | | (233,584,958) | | | | | | (17,009,554) | | | | | | 6,350,663 | | | | | | (16,468,553) | | |
| Investments in affiliated securities | | | | | (29,397,361) | | | | | | (128) | | | | | | (16,275,927) | | | | | | (3,654,527) | | |
| Foreign currency transactions | | | | | (669,959) | | | | | | (116,902) | | | | | | (4,379) | | | | | | (122,778) | | |
| In-kind redemptions - non-affiliated securities | | | | | 287,738,268 | | | | | | 1,969,742 | | | | | | 35,983,621 | | | | | | 14,801,688 | | |
| In-kind redemptions - affiliated securities | | | | | 25,915,881 | | | | | | 142,955 | | | | | | 11,368,061 | | | | | | (75,744) | | |
| Net realized gain (loss) | | | | | 50,001,871 | | | | | | (15,013,887) | | | | | | 37,422,039 | | | | | | (5,519,914) | | |
| Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Investments in non-affiliated securities | | | | | (82,865,706) | | | | | | 5,773,795 | | | | | | (47,116,138) | | | | | | (27,323,117) | | |
| Investments in affiliated securities | | | | | 25,383,450 | | | | | | (1,196,685) | | | | | | (18,488,243) | | | | | | (1,155,730) | | |
| Foreign currency translation | | | | | (13,792) | | | | | | (1,593) | | | | | | (2,377) | | | | | | (532) | | |
| Change in unrealized appreciation (depreciation) | | | | | (57,496,048) | | | | | | 4,575,517 | | | | | | (65,606,758) | | | | | | (28,479,379) | | |
| Net realized and unrealized loss on investments and foreign currency translation | | | | | (7,494,177) | | | | | | (10,438,370) | | | | | | (28,184,719) | | | | | | (33,999,293) | | |
| Net Decrease in Net Assets Resulting From Operations | | | | $ | (22,606,734) | | | | | $ | (10,966,226) | | | | | $ | (28,168,798) | | | | | $ | (33,712,257) | | |
(1)
Represents the period March 30, 2021 (commencement of operations) to July 31, 2021.
(2)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(3)
See Notes to Financial Statements (Note 3).
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets
| | | | ARK Genomic
Revolution ETF | | | ARK Autonomous
Technology & Robotics ETF | |
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | |
| OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss(1) | | | | $ | (19,302,419) | | | | | $ | (4,801,803) | | | | | $ | (8,696,574) | | | | | $ | (673,701) | | |
| Net realized gain on investments and foreign currency transactions | | | | | 1,031,287,805 | | | | | | 46,282,958 | | | | | | 327,433,269 | | | | | | 23,237,711 | | |
| Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (1,002,959,757) | | | | | | 354,662,864 | | | | | | (98,689,408) | | | | | | 86,069,260 | | |
| Net increase in net assets resulting from operations | | | | | 9,025,629 | | | | | | 396,144,019 | | | | | | 220,047,287 | | | | | | 108,633,270 | | |
| DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
| Distributions from distributable earnings | | | | | (62,384,714) | | | | | | (15,340,243) | | | | | | (14,434,200) | | | | | | — | | |
| SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Proceeds from shares sold | | | | | 10,605,437,472 | | | | | | 787,535,328 | | | | | | 3,123,783,591 | | | | | | 211,181,482 | | |
| Cost of shares redeemed | | | | | (3,553,920,853) | | | | | | (44,448,521) | | | | | | (970,644,388) | | | | | | (38,824,698) | | |
| Net increase in net assets resulting from shareholder transactions | | | | | 7,051,516,619 | | | | | | 743,086,807 | | | | | | 2,153,139,203 | | | | | | 172,356,784 | | |
| Increase in net assets | | | | | 6,998,157,534 | | | | | | 1,123,890,583 | | | | | | 2,358,752,290 | | | | | | 280,990,054 | | |
| NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Beginning of year | | | | | 1,589,856,215 | | | | | | 465,965,632 | | | | | | 447,887,447 | | | | | | 166,897,393 | | |
| End of year | | | | $ | 8,588,013,749 | | | | | $ | 1,589,856,215 | | | | | $ | 2,806,639,737 | | | | | $ | 447,887,447 | | |
| CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Shares outstanding, beginning of year | | | | | 29,605,000 | | | | | | 13,505,000 | | | | | | 8,500,000 | | | | | | 5,050,000 | | |
| Shares sold | | | | | 113,400,000 | | | | | | 17,450,000 | | | | | | 38,100,000 | | | | | | 4,600,000 | | |
| Shares redeemed | | | | | (41,250,000) | | | | | | (1,350,000) | | | | | | (12,000,000) | | | | | | (1,150,000) | | |
| Shares outstanding, end of year | | | | | 101,755,000 | | | | | | 29,605,000 | | | | | | 34,600,000 | | | | | | 8,500,000 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (continued)
| | | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | |
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | |
| OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss(1) | | | | $ | (112,129,063) | | | | | $ | (17,374,329) | | | | | $ | (35,094,816) | | | | | $ | (4,383,013) | | |
| Net realized gain on investments and foreign currency transactions | | | | | 4,139,590,008 | | | | | | 164,743,201 | | | | | | 1,184,280,101 | | | | | | 107,592,407 | | |
Net change in unrealized appreciation (depreciation) on
investments and foreign currency translations | | | | | (1,127,085,783) | | | | | | 1,753,696,002 | | | | | | (245,805,204) | | | | | | 494,848,037 | | |
| Net increase in net assets resulting from operations | | | | | 2,900,375,162 | | | | | | 1,901,064,874 | | | | | | 903,380,081 | | | | | | 598,057,431 | | |
| DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
| Distributions from distributable earnings | | | | | (291,314,175) | | | | | | (7,062,842) | | | | | | (68,580,176) | | | | | | — | | |
| SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Proceeds from shares sold | | | | | 24,078,752,000 | | | | | | 2,631,373,836 | | | | | | 6,018,769,322 | | | | | | 1,186,185,851 | | |
| Cost of shares redeemed | | | | | (10,324,983,217) | | | | | | (124,030,220) | | | | | | (2,959,974,254) | | | | | | (295,858,352) | | |
| Net increase in net assets resulting from shareholder transactions | | | | | 13,753,768,783 | | | | | | 2,507,343,616 | | | | | | 3,058,795,068 | | | | | | 890,327,499 | | |
| Increase in net assets | | | | | 16,362,829,770 | | | | | | 4,401,345,648 | | | | | | 3,893,594,973 | | | | | | 1,488,384,930 | | |
| NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Beginning of year | | | | | 6,132,599,084 | | | | | | 1,731,253,436 | | | | | | 1,920,044,943 | | | | | | 431,660,013 | | |
| End of year | | | | $ | 22,495,428,854 | | | | | $ | 6,132,599,084 | | | | | $ | 5,813,639,916 | | | | | $ | 1,920,044,943 | | |
| CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Shares outstanding, beginning of year | | | | | 76,300,000 | | | | | | 35,800,000 | | | | | | 19,300,000 | | | | | | 8,250,000 | | |
| Shares sold | | | | | 198,750,000 | | | | | | 42,950,000 | | | | | | 41,000,000 | | | | | | 15,900,000 | | |
| Shares redeemed | | | | | (87,450,000) | | | | | | (2,450,000) | | | | | | (20,850,000) | | | | | | (4,850,000) | | |
| Shares outstanding, end of year | | | | | 187,600,000 | | | | | | 76,300,000 | | | | | | 39,450,000 | | | | | | 19,300,000 | | |
(1)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (continued)
| | | | ARK Fintech Innovation ETF | | | ARK Space
Exploration &
Innovation ETF | |
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | March 30,
2021(1) to
July 31, 2021 | |
| OPERATIONS: | | | | | | | | | | | | | | | | | | | |
Net investment loss(2) | | | | $ | (15,112,557) | | | | | $ | (446,510) | | | | | $ | (527,856) | | |
| Net realized gain (loss) on investments and foreign currency transactions | | | | | 50,001,871 | | | | | | 2,510,078 | | | | | | (15,013,887) | | |
| Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (57,496,048) | | | | | | 77,375,699 | | | | | | 4,575,517 | | |
| Net increase (decrease) in net assets resulting from operations | | | | | (22,606,734) | | | | | | 79,439,267 | | | | | | (10,966,226) | | |
| DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | |
| Distributions from distributable earnings | | | | | (7,191,728) | | | | | | (1,037,795) | | | | | | — | | |
| SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | |
| Proceeds from shares sold | | | | | 4,293,672,073 | | | | | | 197,037,365 | | | | | | 692,463,575 | | |
| Cost of shares redeemed | | | | | (1,000,941,520) | | | | | | (2,334,638) | | | | | | (73,944,045) | | |
| Net increase in net assets resulting from shareholder transactions | | | | | 3,292,730,553 | | | | | | 194,702,727 | | | | | | 618,519,530 | | |
| Increase in net assets | | | | | 3,262,932,091 | | | | | | 273,104,199 | | | | | | 607,553,304 | | |
| NET ASSETS: | | | | | | | | | | | | | | | | | | | |
| Beginning of period | | | | | 347,336,969 | | | | | | 74,232,770 | | | | | | — | | |
| End of period | | | | $ | 3,610,269,060 | | | | | $ | 347,336,969 | | | | | $ | 607,553,304 | | |
| CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | |
| Shares outstanding, beginning of period | | | | | 9,600,001 | | | | | | 3,250,001 | | | | | | — | | |
| Shares sold | | | | | 81,600,000 | | | | | | 6,450,000 | | | | | | 33,500,001 | | |
| Shares redeemed | | | | | (19,950,000) | | | | | | (100,000) | | | | | | (3,650,000) | | |
| Shares outstanding, end of period | | | | | 71,250,001 | | | | | | 9,600,001 | | | | | | 29,850,001 | | |
(1)
Commencement of operations.
(2)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
Statements of Changes in Net Assets (concluded)
| | | | The 3D Printing ETF | | | The ARK Israel
Innovative Technology ETF | |
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | |
| OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income (loss)(1) | | | | $ | 15,921 | | | | | $ | (1,239) | | | | | $ | 287,036 | | | | | $ | (31,574) | | |
| Net realized gain (loss) on investments and foreign currency transactions | | | | | 37,422,039 | | | | | | (599,061) | | | | | | (5,519,914) | | | | | | (355,242) | | |
Net change in unrealized appreciation (depreciation) on investments
and foreign currency translations | | | | | (65,606,758) | | | | | | 1,419,632 | | | | | | (28,479,379) | | | | | | 5,366,586 | | |
| Net increase (decrease) in net assets resulting from operations | | | | | (28,168,798) | | | | | | 819,332 | | | | | | (33,712,257) | | | | | | 4,979,770 | | |
| DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
| Distributions from distributable earnings | | | | | — | | | | | | (23,952) | | | | | | — | | | | | | (392,106) | | |
| SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Proceeds from shares sold | | | | | 660,321,260 | | | | | | 8,287,730 | | | | | | 347,145,781 | | | | | | 26,567,457 | | |
| Cost of shares redeemed | | | | | (157,866,003) | | | | | | (7,537,609) | | | | | | (77,840,654) | | | | | | (2,543,189) | | |
| Net increase in net assets resulting from shareholder transactions | | | | | 502,455,257 | | | | | | 750,121 | | | | | | 269,305,127 | | | | | | 24,024,268 | | |
| Increase in net assets | | | | | 474,286,459 | | | | | | 1,545,501 | | | | | | 235,592,870 | | | | | | 28,611,932 | | |
| NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Beginning of year | | | | | 41,217,067 | | | | | | 39,671,566 | | | | | | 48,123,476 | | | | | | 19,511,544 | | |
| End of year | | | | $ | 515,503,526 | | | | | $ | 41,217,067 | | | | | $ | 283,716,346 | | | | | $ | 48,123,476 | | |
| CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Shares outstanding, beginning of year | | | | | 1,850,001 | | | | | | 1,800,001 | | | | | | 1,925,001 | | | | | | 950,001 | | |
| Shares sold | | | | | 15,800,000 | | | | | | 400,000 | | | | | | 10,100,000 | | | | | | 1,100,000 | | |
| Shares redeemed | | | | | (4,100,000) | | | | | | (350,000) | | | | | | (2,650,000) | | | | | | (125,000) | | |
| Shares outstanding, end of year | | | | | 13,550,001 | | | | | | 1,850,001 | | | | | | 9,375,001 | | | | | | 1,925,001 | | |
(1)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
See accompanying Notes to Financial Statements.
ARK Genomic Revolution ETF
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | Year Ended
July 31, 2018 | | | For the
Period Ended
July 31, 2017(1) | | | Year Ended
August 31, 2016 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | | | | $ | 22.24 | | | | | $ | 18.03 | | | | | $ | 20.85 | | |
Net investment loss(2) | | | | | (0.24) | | | | | | (0.28) | | | | | | (0.19) | | | | | | (0.18) | | | | | | (0.12) | | | | | | (0.12) | | |
| Net realized and unrealized gain (loss) on investments | | | | | 31.73 | | | | | | 20.53 | | | | | | 5.80 | | | | | | 7.63 | | | | | | 4.33 | | | | | | (2.70) | | |
| Total gain (loss) from investment operations | | | | | 31.49 | | | | | | 20.25 | | | | | | 5.61 | | | | | | 7.45 | | | | | | 4.21 | | | | | | (2.82) | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net realized gains | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | | | | | — | | | | | | — | | |
| Total distributions | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | | | | | — | | | | | | — | | |
| Net asset value, end of period | | | | $ | 84.40 | | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | | | | $ | 22.24 | | | | | $ | 18.03 | | |
| Market value, end of period | | | | $ | 84.35 | | | | | $ | 53.70 | | | | | $ | 34.58 | | | | | $ | 29.40 | | | | | $ | 22.29 | | | | | $ | 18.01 | | |
Total Return at Net Asset Value(3) | | | | | 58.48% | | | | | | 60.41% | | | | | | 19.87% | | | | | | 33.80% | | | | | | 23.34% | | | | | | (13.52)% | | |
Total Return at Market Value(3) | | | | | 58.39% | | | | | | 60.05% | | | | | | 20.00% | | | | | | 33.66% | | | | | | 23.77% | | | | | | (14.77)% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 8,588,014 | | | | | $ | 1,589,856 | | | | | $ | 465,966 | | | | | $ | 232,115 | | | | | $ | 23,460 | | | | | $ | 7,302 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | | | | | 0.90% | | |
Net investment loss(5) | | | | | (0.28)% | | | | | | (0.73)% | | | | | | (0.63)% | | | | | | (0.64)% | | | | | | (0.67)%(4) | | | | | | (0.67)% | | |
Portfolio turnover rate(6) | | | | | 45% | | | | | | 50% | | | | | | 64% | | | | | | 80% | | | | | | 65% | | | | | | 77% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Autonomous Technology & Robotics ETF
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | Year Ended
July 31, 2018 | | | For the
Period Ended
July 31, 2017(1) | | | Year Ended
August 31, 2016 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | | | | $ | 29.59 | | | | | $ | 21.14 | | | | | $ | 18.33 | | |
Net investment loss(2) | | | | | (0.33) | | | | | | (0.13) | | | | | | (0.13) | | | | | | (0.05) | | | | | | (0.07) | | | | | | (0.07) | | |
| Net realized and unrealized gain (loss) on investments | | | | | 29.42 | | | | | | 19.77 | | | | | | (0.91) | | | | | | 5.89 | | | | | | 8.52 | | | | | | 3.07 | | |
| Total gain (loss) from investment operations | | | | | 29.09 | | | | | | 19.64 | | | | | | (1.04) | | | | | | 5.84 | | | | | | 8.45 | | | | | | 3.00 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | (0.02) | | | | | | — | | | | | | — | | |
| Net realized gains | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.48) | | | | | | — | | | | | | (0.19) | | |
| Total distributions | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.50) | | | | | | — | | | | | | (0.19) | | |
| Net asset value, end of period | | | | $ | 81.12 | | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | | | | $ | 29.59 | | | | | $ | 21.14 | | |
| Market value, end of period | | | | $ | 81.18 | | | | | $ | 52.78 | | | | | $ | 33.06 | | | | | $ | 35.01 | | | | | $ | 29.63 | | | | | $ | 21.14 | | |
Total Return at Net Asset Value(3) | | | | | 55.31% | | | | | | 59.43% | | | | | | (2.66)% | | | | | | 19.86% | | | | | | 39.97% | | | | | | 16.43% | | |
Total Return at Market Value(3) | | | | | 55.17% | | | | | | 59.65% | | | | | | (2.84)% | | | | | | 19.98% | | | | | | 40.16% | | | | | | 15.84% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 2,806,640 | | | | | $ | 447,887 | | | | | $ | 166,897 | | | | | $ | 155,448 | | | | | $ | 66,578 | | | | | $ | 15,853 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | | | | | 0.89% | | |
Net investment loss(5) | | | | | (0.41)% | | | | | | (0.34)% | | | | | | (0.39)% | | | | | | (0.15)% | | | | | | (0.31)%(4) | | | | | | (0.38)% | | |
Portfolio turnover rate(6) | | | | | 86% | | | | | | 71% | | | | | | 54% | | | | | | 57% | | | | | | 44% | | | | | | 67% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | Year Ended
July 31, 2018 | | | For the
Period Ended
July 31, 2017(1) | | | Year Ended
August 31, 2016 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | | | | $ | 29.59 | | | | | $ | 20.60 | | | | | $ | 20.06 | | |
Net investment loss(2) | | | | | (0.75) | | | | | | (0.38) | | | | | | (0.30) | | | | | | (0.13) | | | | | | (0.15) | | | | | | (0.15) | | |
| Net realized and unrealized gain on investments | | | | | 42.33 | | | | | | 32.58 | | | | | | 5.32 | | | | | | 15.54(3) | | | | | | 9.14 | | | | | | 1.16 | | |
| Total gain from investment operations | | | | | 41.58 | | | | | | 32.20 | | | | | | 5.02 | | | | | | 15.41 | | | | | | 8.99 | | | | | | 1.01 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | (0.09) | | | | | | — | | | | | | — | | |
| Net realized gains | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.40) | | | | | | — | | | | | | (0.47) | | |
| Total distributions | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.49) | | | | | | — | | | | | | (0.47) | | |
| Net asset value, end of period | | | | $ | 119.91 | | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | | | | $ | 29.59 | | | | | $ | 20.60 | | |
| Market value, end of period | | | | $ | 120.00 | | | | | $ | 80.37 | | | | | $ | 48.46 | | | | | $ | 44.55 | | | | | $ | 29.62 | | | | | $ | 20.61 | | |
Total Return at Net Asset Value(4) | | | | | 51.65% | | | | | | 66.82% | | | | | | 12.14% | | | | | | 52.38%(3) | | | | | | 43.64% | | | | | | 4.98% | | |
Total Return at Market Value(4) | | | | | 51.76% | | | | | | 66.47% | | | | | | 12.27% | | | | | | 52.38%(3) | | | | | | 43.72% | | | | | | 4.90% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 22,495,429 | | | | | $ | 6,132,599 | | | | | $ | 1,731,253 | | | | | $ | 1,170,588 | | | | | $ | 85,813 | | | | | $ | 9,271 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(5) | | | | | | 0.89% | | |
Net investment loss(6) | | | | | (0.63)% | | | | | | (0.70)% | | | | | | (0.67)% | | | | | | (0.33)% | | | | | | (0.67)%(5) | | | | | | (0.76)% | | |
Portfolio turnover rate(7) | | | | | 71% | | | | | | 80% | | | | | | 80% | | | | | | 89% | | | | | | 70% | | | | | | 110% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
The Adviser has reimbursed the Fund $15,999 for a procedural error. The impact was deemed immaterial to net realized and unrealized gain on investments and the Fund’s total return, representing less than $0.005 per share.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Next Generation Internet ETF
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | Year Ended
July 31, 2018 | | | For the
Period Ended
July 31, 2017(1) | | | Year Ended
August 31, 2016 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | | | | $ | 36.82 | | | | | $ | 24.42 | | | | | $ | 22.02 | | |
Net investment loss(2) | | | | | (0.98) | | | | | | (0.45) | | | | | | (0.33) | | | | | | (0.09) | | | | | | (0.17) | | | | | | (0.17) | | |
| Net realized and unrealized gain on investments | | | | | 50.76 | | | | | | 47.61 | | | | | | 3.09 | | | | | | 19.32(3) | | | | | | 12.57 | | | | | | 3.10 | | |
| Total gain from investment operations | | | | | 49.78 | | | | | | 47.16 | | | | | | 2.76 | | | | | | 19.23 | | | | | | 12.40 | | | | | | 2.93 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | (0.13) | | | | | | — | | | | | | — | | |
| Net realized gains | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.82) | | | | | | — | | | | | | (0.53) | | |
| Total distributions | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.95) | | | | | | — | | | | | | (0.53) | | |
| Net asset value, end of period | | | | $ | 147.37 | | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | | | | $ | 36.82 | | | | | $ | 24.42 | | |
| Market value, end of period | | | | $ | 147.55 | | | | | $ | 99.49 | | | | | $ | 52.48 | | | | | $ | 55.08 | | | | | $ | 36.85 | | | | | $ | 24.38 | | |
Total Return at Net Asset Value(4) | | | | | 50.06% | | | | | | 90.13% | | | | | | 7.49% | | | | | | 52.71%(3) | | | | | | 50.77% | | | | | | 13.43% | | |
Total Return at Market Value(4) | | | | | 50.24% | | | | | | 89.58% | | | | | | 7.80% | | | | | | 52.53%(3) | | | | | | 51.15% | | | | | | 13.83% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 5,813,640 | | | | | $ | 1,920,045 | | | | | $ | 431,660 | | | | | $ | 672,276 | | | | | $ | 68,109 | | | | | $ | 14,654 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(5) | | | | | | 0.89% | | |
Net investment loss(6) | | | | | (0.69)% | | | | | | (0.68)% | | | | | | (0.63)% | | | | | | (0.18)% | | | | | | (0.62)%(5) | | | | | | (0.78)% | | |
Portfolio turnover rate(7) | | | | | 120% | | | | | | 93% | | | | | | 92% | | | | | | 68% | | | | | | 52% | | | | | | 86% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Based on average daily shares outstanding.
(3)
The Adviser has reimbursed the Fund $13,774 for a procedural error. The impact was deemed immaterial to net realized and unrealized gain on investments and the Fund’s total return, representing less than $0.005 per share.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Fintech Innovation ETF
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | For the Period
February 4, 2019(1)
through
July 31, 2019 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 36.18 | | | | | $ | 22.84 | | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.30) | | | | | | (0.10) | | | | | | (0.03) | | |
| Net realized and unrealized gain on investments | | | | | 14.97 | | | | | | 13.74 | | | | | | 2.87 | | |
| Total gain from investment operations | | | | | 14.67 | | | | | | 13.64 | | | | | | 2.84 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | |
| Net realized gains | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
| Total distributions | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
| Net asset value, end of period | | | | $ | 50.67 | | | | | $ | 36.18 | | | | | $ | 22.84 | | |
| Market value, end of period | | | | $ | 50.68 | | | | | $ | 36.26 | | | | | $ | 22.86 | | |
Total Return at Net Asset Value(3) | | | | | 40.58% | | | | | | 60.36% | | | | | | 14.21% | | |
Total Return at Market Value(3) | | | | | 40.29% | | | | | | 60.59% | | | | | | 14.30% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 3,610,269 | | | | | $ | 347,337 | | | | | $ | 74,233 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | |
Net investment loss(5) | | | | | (0.60)% | | | | | | (0.40)% | | | | | | (0.24)%(4) | | |
Portfolio turnover rate(6) | | | | | 78% | | | | | | 55% | | | | | | 22% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
ARK Space Exploration & Innovation ETF
For a share outstanding throughout the period presented.
| | | | For the Period
March 30, 2021(1)
through
July 31, 2021 | |
| Per Share Data: | | | | | | | |
| Net asset value, beginning of period | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.02) | | |
| Net realized and unrealized loss on investments | | | | | 0.37 | | |
| Total loss from investment operations | | | | | 0.35 | | |
| Net asset value, end of period | | | | $ | 20.35 | | |
| Market value, end of period | | | | $ | 20.34 | | |
Total Return at Net Asset Value(3) | | | | | 1.77% | | |
Total Return at Market Value(3) | | | | | 1.70% | | |
| Ratios/Supplemental Data: | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 607,553 | | |
| Ratio to average net assets of: | | | | | | | |
| Expenses, prior to expense waivers and reimbursements | | | | | 0.75%(4) | | |
| Expenses, net of expense waivers and reimbursements | | | | | 0.71%(4) | | |
Net investment loss(5) | | | | | (0.26)%(4) | | |
Portfolio turnover rate(6) | | | | | 46% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the NYSE Arca, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(4)
Annualized.
(5)
Net investment loss represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(6)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (continued)
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | Year Ended
July 31, 2018 | | | For the
Period Ended
July 31, 2017(1) | | | For the Period
July 19, 2016(2)
through
August 31, 2016 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | | | | $ | 25.52 | | | | | $ | 20.81 | | | | | $ | 20.00 | | |
Net investment income (loss)(3) | | | | | 0.00(4) | | | | | | (0.00)(4) | | | | | | (0.01) | | | | | | (0.04) | | | | | | (0.03) | | | | | | 0.00(4) | | |
| Net realized and unrealized gain (loss) on investments | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.01) | | | | | | (0.73) | | | | | | 4.74 | | | | | | 0.81 | | |
| Total gain (loss) from investment operations | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.02) | | | | | | (0.77) | | | | | | 4.71 | | | | | | 0.81 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net investment income | | | | | — | | | | | | (0.01) | | | | | | — | | | | | | — | | | | | | (0.00)(4) | | | | | | — | | |
| Net realized gains | | | | | — | | | | | | — | | | | | | (0.16) | | | | | | (0.53) | | | | | | — | | | | | | — | | |
| Total distributions | | | | | — | | | | | | (0.01) | | | | | | (0.16) | | | | | | (0.53) | | | | | | — | | | | | | — | | |
| Net asset value, end of period | | | | $ | 38.04 | | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | | | | $ | 25.52 | | | | | $ | 20.81 | | |
| Market value, end of period | | | | $ | 38.00 | | | | | $ | 22.16 | | | | | $ | 22.25 | | | | | $ | 24.32 | | | | | $ | 25.52 | | | | | $ | 20.90 | | |
Total Return at Net Asset Value(5) | | | | | 70.76% | | | | | | 1.15% | | | | | | (8.25)% | | | | | | (3.05)% | | | | | | 22.64% | | | | | | 4.05% | | |
Total Return at Market Value(5) | | | | | 71.48% | | | | | | (0.34)% | | | | | | (7.76)% | | | | | | (2.64)% | | | | | | 22.11% | | | | | | 4.50% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 515,504 | | | | | $ | 41,217 | | | | | $ | 39,672 | | | | | $ | 47,220 | | | | | $ | 35,726 | | | | | $ | 6,243 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66%(6) | | | | | | 0.67%(6) | | |
Net investment income (loss)(7) | | | | | 0.00%(8) | | | | | | 0.00%(8) | | | | | | (0.04)% | | | | | | (0.17)% | | | | | | (0.14)%(6) | | | | | | 0.19%(6) | | |
Portfolio turnover rate(9) | | | | | 59% | | | | | | 37% | | | | | | 51% | | | | | | 53% | | | | | | 65% | | | | | | —% | | |
(1)
The Trust changed its fiscal and tax reporting period from August 31 to July 31.
(2)
Commencement of operations.
(3)
Based on average daily shares outstanding.
(4)
Amount represents less than $0.005.
(5)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(6)
Annualized.
(7)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(8)
Amount represents less than 0.00%.
(9)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Financial Highlights (concluded)
The ARK Israel Innovative Technology ETF
For a share outstanding throughout each period presented.
| | | | Year Ended
July 31, 2021 | | | Year Ended
July 31, 2020 | | | Year Ended
July 31, 2019 | | | For the Period
December 5, 2017(1)
through
July 31, 2018 | |
| Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net asset value, beginning of period | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | | | | $ | 20.00 | | |
Net investment income (loss)(2) | | | | | 0.05 | | | | | | (0.03) | | | | | | 0.08 | | | | | | (0.00)(3) | | |
| Net realized and unrealized gain on investments | | | | | 5.21 | | | | | | 4.97 | | | | | | 0.18 | | | | | | 0.85 | | |
| Total gain from investment operations | | | | | 5.26 | | | | | | 4.94 | | | | | | 0.26 | | | | | | 0.85 | | |
| Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net investment income | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
| Total distributions | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
| Net asset value, end of period | | | | $ | 30.26 | | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | |
| Market value, end of period | | | | $ | 30.15 | | | | | $ | 24.74 | | | | | $ | 20.64 | | | | | $ | 21.04 | | |
Total Return at Net Asset Value(4) | | | | | 21.06% | | | | | | 24.31% | | | | | | 1.57% | | | | | | 4.27% | | |
Total Return at Market Value(4) | | | | | 21.87% | | | | | | 22.41% | | | | | | 1.20% | | | | | | 5.20% | | |
| Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net assets, end of period (000’s omitted) | | | | $ | 283,716 | | | | | $ | 48,123 | | | | | $ | 19,512 | | | | | $ | 21,896 | | |
| Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | |
| Expenses | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49%(5) | | |
Net investment income (loss)(6) | | | | | 0.15% | | | | | | (0.14)% | | | | | | 0.37% | | | | | | (0.03)%(5) | | |
Portfolio turnover rate(7) | | | | | 88% | | | | | | 86% | | | | | | 57% | | | | | | 40% | | |
(1)
Commencement of operations.
(2)
Based on average daily shares outstanding.
(3)
Amount represents less than $0.005.
(4)
Net asset value total return is calculated assuming an initial investment made at the net asset value at the beginning of the period, reinvestment of all dividends and distributions at net asset value during the period and redemption on the last day of the period at net asset value. Market value total return is calculated assuming an initial investment made at the market value at the beginning of the period, reinvestment of all dividends, and distributions at market value during the period, and sale at the market value on the last day of the period. Market returns are based on the trade price at which shares are bought and sold on the Cboe BZX Exchange, Inc. using the last share trade. Total return calculated for a period of less than one year is not annualized.
(5)
Annualized.
(6)
Net investment income (loss) represents dividends received by the Fund from its underlying investments less expenses paid by the Fund during the period.
(7)
Portfolio turnover rate is not annualized and excludes the value of portfolio securities received or delivered as a result of in-kind creations or redemptions of the Fund’s capital shares.
See accompanying Notes to Financial Statements.
Notes to Financial Statements
1. Organization
ARK ETF Trust (“Trust”) is an open-end management investment company registered under the Investment Company Act of 1940, as amended (“1940 Act”). The Trust was organized as a Delaware statutory trust on June 7, 2013. The Trust consists of eight (8) investment portfolios: ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, ARK Space Exploration & Innovation ETF, The 3D Printing ETF, and The ARK Israel Innovative Technology ETF (each, a “Fund” and collectively, “Funds”). Each Fund is classified as a non-diversified management investment company under the 1940 Act.
The investment objective of the ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF is long-term growth of capital. The ARK Israel Innovative Technology ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israel Innovation Index. The 3D Printing ETF seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Total 3D-Printing Index. There can be no assurance that the Funds will achieve their respective investment objectives.
The Trust’s fiscal and tax reporting period is July 31.
2. Significant Accounting Policies
These financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which require management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amount of increase and decrease in net assets from operations during the fiscal period. Actual amounts could differ from these estimates. The Trust is an investment company and follows the investment company accounting standards and reporting guidance under Financial Accounting Standards Board (FASB) Accounting Standard Codification (“ASC”) Topic 946, “Financial Services — Investment Companies”. The following summarizes the significant accounting policies of the Funds:
Investment Valuation
The values of each Fund’s securities are based on such securities’ closing prices on the principal market on which the securities are traded. Such valuations would typically be categorized as Level 1 in the fair value hierarchy. If a security’s market price is not readily available or does not otherwise accurately reflect the market value of such security, the security will be fair valued by ARK Investment Management LLC (“Adviser”) in accordance with the Trust’s valuation policies and procedures that were approved by the Board of Trustees of the Trust (“Board”). Each Fund may use fair value pricing in a variety of circumstances, including but not limited to, situations when the value of a Fund’s security has been materially affected by events occurring after the close of the market on which such security is principally traded (such as a corporate action or other news that may materially affect the price of such security) or trading in such security has been suspended or halted. Such valuations would typically be categorized as Level 2 or Level 3 in the fair value hierarchy. Fair value pricing involves subjective judgments and it is possible that a fair value determination for a security could be materially different than the value that could be realized upon the sale of such security.
Investment Transactions
Investment transactions are accounted for on the trade date. Realized gains and losses on sales of investment securities are calculated using the identified cost method. Dividend income is recognized on the ex-dividend date, except for certain foreign dividends that may be recorded as soon as such information becomes available. Interest income and expenses are recognized on the accrual basis.
Dividend Distributions
Distributions to shareholders are recorded on the ex-dividend date and are determined in accordance with federal income tax regulations, which may differ from U.S. GAAP. Each Fund distributes all or substantially all of its net investment income to shareholders in the form of dividends.
Currency Translation
Assets and liabilities, including investment securities, denominated in currencies other than U.S. dollars are translated into U.S. dollars at the exchange rates supplied by one or more pricing vendors on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the exchange rates on the dates of such transactions.
The effects of changes in exchange rates on investment securities are included with the net realized gain or loss and net unrealized appreciation or depreciation on investments in each Fund’s statement of operations. The realized gain or loss and unrealized appreciation or depreciation resulting from all other transactions denominated in currencies other than U.S. dollars are disclosed separately.
Notes to Financial Statements (continued)
July 31, 2021
3. Management and Other Agreements
Management
The ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, and ARK Space Exploration & Innovation ETF, each pay the Adviser a fee calculated daily and payable monthly at an annual rate (stated as a percentage of the average daily net assets of the Fund) of 0.75% (“Management Fee”) in return for providing investment management and supervisory services under a comprehensive unitary structure. The 3D Printing ETF pays the Adviser a Management Fee of 0.65% in return for providing investment management and supervisory services under a comprehensive unitary structure. The ARK Israel Innovative Technology ETF pays the Adviser a Management Fee of 0.48% in return for providing investment management and supervisory services under a comprehensive unitary structure. Subject to the supervision of the Board, the Adviser provides investment management services to each Fund and provides, or causes to be furnished, all supervisory and other services reasonably necessary for the operation of each Fund and also bears the costs of various third-party services required by the Funds, including administration, certain custody, audit, legal, transfer agency, and printing costs. In addition to the Management Fee, each Fund bears other fees and expenses, such as taxes and governmental fees, brokerage fees, commissions and other transaction expenses, certain foreign custodial fees and expenses, costs of borrowing money, including interest expenses, and extraordinary expenses (such as litigation and indemnification expenses).
The Advisor has agreed to reduce their Management Fee for the ARK Space Exploration & Innovation ETF as a result of investing in The 3D Printing ETF. As such, the Management Fees in the Statement of Operations have been reduced by $86,395.
Administrator, Custodian, Transfer Agent and Accounting Agent
The Bank of New York Mellon is the administrator for the Funds, the custodian of the Funds’ assets and provides transfer agency, fund accounting and various administrative services to the Funds (in each capacity, “Administrator,” “Custodian,” “Transfer Agent” or “Accounting Agent”). The Bank of New York Mellon is a subsidiary of The Bank of New York Mellon Corporation, a financial holding company.
Distribution
Foreside Fund Services, LLC serves as the Funds’ distributor (“Distributor”). The Trust has adopted a distribution and service plan (“Rule 12b-1 Plan”) pursuant to Rule 12b-1 under the 1940 Act. Under the Rule 12b-1 Plan, each Fund is authorized to pay distribution fees in connection with the sale and distribution of its shares and pay service fees in connection with the provision of ongoing services to shareholders. To date, the Rule 12b-1 Plan has not been implemented for the Funds and there is no current intention to implement the Rule 12b-1 Plan.
Board of Trustees
Effective January 1, 2021, each Independent Trustee receives an annual retainer fee of $170,000 for services provided as a Trustee of the Trust, plus out-of-pocket expenses related to attendance at Board and Committee Meetings. The Chairs of the Board and of the Audit Committee each also receive an additional annual retainer fee of $25,000 and $15,000, respectively, for their service as such. Prior to this date, each Independent Trustee received an annual retainer fee of $85,000 for services provided as a Trustee of the Trust, plus out-of-pocket expenses related to attendance at Board and Committee Meetings. The Chairs of the Board and of the Audit Committee each also received an additional annual retainer fee of $20,000 and $15,000, respectively, for their service as such.
4. Creation and Redemption Transactions
As of July 31, 2021, there were an unlimited number of shares of beneficial interest without par value authorized by the Trust. Individual shares of a Fund may only be purchased and sold at market prices on a national securities exchange through a broker-dealer. Such transactions may be subject to customary commission rates imposed by the broker-dealer, and market prices for a Fund’s shares may be at, above or below its net asset value (“NAV”) depending on the premium or discount at which the Fund’s shares trade.
Each Fund issues and redeems shares at its NAV only in a large specified number of shares each called a “Creation Unit,” or multiples thereof, and only with “authorized participants” who have entered into contractual arrangements with the Distributor. A Creation Unit consists of 50,000 shares (25,000 shares with respect to the ARK Israel Innovative Technology ETF). Except when aggregated in Creation Units, shares of each Fund are not redeemable. Transactions in shares for each Fund are disclosed in detail in the Statements of Changes in Net Assets. The consideration for a purchase of Creation Units generally consists of the in-kind deposit of specified securities and an amount of cash or, as permitted or required by a Fund, of cash. A fixed transaction fee is imposed on each creation and redemption transaction. In addition, a variable charge for certain creation and redemption transactions may be imposed.
Notes to Financial Statements (continued)
5. Investment Transactions
The cost of purchases and the proceeds from sales of investment securities (excluding in-kind subscriptions and redemptions and short-term investments) for the year ended July 31, 2021 were as follows:
| Fund | | | Purchases | | | Sales | |
| ARK Genomic Revolution ETF | | | | $ | 6,023,035,401 | | | | | $ | 3,043,421,546 | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 2,026,997,640 | | | | | | 1,785,755,500 | | |
| ARK Innovation ETF | | | | | 17,220,277,470 | | | | | | 12,208,429,949 | | |
| ARK Next Generation Internet ETF | | | | | 6,291,894,318 | | | | | | 5,972,889,535 | | |
| ARK Fintech Innovation ETF | | | | | 2,156,429,841 | | | | | | 1,930,914,662 | | |
| ARK Space Exploration & Innovation ETF | | | | | 213,505,411 | | | | | | 198,132,808 | | |
| The 3D Printing ETF | | | | | 189,700,001 | | | | | | 184,641,196 | | |
| The ARK Israel Innovative Technology ETF | | | | | 163,991,779 | | | | | | 169,818,608 | | |
For the year ended July 31, 2021, the cost of in-kind subscriptions and the proceeds from in-kind redemptions were as follows:
| | | | In-Kind | |
| Fund | | | Subscriptions | | | Redemptions | |
| ARK Genomic Revolution ETF | | | | $ | 7,515,842,556 | | | | | $ | 3,535,139,420 | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 2,796,887,750 | | | | | | 969,012,511 | | |
| ARK Innovation ETF | | | | | 18,611,885,596 | | | | | | 10,296,283,190 | | |
| ARK Next Generation Internet ETF | | | | | 5,590,518,892 | | | | | | 2,956,505,491 | | |
| ARK Fintech Innovation ETF | | | | | 3,972,934,652 | | | | | | 935,384,284 | | |
| ARK Space Exploration & Innovation ETF | | | | | 670,995,540 | | | | | | 70,264,106 | | |
| The 3D Printing ETF | | | | | 651,830,238 | | | | | | 154,668,053 | | |
| The ARK Israel Innovative Technology ETF | | | | | 346,691,210 | | | | | | 72,145,658 | | |
6. Federal Income Tax
Each Fund intends to qualify as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended. If so qualified, a Fund will not be subject to federal income tax to the extent it distributes substantially all of its net investment income and net capital gains to its shareholders. Accounting for Uncertainty in Income Taxes provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements, and requires the evaluation of tax positions taken or expected to be taken in the course of preparing a Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the more-than-likely-than-not threshold would be recorded as a tax benefit or expense in the current year. Interest and penalty related to income taxes would be recorded as income tax expense. The management of the Funds is required to analyze all open tax years (2018 − 2021), as defined by IRS statute of limitations, for all major jurisdictions, including federal tax authorities and certain state tax authorities. As of July 31, 2021, the Funds did not have a liability for any unrecognized tax benefits. The Funds have no examination in progress and are not aware of any tax positions for which it is reasonably possible that the amounts of unrecognized tax benefits will significantly change in the next twelve months.
At July 31, 2021, the approximate cost of investments and net unrealized appreciation (depreciation) for federal income tax purposes was as follows:
| Fund | | | Cost | | | Gross
Unrealized
Appreciation | | | Gross
Unrealized
Depreciation | | | Net Unrealized
Appreciation
(Depreciation) | |
| ARK Genomic Revolution ETF | | | | $ | 9,270,375,013 | | | | | $ | 762,324,119 | | | | | $ | (1,439,848,029) | | | | | $ | (677,523,910) | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 2,838,248,197 | | | | | | 198,776,586 | | | | | | (222,356,196) | | | | | | (23,579,610) | | |
| ARK Innovation ETF | | | | | 21,910,871,348 | | | | | | 2,420,186,414 | | | | | | (1,815,532,552) | | | | | | 604,653,862 | | |
| ARK Next Generation Internet ETF | | | | | 5,619,999,803 | | | | | | 630,161,935 | | | | | | (422,968,595) | | | | | | 207,193,340 | | |
| ARK Fintech Innovation ETF | | | | | 3,657,089,669 | | | | | | 286,601,312 | | | | | | (331,425,555) | | | | | | (44,824,243) | | |
| ARK Space Exploration & Innovation ETF | | | | | 614,076,444 | | | | | | 23,230,607 | | | | | | (25,165,785) | | | | | | (1,935,178) | | |
| The 3D Printing ETF | | | | | 577,641,235 | | | | | | 43,618,201 | | | | | | (105,755,795) | | | | | | (62,137,594) | | |
| The ARK Israel Innovative Technology ETF | | | | | 311,341,527 | | | | | | 17,689,915 | | | | | | (44,891,520) | | | | | | (27,201,605) | | |
The differences between book-basis and tax-basis components of net assets are primarily attributable to tax deferral of losses on wash sales, non-REIT income and basis adjustments, grantor trust adjustments, and undistributed short-term capital gains treated as ordinary income for tax purposes.
Notes to Financial Statements (continued)
July 31, 2021
At July 31, 2021, the components of distributable earnings/loss on a tax basis were as follows:
| Fund | | | Undistributed
Income | | | Undistributed
Long-term
Capital Gains | | | Accumulated
Capital
Gains/(Losses) | | | Net Unrealized
Appreciation
(Depreciation) | | | Total Earnings
(Losses) | |
| ARK Genomic Revolution ETF | | | | $ | 32,103,509 | | | | | $ | — | | | | | $ | — | | | | | $ | (677,523,910) | | | | | $ | (645,420,401) | | |
| ARK Autonomous Technology & Robotics ETF | | | | | — | | | | | | 729,419 | | | | | | (7,496,660) | | | | | | (23,579,610) | | | | | | (30,346,851) | | |
| ARK Innovation ETF | | | | | 87,371,749 | | | | | | 46,601,172 | | | | | | — | | | | | | 604,653,862 | | | | | | 738,626,783 | | |
| ARK Next Generation Internet ETF | | | | | 6,287,756 | | | | | | 35,775,962 | | | | | | — | | | | | | 207,193,340 | | | | | | 249,257,058 | | |
| ARK Fintech Innovation ETF | | | | | — | | | | | | — | | | | | | (183,568,907) | | | | | | (44,838,580) | | | | | | (228,407,487) | | |
| ARK Space Exploration & Innovation ETF | | | | | — | | | | | | — | | | | | | (10,320,213) | | | | | | (1,936,771) | | | | | | (12,256,984) | | |
| The 3D Printing ETF | | | | | 6,420 | | | | | | — | | | | | | (19,425,109) | | | | | | (62,139,260) | | | | | | (81,557,949) | | |
| The ARK Israel Innovative Technology ETF | | | | | 726,959 | | | | | | — | | | | | | (18,107,188) | | | | | | (27,202,123) | | | | | | (44,582,352) | | |
At July 31, 2021, the effect of permanent book/tax reclassifications resulted in increase/(decrease) to the components of net assets as follows:
| Fund | | | Total Distributable
Earnings | | | Paid-in Capital | |
| ARK Genomic Revolution ETF | | | | $ | (1,010,263,903) | | | | | $ | 1,010,263,903 | | |
| ARK Autonomous Technology & Robotics ETF | | | | | (330,650,278) | | | | | | 330,650,278 | | |
| ARK Innovation ETF | | | | | (3,878,564,114) | | | | | | 3,878,564,114 | | |
| ARK Next Generation Internet ETF | | | | | (1,071,028,708) | | | | | | 1,071,028,708 | | |
| ARK Fintech Innovation ETF | | | | | (283,292,512) | | | | | | 283,292,512 | | |
| ARK Space Exploration & Innovation ETF | | | | | (1,290,758) | | | | | | 1,290,758 | | |
| The 3D Printing ETF | | | | | (46,566,867) | | | | | | 46,566,867 | | |
| The ARK Israel Innovative Technology ETF | | | | | (13,781,738) | | | | | | 13,781,738 | | |
The tax character of distributions paid during the years indicated was as follows:
| | | | Period Ended July 31, 2021 | | | Period Ended July 31, 2020 | |
| Fund | | | Ordinary
Income* | | | Long-Term
Capital Gain | | | Ordinary
Income* | | | Long-Term
Capital Gain | |
| ARK Genomic Revolution ETF | | | | $ | 39,550,514 | | | | | $ | 22,834,200 | | | | | $ | 15,340,243 | | | | | $ | — | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 6,569,669 | | | | | | 7,864,531 | | | | | | — | | | | | | — | | |
| ARK Innovation ETF | | | | | 231,952,950 | | | | | | 59,361,225 | | | | | | 7,062,842 | | | | | | — | | |
| ARK Next Generation Internet ETF | | | | | 68,580,176 | | | | | | — | | | | | | — | | | | | | — | | |
| ARK Fintech Innovation ETF | | | | | 7,119,392 | | | | | | 72,336 | | | | | | 1,037,795 | | | | | | — | | |
| ARK Space Exploration & Innovation ETF | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| The 3D Printing ETF | | | | | — | | | | | | — | | | | | | 23,952 | | | | | | — | | |
| The ARK Israel Innovative Technology ETF | | | | | — | | | | | | — | | | | | | 392,106 | | | | | | — | | |
*
For tax purposes short-term capital gain distributions are considered ordinary income distributions.
Under current tax regulations, capital losses on securities transactions realized after October 31 (“Post-October Losses”) may be deferred and treated as occurring on the first business day of the following fiscal year. For the year ended July 31, 2021, the Funds incurred and elected to defer to August 1, 2021 Post-October Losses and ordinary income losses as follows:
| Fund | | | Late Year
Ordinary
Deferral | | | Capital
Post-October
Loss | |
| ARK Genomic Revolution ETF | | | | $ | — | | | | | $ | — | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 7,496,660 | | | | | | — | | |
| ARK Innovation ETF | | | | | — | | | | | | — | | |
| ARK Next Generation Internet ETF | | | | | — | | | | | | — | | |
| ARK Fintech Innovation ETF | | | | | — | | | | | | — | | |
| ARK Space Exploration & Innovation ETF | | | | | — | | | | | | — | | |
| The 3D Printing ETF | | | | | — | | | | | | — | | |
| The ARK Israel Innovative Technology ETF | | | | | — | | | | | | — | | |
Notes to Financial Statements (continued)
At July 31, 2021, for Federal income tax purposes, the Funds have capital loss carryforwards available as shown in the table below, to the extent provided by regulations, to offset future capital gains for an unlimited period. To the extent that these capital loss carryforwards are used to offset future capital gains, it is probable that the capital gains so offset will not be distributed to shareholders.
| | | | Short-Term | | | Long-Term | | | Total Amount | |
| ARK Genomic Revolution ETF | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| ARK Autonomous Technology & Robotics ETF | | | | | — | | | | | | — | | | | | | — | | |
| ARK Innovation ETF | | | | | — | | | | | | — | | | | | | — | | |
| ARK Next Generation Internet ETF | | | | | — | | | | | | — | | | | | | — | | |
| ARK Fintech Innovation ETF | | | | | 183,568,907 | | | | | | — | | | | | | 183,568,907 | | |
| ARK Space Exploration & Innovation ETF | | | | | 10,320,213 | | | | | | — | | | | | | 10,320,213 | | |
| The 3D Printing ETF | | | | | 13,257,088 | | | | | | 6,168,021 | | | | | | 19,425,109 | | |
| The ARK Israel Innovative Technology ETF | | | | | 17,719,738 | | | | | | 387,450 | | | | | | 18,107,188 | | |
7. Indemnification Obligations
The Funds have a variety of indemnification obligations under contracts with their service providers. The Funds’ maximum exposure under these arrangements is unknown. However, the Funds have not had prior claims or losses pursuant to these contracts and expect the risk of loss to be remote.
8. Investment Risks
Concentration Risk: The ARK Autonomous Technology & Robotics ETF will be concentrated in securities of issuers having their principal business activities in groups of industries in the industrials and information technology sectors, although it will not concentrate in any specific industry. The ARK Fintech Innovation ETF will be concentrated in securities of issuers having their principal business activities in the communication, technology and financials group of industries. The ARK Genomic Revolution ETF will be concentrated in securities of issuers having their principal business activities in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The ARK Next Generation Internet ETF will be concentrated in securities of issuers having their principal business activities in the internet information provider and catalog and mail order house industry. The 3D Printing ETF, The ARK Space Exploration & Innovation ETF and the ARK Israel Innovative Technology ETF may each invest 25% or more of the value of its respective net assets in securities of issuers in any one industry or group of industries if the applicable index that the Fund replicates concentrates in an industry or group of industries. This concentration limit does not apply to securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities. The ARK Innovation ETF will not be concentrated in any industry.
As of July 31, 2021, the ARK Genomic Revolution ETF had more than 25% of its assets invested in the biotechnology industry, the ARK Space Exploration & Innovation ETF had more than 25% of its assets invested in the aerospace & defense industry and the 3D Printing ETF had more than 25% of its assets invested in the software industry. To the extent a Fund’s holdings are concentrated in a particular industry or group of industries, adverse market conditions affecting those industries may have a more significant impact on the Fund than they would on a Fund investing in a broader range of securities and the value of the Fund’s shares may fluctuate more than shares of a fund investing in a broader range of securities.
The Funds’ prospectuses contain additional information regarding the risks associated with an investment in a Fund.
Market Risk: A novel strain of coronavirus (COVID-19) outbreak was declared a pandemic by the World Health Organization on March 11, 2020. The situation is evolving with various cities and countries around the world responding in different ways to address the outbreak. There are direct and indirect economic effects developing for various industries and individual companies throughout the world. The outbreak of COVID-19 has resulted in travel and border restrictions, quarantines, supply chain disruptions, lower consumer demand and general market uncertainty. The global economy, the economies of certain nations and individual issuers have been and may continue to be adversely affected by COVID-19, particularly in light of the interconnectivity between economies and financial markets, all of which may negatively impact the Funds’ performance as well as the operations of the Trust. In addition, COVID-19 and governmental responses to COVID-19 may negatively impact the capabilities of the Funds’ service providers, disrupt the Funds’ operations, exacerbate other pre-existing political, social and economic risks to the Funds and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations may take actions in response to the pandemic that affect the instruments in which the Funds invest, or the issuers of such instruments, in ways that could also have a significant negative impact on a Fund’s investment performance. Management will continue to monitor the impact COVID-19 has on the Funds and reflect the consequences as appropriate in the Funds’ accounting and financial reporting. The recent pandemic spread of COVID-19 and related geopolitical events could lead to increased market volatility, disruption to
Notes to Financial Statements (concluded)
July 31, 2021
U.S. and world economies and markets and may have significant adverse effects on the Funds and their investments. The full impact of this COVID-19 pandemic, or other future epidemics/pandemics, is currently unknown.
9. Subsequent Events
Subsequent events occurring after the date of this Report have been evaluated for potential impact to this Report through the date the Report was issued, and it has been determined that no events have occurred that require disclosure.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees and Shareholders of
ARK ETF Trust
Opinion on the Financial Statements
We have audited the accompanying statements of assets and liabilities of ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF, ARK Fintech Innovation ETF, ARK Space Exploration & Innovation ETF, The 3D Printing ETF, and The ARK Israel Innovative Technology ETF (the “Funds”), each a series of ARK ETF Trust (the “Trust”), including the schedules of investments, as of July 31, 2021, the related statements of operations, the statements of changes in net assets and the financial highlights for each of the periods indicated in the table below, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Funds as of July 31, 2021, the results of their operations, the changes in their net assets, and their financial highlights for each of the periods indicated in the table below, in conformity with accounting principles generally accepted in the United States of America.
Individual Funds
constituting
ARK ETF Trust | | | Statement of
operations | | | Statements of
changes in net assets | | | Financial highlights | |
| ARK Genomic Revolution ETF, ARK Autonomous Technology & Robotics ETF, ARK Innovation ETF, ARK Next Generation Internet ETF | | | For the year ended July 31, 2021 | | | For each of the two years in the period ended July 31, 2021 | | | For each of the four years in the period ended July 31, 2021, for the eleven months ended July 31, 2017 and for the year ended August 31, 2016 | |
| ARK Fintech Innovation ETF | | | For the year ended July 31, 2021 | | | For each of the two years in the period ended July 31, 2021 | | | For the each of the two years in the period ended July 31, 2021 and for the period February 4, 2019 (commencement of operations) through July 31, 2019 | |
| ARK Space Exploration & Innovation ETF | | | For the period March 30, 2021 (commencement of operations) through July 31, 2021 | | | For the period March 30, 2021 (commencement of operations) through July 31, 2021 | | | For the period March 30, 2021 (commencement of operations) through July 31, 2021 | |
| The 3D Printing ETF | | | For the year ended July 31, 2021 | | | For each of the two years in the period ended July 31, 2021 | | | For each of the four years in the period ended July 31, 2021, for the eleven months ended July 31, 2017 and for the period July 19, 2016 (commencement of operations) through August 31, 2016 | |
| The ARK Israel Innovative Technology ETF | | | For the year ended July 31, 2021 | | | For each of the two years in the period ended July 31, 2021 | | | For each of the three years in the period ended July 31, 2021 and for the period December 5, 2017 through July 31, 2018 | |
To the Board of Trustees and Shareholders of
ARK ETF Trust
Page Two
Basis for Opinion
These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We have served as the auditor of one or more of the funds in the Trust since 2014.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Funds are not required to have, nor were we engaged to perform, an audit of the Funds’ internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of July 31, 2021 by correspondence with the custodian and brokers, and other appropriate auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
TAIT, WELLER & BAKER LLP
Philadelphia, Pennsylvania
September 24, 2021
Supplemental Information (Unaudited)
Quarterly Portfolio Schedule. The ARK ETF Trust files with the Securities and Exchange Commission on Form N-Q (prior to March 31, 2020) or Form N-PORT (after March 31, 2020) the complete schedule of portfolio holdings for each ARK ETF for the first and third quarters of each fiscal year. The ARK ETF Trust’s Forms N-Q or Form N-PORT are available on the Securities and Exchange Commission’s website at www.sec.gov. Copies of the filings are available without charge, upon request, by calling 1-212-426-7040. In addition, each ARK ETF’s current portfolio holdings are updated daily and are available on our website, www.ark-funds.com.
Proxy Voting Policies and Procedures. A description of ARK Investment Management LLC’s proxy voting policies and procedures, which are applicable to the ARK ETFs, is available without charge, upon request, by calling 1-212-426-7040 collect or visiting our website at www.ark-funds.com or the Securities and Exchange Commission’s website at www.sec.gov.
Proxy Voting Record. The ARK ETFs file with the Securities and Exchange Commission their proxy voting records on Form N-PX for each 12 month period ending June 30. Form N-PX must be filed each year by August 31. The most recent Form N-PX or voting record information is available without charge, upon request, by calling 1-212-426-7040 collect or visiting the Securities and Exchange Commission’s website at www.sec.gov.
Premium/Discount Information. Information about the difference between daily market prices on the secondary market for shares of each ARK ETF and the ARK ETF’s net asset value can be found on our website, www.ark-funds.com.
Tax Information
Form 1099-DIV and other year-end tax information provide shareholders with actual calendar year amounts that should be included in their tax returns. Shareholders should consult their tax advisors. Each Fund designates the following amounts or, if subsequently determined to be different, the maximum allowable for its year ended July 31, 2021.
| | | | Qualified
Dividend
Income* | | | Dividends
Received
Deduction* | |
| ARK Genomic Revolution ETF | | | | | 24% | | | | | | 5% | | |
| ARK Autonomous Technology & Robotics ETF | | | | | 0% | | | | | | 0% | | |
| ARK Innovation ETF | | | | | 5% | | | | | | 2% | | |
| ARK Next Generation Internet ETF | | | | | 4% | | | | | | 2% | | |
| ARK Fintech Innovation ETF | | | | | 7% | | | | | | 4% | | |
| ARK Space Exploration & Innovation ETF | | | | | 0% | | | | | | 0% | | |
| The 3D Printing ETF | | | | | 0% | | | | | | 0% | | |
| The ARK Israel Innovative Technology ETF | | | | | 0% | | | | | | 0% | | |
*
The above percentage is based on ordinary income dividends paid to shareholders during each Fund’s fiscal year.
Pursuant to Rule 22e-4 (the “Liquidity Rule”) under the Investment Company Act of 1940 (“1940 Act”), the Funds have adopted and implemented a Liquidity Risk Management Program (the “Program”). The Program addresses the Liquidity Rule’s requirements for the periodic assessment and management of Fund liquidity risk and compliance with the Liquidity Rule’s restrictions on investments in illiquid investments. The ARK Liquidity Committee (“Administrator”) has been designated to administer the Program. The Administrator consists of certain Trust officers and representatives from compliance and trading functions.
Each of the Funds qualifies as an “In-Kind ETF” under the Liquidity Rule, which means that it meets redemptions through in-kind transfers of securities, positions and assets other than a de minimis amount of cash and publishes its portfolio holdings daily. In-Kind ETFs are exempt from certain Liquidity Rule requirements. The Program includes provisions regarding the maintenance of In-Kind ETF status.
At its March 23, 2021 meeting, the Board of Trustees (“Board”) reviewed a written report prepared by the Administrator addressing the operation of the Program and assessing its adequacy and effectiveness of implementation, as required under the Liquidity Rule. Among other things, this report summarized the Administrator’s annual liquidity risk assessment, testing for In-Kind ETF status and monitoring for compliance with the Liquidity Rule’s restrictions on investments in illiquid investments. The report noted the Administrator’s conclusion that the implementation and ongoing operation of the Program and related procedures were adequate and effective in managing the Funds’ liquidity risk.
Board Approval of Management Agreements (Unaudited)
Annual Review and Approval of Trust Contracts
Under section 15(c) of the Investment Company Act of 1940 (“1940 Act”), the ARK ETF Trust’s (“Trust”) Board of Trustees (“Trustees” or “Board”), including a majority of Trustees who are not “interested persons” of the Trust (as that term is defined in the 1940 Act) (“Independent Trustees”), is required annually to consider the continuation of (i) the Supervision Agreement between the Trust and ARK Investment Management, LLC (“ARK”) on behalf of each series of the Trust (each, a “Fund” and, collectively, “Funds”); and (ii) the Investment Advisory Agreement between the Trust and ARK (collectively, “Management Agreements”) on behalf of each Fund. In advance of the quarterly Board meeting held via video conference on June 22, 2021 (“Meeting”), the Independent Trustees and their counsel reviewed and discussed with representatives of an independent data provider that had prepared a report which compared, among other things, each Fund’s performance, fees and expenses with those of comparable funds managed by other investment advisers in connection with the Independent Trustees’ consideration of the continuation of the Management Agreements. The Independent Trustees also considered other information, provided to the Board during the year, as part of its evaluation process. Prior to voting on the Management Agreements, the Independent Trustees met in Executive Session with ARK’s senior management and also met in private sessions with their counsel at which time no representatives of management were present.
After the presentation of relevant information by ARK’s senior management and extensive discussions prior to and at the Meeting, the Trustees, including the Independent Trustees voting separately, unanimously approved the continuance of the Management Agreements on behalf of the Funds. The determination made by all of the Trustees to approve the continuation of the Management Agreements was made on the basis of each Trustee’s business judgment after considering all of the information presented to them. Individual Trustees may have given different weights to certain factors and assigned various degrees of materiality to information received in connection with the contract review process. In approving the continuation of the Management Agreements for each Fund, the following factors were considered by the Trustees, and no one factor was determinative:
(a) The nature, extent and quality of the services provided by ARK to the Funds under the Management Agreements. The Trustees considered the nature, extent and quality of the services that ARK provides and will continue to provide under the Management Agreements, including: (i) the qualifications of the portfolio manager, analysts and other key personnel of ARK who provide and will continue to provide the supervisory and investment advisory services to the Trust; and (ii) the terms of the Management Agreements. The Trustees considered ARK’s senior management’s discussion of the various duties and responsibilities of ARK under the Management Agreements. The Trustees also considered the organizational structure of ARK, the quality of ARK’s investment, administrative, operations, and legal personnel and ARK’s management of the operations of the Funds.
Based on these and other factors, the Trustees concluded that the nature, extent and quality of the supervisory and investment advisory services that would continue to be provided to the Funds by ARK were satisfactory and supported the decision of the Trustees to approve the continuation of the Management Agreements with respect to each Fund.
(b) The investment performance of the Funds relative to comparable funds managed by other investment advisers. The Trustees considered a report prepared by an independent data provider, which compared the performance of each of the Funds to that of comparable ETFs as identified by such independent data provider and appropriate, recognized market indices for the one-year, three-year, five-year and since inception periods ended March 31, 2021, as applicable. The Trustees also considered ARK’s senior management’s discussion of the relative performance of the Funds for the period ended March 31, 2021 and year to date.
Based upon their review of the investment performance of each Fund and ARK’s senior management’s discussion of the investment performance of the Funds, the Trustees concluded that each Fund’s overall performance was satisfactory relative to the performance of comparable ETFs and relevant market indices.
(c) A comparison of the advisory fees of the Funds with those of other funds and other funds and accounts managed by ARK with comparable investment strategies. The Trustees considered a report prepared by an independent data provider, which compared the advisory fees paid by the Funds with those paid by comparable ETFs as identified by such independent data provider. The Board noted that the advisory fee paid by each actively-managed Fund generally was below the applicable actively-managed peer group median and that the advisory fee paid by each passively-managed Fund was either below or in line with the applicable passively-managed peer group median. The Board also considered fee information for comparable funds and accounts managed by ARK. The Board noted that the fees paid by certain funds and accounts managed by ARK are the same as the advisory fees paid by the Funds and that in instances where comparable funds or accounts managed by ARK paid lower fees than the Funds, ARK generally provides these clients with fewer services than it provides to the Funds. The Board noted the relatively small number of ETFs in the Funds’ respective peer groups given the limited number of ETFs with strategies that are comparable to those of the Funds.
Based on their review of the comparative fee data and the other factors considered, the Trustees concluded that the advisory fee paid by each Fund was reasonable considering the services received by the Fund.
Board Approval of Management Agreements (Unaudited) (concluded)
(d) A comparison of the management fees (under the Supervision Agreement, which includes the advisory fees under the Investment Advisory Agreement) for the Funds with the fees of comparable funds and other accounts managed by other advisers. The Trustees considered a report prepared by an independent data provider, which compared the net expense ratios of the Funds with the net expense ratios of comparable ETFs as identified by such independent data provider. The Trustees noted that the actively-managed Funds’ net expense ratios were below the applicable actively-managed peer group median and that the passively managed Funds’ net expense ratios were either below or in line with the applicable passively-managed peer group median. The Trustees noted the relatively small number of ETFs in the Funds’ peer groups given the given the limited number of ETFs with strategies that are comparable to those of the Funds.
The Trustees also took into consideration ARK’s view that the unitary structure of the Funds’ management fees (which includes, among other things, the advisory fees) would continue to be easy to understand by investors and would provide a level of predictability with respect to the total expense ratios for the Funds.
Based on the fee comparisons provided to the Board and other factors considered, the Trustees concluded that the net expense ratio of each Fund, which reflected both the advisory fee and management fee, was reasonable.
(e) The extent to which economies of scale may be realized as the Funds’ assets increase and whether fee levels would reflect economies of scale. The Trustees considered ARK’s senior management’s discussion of the structure of the current management fees and advisory fees and noted that the unitary fee structure effectively acts as a cap on the fees and expenses (excluding certain specific investment-related and extraordinary fees and expenses) that are borne by the Funds. The Trustees noted that ARK still bears most of the ordinary fees and expenses of each passively-managed Fund. The Trustees also noted that, although there currently are no breakpoints in any Fund’s management fees or advisory fees, if a Fund’s assets increase over time, the Fund might realize other economies of scale if assets increase proportionally more than certain other expenses.
Based on these considerations, the Trustees concluded that adding breakpoints at specified levels to the Funds’ management fees and advisory fees was not appropriate at that time.
(f) The cost of the services provided and profits realized by ARK from the relationship with the Funds. The Trustees considered that certain fees and expenses of the Funds had been assumed and paid by ARK in accordance with the Management Agreements. The Trustees noted that for the 2020 calendar year, all but two of the Funds had been profitable to ARK.
Based on the information provided to the Trustees, the Trustees concluded that ARK’s profitability was reasonable given the quality and scope of services provided by ARK and the overall investment performance of the Funds.
(g) Benefits derived or to be derived by ARK and its affiliates from ARK’s relationship with the Funds. The Trustees noted that ARK’s reputation as an asset manager has likely benefitted from the performance of the Funds and had the potential to aid ARK in gathering assets for its non-fund business operations. The Trustees also considered that ARK’s affiliates were likely to benefit from the popularity and positive reception of the Funds.
The Board concluded that the nature and amount of any indirect benefits received by ARK and its affiliates from ARK’s relationship with the Funds are reasonable.
(h) Financial Resources of ARK. The Trustees then considered whether ARK was financially sound and had adequate resources to perform its obligations under the Management Agreements.
Based on the information provided to the Board, the Trustees concluded that ARK had sufficient financial resources necessary to continue to perform its obligations under the Management Agreements.
General Conclusion. Based on its consideration of all of the above factors, and such other information as it deemed appropriate and relevant, the Board concluded that it would be in the best interest of each Fund and its shareholders to approve the continuation of the Management Agreements, including the fees payable under those Agreements. Accordingly, the Board, with Independent Trustees voting separately, unanimously approved the continuation of the Management Agreements with respect to each Fund for an additional one-year period.
Board of Trustees and Executive Officers (Unaudited)
Trustees and Executive Officers. Information about the Trustees and Executive Officers of the Trust as of July 31, 2020, including their business addresses, ages and principal occupations during the past five years, and other directorships of publicly traded companies or funds, is set forth in the table below.
Independent Trustees
Name, Address(1) and Age | | | Position(s)
Held with
the Trust | | | Term of Office(2)
and Length of
Time Served | | | Principal Occupation(s)
During Past Five Years | | | Other Directorships
Held By Trustee
During Past Five Years | |
| Scott R. Chichester, 51 | | | Trustee | | | Since June 30, 2014 | | | Chief Financial Officer, Sterling Consolidated Corp (since 2011); Director and Founder, DirectPay USA LLC (since 2006) (payroll company); Founder, Madison Park Advisors LLC (since 2011) (public company advisory); Proprietor, Scott R. Chichester CPA (since 2001) (CPA firm). | | | Trustee and audit committee chairman of Global X ETF fund complex (2008 – 2018); Director of Sterling Consolidated Corp (since 2011). | |
| Darlene T. DeRemer, 65 | | | Trustee | | | Since June 30, 2014 | | | Managing Partner, Grail Partners LLC
(2005 – 2019). | | | Trustee, Member of Investment and Endowment Committee of Syracuse University (since 2010); Interested Trustee, American Independence Funds (2015 – 2019); Trustee, Risk X Investment Funds (2016 – 2020); Director, United Capital Financial Planners (2008 – 2019); Director, Hillcrest Asset Management (since 2007); Board Member, Confluence Technologies LLC (2018 – 2021). | |
| Robert G. Zack, 73 | | | Trustee | | | Since June 30, 2014 | | | Adjunct Professor at the University of Virginia School of Law; Counsel, Dechert LLP
(2012 – 2014); Executive Vice President, OppenheimerFunds, Inc. (2004 – 2011); General Counsel, OppenheimerFunds, Inc. (2002 – 2010); Secretary and General Counsel, Oppenheimer Acquisition Corp. (2001 – 2011); Executive Vice President, General Counsel and Director, OFI Trust Co. (2001 – 2011); Vice President and Secretary, Oppenheimer Funds (2002 – 2011). | | | Trustee of University of Virginia Law School Foundation (since 2011). | |
(1)
The address for each Trustee and officer is 3 E. 28th Street, 7th Floor, New York, NY 10016.
(2)
Each Trustee serves until resignation, death, retirement or removal.
Board of Trustees and Executive Officers (Unaudited) (concluded)
Interested Trustee
Name, Address(1) and Age | | | Position(s)
Held with
the Trust | | | Term of Office(2)
and Length of
Time Served | | | Principal Occupation(s)
During Past Five Years | | | Other Directorships
Held By Trustee
During Past Five Years | |
| Catherine D. Wood, 65 | | | Chief Executive Officer, Chief Investment Officer and Trustee | | | Since June 7, 2013 | | | Managing Member, Founder and Chief Executive Officer, ARK Investment Management LLC (since 2013); President, ARK ETF Trust (2014 – 2015); Senior Vice President and Chief Investment Officer of Thematic Portfolios, AllianceBernstein L.P. (2009 – 2013). | | | Executive Director, Wall Street Blockchain Alliance (since 2018); Independent Non-Executive Director, Amun Holdings Ltd (since 2018); Director, NexPoint Advisors: NexPoint Residential Trust Inc., NexPoint Real Estate Finance Inc. and VineBrook Homes Trust Inc. (since 2020); Director, MIMIK Technologies Inc. (since 2021); Board Member, Strange Brewing SA (since 2018). | |
(1)
The address for each Trustee and officer is 3 E. 28th Street, 7th Floor, New York, NY 10016.
(2)
Each Trustee serves until resignation, death, retirement or removal.
Officer Information
Officer’s Name, Address(1) and Age | | | Position(s)
Held with
the Trust | | | Term of Office(2)
and Length of
Time Served | | | Principal Occupation(s)
During The Past Five Years | |
| Catherine D. Wood, 65 | | | Trustee, Chief Executive Officer and Chief Investment Officer | | | Since 6/30/14 | | | Managing Member, Founder and Chief Executive Officer, ARK Investment Management LLC (since 2013); President, ARK ETF Trust (2014 – 2015). | |
| William C. Cox, 55 | | | Treasurer and Chief Financial Officer | | | Since 6/30/14* | | | Principal Financial Officer, Investment Products, ARK Investment Management LLC (since June 2018); Fund Principal Financial Officer, Foreside Financial Group, LLC (2013 – 2018). | |
| Kellen Carter, 38 | | | Chief Compliance Officer; Secretary; Chief Legal Officer | | | Since 5/26/16
Since 5/26/16
Since 12/16/16 | | | Chief Compliance Officer, Associate General Counsel (since April 2016), Interim General Counsel, ARK Investment Management LLC (2016 – 2018), Corporate Counsel, ARK Investment Management LLC (since July 2018); Management Consultant, Wealth and Asset Management Division Ernst & Young LLP (2014 – 2016). | |
| Thomas G. Staudt, 33 | | | President
Vice President | | | Since 12/16/16
03/27/15 – 12/16/16 | | | Director of Product Development and Associate Operating Officer (2015 – 2016), Interim Chief Operating Officer, ARK Investment Management LLC (2016 – 2018), Chief Operating Officer, ARK Investment Management LLC (since April 2018); Associate Portfolio Manager, ARK Investment Management LLC (2014 – 2015). | |
(1)
The address for each officer is 3 E. 28th Street, 7th Floor, New York, NY 10016.
(2)
Officers are elected yearly by the Trustees.
The Statement of Additional Information for the Trust includes additional information about the Trustees and is available, without charge, upon request, by calling 1-212-426-7040 collect or visiting our website at www.ark-funds.com.
*
In January 2018, William C. Cox resigned from Foreside Financial Group. In his place, Joshua G. Hunter served as Treasurer & CFO of the Trust. In June 2018, William was subsequently hired as an employee of ARK Investment Management, LLC and resumed his responsibilities as Treasurer & CFO of the Trust.
General Information (Unaudited)
Investment Adviser
ARK Investment Management LLC
3 E. 28th Street, 7th Floor
New York, NY 10016
Administrator, Custodian, Transfer Agent, and Accounting Agent
The Bank of New York Mellon
240 Greenwich Street
New York, NY 10286
Distributor
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, ME 04101
Independent Registered Public Accounting Firm
Tait, Weller & Baker LLP
50 S.16th Street, 29th Floor
Philadelphia, PA 19102
This report is submitted for the general information of the shareholders of each Fund. It is not authorized for distribution to prospective investors unless preceded or accompanied by an effective prospectus, which includes information regarding the Funds’ risks, objectives, fees and expenses, experience of their management, and other information.
ARK Invest | 3 E. 28th Street, 7th Floor, New York, NY 10016 | 212.426.7040 | info@ark-invest.com | ark-funds.com
(b) Not applicable
Item 2. Code of Ethics.
| (a) | As of the end of the period covered by this report, the registrant has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party (“Code of Ethics”). |
| (b) | For purposes of this Item, the term “code of ethics” means written standards that are reasonably designed to deter wrongdoing and to promote: |
| (1) | Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; |
| (2) | Full, fair, accurate, timely, and understandable disclosure in reports and documents that a registrant files with, or submits to, the Commission and in other public communications made by the registrant; |
| (3) | Compliance with applicable governmental laws, rules, and regulations; |
| (4) | The prompt internal reporting of violations of the code to an appropriate person or persons identified in the code; and |
| (5) | Accountability for adherence to the code. |
| (c) | There have been no amendments, during the period covered by this report, to a provision of the code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, and that relates to any element of the code of ethics description enumerated in paragraph (b) of this item. |
| (d) | During the period covered by this report, the registrant did not grant any waivers, including an implicit waiver, from a provision of the Code of Ethics that relates to one or more of the items set forth in paragraph (b) of this Item’s instructions. |
| (e) | The registrant does not intend to satisfy the disclosure requirements under paragraph (c) or (d) of this Item regarding an amendment to, or a waiver from, a provision of its code of ethics and that relates to any element of the code of ethics definition enumerated in paragraph (b) of this Item by posting such information on its Internet website. |
| (f) | The Code of Ethics is attached hereto as Exhibit 13(a)(1). |
Item 3. Audit Committee Financial Expert.
The registrant’s board of trustees has determined that the registrant has at least one “audit committee financial expert” (as defined in Item 3 of Form N-CSR) serving on its audit committee. Scott R. Chichester is qualified to serve as an “audit committee financial expert” and is “independent” (as each term is defined in Item 3 of Form N-CSR).
Item 4. Principal Accountant Fees and Services.
Audit Fees
| (a) | The aggregate fees billed for professional services rendered by the principal accountant for the audit of the registrant’s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for the fiscal years are $105,000 for July 31, 2020 and $122,000 for July 31, 2021. |
Audit-Related Fees
| (b) | The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the registrant’s financial statements and are not reported under paragraph (a) of this Item are $0 for July 31, 2020 and $0 for July 31, 2021. |
Tax Fees
| (c) | The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning are $28,000 for July 31, 2020 and $32,000 for July 31, 2021. |
All Other Fees
| (d) | The aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported in paragraphs (a) through (c) of this Item are $0 for July 31, 2020 and $0 for July 31, 2021. |
| (e)(1) | The registrant’s audit committee (“Audit Committee”) has adopted an Audit and Non-Audit Services Pre-Approval Policy (“Pre-Approval Policy”) that applies to any and all engagements of the independent auditor to the registrant for audit, non-audit, tax or other services. Pursuant to the Pre-Approval Policy, the Audit Committee is required to pre-approve the audit services and permissible non-audit services proposed to be performed by the independent auditor for the registrant to assure that the independence of the auditor is not in any way compromised or impaired. In assessing whether a particular audit or non-audit service should be approved, the Audit Committee will take into account the ratio between the total amounts paid for audit, audit-related, tax and other services, based on historical patterns, with a view toward assuring that the level of fees paid for non-audit services as they relate to the fees paid for audit services does not compromise or impair the independence of the auditor. The Audit Committee may either grant general pre-approval of proposed services of the independent auditor through adoption of a list of authorized services together with a budget of expected costs for those services (“general pre-approval”), or specific pre-approval of services provided on a case-by-case basis (“specific pre-approval”). Unless particular services have received general pre-approval, those services will require specific pre-approval by the Audit Committee before any such services can be provided by the independent auditor. The annual audit services engagement terms and fees for the independent auditor for the registrant require specific pre-approval of the Audit Committee. The Audit Committee may grant general pre-approval for (i) other audit services, which are those services that only the independent auditor reasonably can provide, (ii) audit related services, (iii) those tax services that have historically been provided by the independent auditor, and (iv) those permissible non-audit services classified as “all other” services that the Audit Committee believes are routine and recurring services. The Audit Committee from time to time may delegate either general or specific pre-approval authority to one or more of its members. Any member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee has not delegated either general or specific pre-approval authority to one or more of its members. |
| | | |
| (e)(2) | The percentage of services described in each of paragraphs (b) through (d) of this Item that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X are as follows: |
(b) N/A
(c) 21%
(d) N/A
| (f) | The percentage of hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees was less than fifty percent. |
| (g) | The aggregate non-audit fees billed by the registrant’s accountant for services rendered to the registrant, and rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant for the registrant’s fiscal year ended July 31, 2020 were $0 and for July 31, 2021 were $0. |
| (h) | The registrant’s audit committee of the board of trustees has considered whether the provision of non-audit services that were rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence. |
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
| (a) | The Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1(a) of this form. |
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s board of trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 11. Controls and Procedures.
| (a) | As of a date within 90 days of the filing date of this Form N-CSR, the registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c))) are effective, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)). |
| (b) | There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
| | | |
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) ARK ETF Trust
By (Signature and Title)* /s/ Catherine D. Wood
Catherine D. Wood, Chief Executive Officer and Chief Investment Officer
(principal executive officer)
Date 9/29/2021
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)* /s/ Catherine D. Wood
Catherine D. Wood, Chief Executive Officer and Chief Investment Officer
(principal executive officer)
Date 9/29/2021
By (Signature and Title)* /s/ William C. Cox
William C. Cox, Treasurer and Chief Financial Officer
(principal financial officer)
Date 9/29/2021
* Print the name and title of each signing officer under his or her signature.
![[MISSING IMAGE: lg_arketfnew-bw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/lg_arketfnew-bw.jpg)
![[MISSING IMAGE: ark_cov-bkg.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/ark_cov-bkg.jpg)
![[MISSING IMAGE: sg_cathie-wood.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/sg_cathie-wood.jpg){kind=small}
![[MISSING IMAGE: tm2123948d1-lc_arkgbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkgbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_arkqbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkqbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_arkkbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkkbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_arkwbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkwbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_arkfbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkfbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_arkxbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_arkxbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_prntbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_prntbw.jpg)
![[MISSING IMAGE: tm2123948d1-lc_izrlbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-lc_izrlbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkgbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkgbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkqbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkqbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkkbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkkbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkwbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkwbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkfbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkfbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_arkxbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_arkxbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_prntbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_prntbw.jpg)
![[MISSING IMAGE: tm2123948d1-pc_izrlbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2123948d1-pc_izrlbw.jpg)
![[MISSING IMAGE: tm2029505d1-lthd_taitbw.jpg]](https://capedgeqa.com/proxy/N-CSR/0001104659-21-120796/tm2029505d1-lthd_taitbw.jpg)